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Abstract 
Yersiniosis is an acute or chronic enteric zoonosis caused by enteropathogenic 
Yersinia species. Although yersiniosis is predominantly associated with 
gastroenteric forms of infection, extraintestinal forms are often reported from the 
elderly or patients with predisposing factors. 
Yersiniosis is often reported in countries with cold and mild climates (Northern and 
Central Europe, New Zealand and North of Russian Federation). The Irish Health 
Protection Surveillance Centre (HPSC) currently records only 3-7 notified cases of 
yersiniosis per year. At the same time pathogenic Yersinia enterocolitica is recovered 
from pigs (main source of pathogenic Y. enterocolitica) at the levels similar to that 
observed in Yersinia endemic countries. Introduction of Yersinia selective culture 
procedures may increase Yersinia isolation rates. To establish whether the small 
number of notifications of human disease was an underestimate due to lack of 
specific selective culture for Yersinia we carried out a prospective culture study of 
faecal samples from outpatients with diarrhoea, with additional culture of appendix 
and throat swabs. Higher levels of anti-Yersinia seroprevalence than yersiniosis 
notification rates in endemic countries suggests that most yersiniosis cases are 
unrecognised by culture. Subsequently, in addition to a prospective culture study of 
clinical specimens, we carried out serological screening of Irish blood donors and 
environmental screening of human sewage. Pathogenic Yersinia strains were not 
isolated from 1,189 faeces samples, nor from 297 throat swabs, or 23 appendix 
swabs. This suggested that current low notification rates in Ireland are not due to 
the lack of specific Yersinia culture procedures. Molecular screening detected a 
wider variety of Y. enterocolitica-specific targets in pig slurry than in human sewage. 
A serological survey for antibodies against Yersinia YOP (Yersinia Outer Proteins) 
proteins in Irish blood donors found antibodies in 25%, with an age-related trend to 
increased seropositivity, compatible with the hypothesis that yersiniosis may have 
been more prevalent in Ireland in the recent past. 
Y. enterocolitica is a heterogeneous group of microorganisms that comprises strains 
with different degree of pathogenicity. Although non-pathogenic Y. enterocolitica 
lack conventional virulence factors, these strains can be isolated from patients with 
diarrhoea. Insecticidal Toxin Complex (ITC) and Cytolethal Distending Toxins can 
xiv 
 
potentially contribute to the virulence of non-pathogenic Y. enterocolitica in the 
absence of other virulence factors. We compared distribution of ITC and CDT loci 
among pathogenic and non-pathogenic Y. enterocolitica. Additionally, to 
demonstrate potential pathogenicity of non-pathogenic Y. enterocolitica we 
compared their virulence towards Galleria mellonella larvae (a non-mammalian 
model of human bacterial infections) with the virulence of highly and mildly 
pathogenic Y. enterocolitica strains. Surprisingly, virulence of pathogenic and non-
pathogenic Y. enterocolitica in Galleria mellonella larvae observed at 37°C did not 
correlate with their pathogenic potential towards humans. 
Comparative phylogenomic analysis detects predicted coding sequences (CDSs) that 
define host-pathogen interactions and hence providing insights into molecular 
evolution of bacterial virulence. Comparative phylogenomic analysis of microarray 
data generated in Y. enterocolitica strains isolated in the Great Britain from humans 
with diarrhoea and domestic animals revealed high genetic heterogeneity of these 
species. Because of the extensive human, animal and food exchanges between the 
UK and Ireland the objective of this study was to gain further insight into genetic 
heterogeneity and relationships among clinical and non-clinical Y. enterocolitica 
strains of various pathogenic potential isolated in Ireland and Great Britain. No 
evidence of direct transfer of strains between the two countries was found. 
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Chapter 1 Literature Review 
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1.1 Epidemiology 
The genus Yersinia belongs to the family Enterobacteriaceae and comprises 18 species 
[1-7] three of which are pathogenic for humans (Y. pestis, Y. pseudotuberculosis and Y. 
enterocolitica). 
 
Figure 1.1 Neighbour-joining phylogenetic analysis of the Yersinia taxa based on 16S 
rDNA sequences 
The evolutionary history was inferred using the Neighbor-Joining method [8]. The optimal 
tree with the sum of branch length = 0.12756774 is shown. The percentage of replicate trees 
in which the associated taxa clustered together in the bootstrap test (1000 replicates) are 
shown next to the branches [9]. The tree is drawn to scale, with branch lengths in the same 
units as those of the evolutionary distances used to infer the phylogenetic tree. The 
evolutionary distances were computed using the p-distance method [10] and are in the 
units of the number of base differences per site. The analysis involved 19 nucleotide 
sequences. Codon positions included were 1st+2nd+3rd+Noncoding. All positions 
containing gaps and missing data were eliminated. There were a total of 1403 positions in 
the final dataset. Evolutionary analyses were conducted in MEGA5 [11]. 
1.1.1 Incidence rates of enteric yersiniosis in humans 
Yersiniosis is an acute or chronic enteric zoonosis caused by infection with 
enteropathogenic Yersinia species. The mean annual incidence rate of enteric 
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yersiniosis notified from 2006-8 inclusive in European Union countries was 
2.65/100,000, with the highest incidence rates reported from Northern and Central 
European countries such as Finland (12.03/100,000), Sweden (6.1/100,000), Germany 
(5.9/100,000), Czech Republic (5.4/100,000) and Denmark (5.0/100,000). Yersiniosis 
was generally not reported from Southern European countries [12]. Over the same 
period, the highest incidences of yersiniosis outside the European Union were reported 
in the Arkhangelsk region of the Russian Federation (16.5/100,000) 
(www.epinorth.org) and New Zealand (12.0/100,000) [13]. In Ireland the annual 
incidence rate of yersiniosis notified during this period was the lowest in Europe, and 
did not exceed 10 cases per year (≤0.1 per 100,000 population) [12]. 
Most yersiniosis cases are sporadic [14-17] but outbreaks of Y. pseudotuberculosis [18, 
19] and Y. enterocolitica [20-29] involving food have been reported worldwide (Table 
1.1). 
Table 1.1 Outbreaks of Y. pseudotuberculosis and Y. enterocolitica infections 
Microorganism Source Country Year Ref 
Y. pseudotuberculosis ND Finland 1981-1982* [30] 
Y. pseudotuberculosis Iceberg lettuce Finland 1998 [18] 
Y. pseudotuberculosis ND Finland 2001 [31] 
Y. pseudotuberculosis Grated carrots Finland 2003 [32] 
Y. pseudotuberculosis Grated carrots Finland 2006 [19] 
Y. enterocolitica Chocolate milk USA 1976 [27] 
Y. enterocolitica Food handler USA 1981 [24] 
Y. enterocolitica ND Canada 1981 [33] 
Y. enterocolitica Tofu USA 1981-1982* [34] 
Y. enterocolitica Pasteurized Milk USA 1982 [26] 
Y. enterocolitica Pork USA 1988 [28] 
Y. enterocolitica Pasteurized milk USA 1995 [20] 
Y. enterocolitica Canteen salad Japan 2004 [25] 
Y. enterocolitica Pork Norway 2005-2006** [21] 
Y. enterocolitica ND Croatia 2006 [35] 
Y. enterocolitica ND Japan 2006 [36] 
Y. enterocolitica Salad mix Norway 2011 [23] 
ND - source of the epidemic is not determined 
*   Late 1981 –:Early 1982 
** Late 2005 – Early 2006 
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1.1.2 Risk factors and transmission of enteropathogenic Yersinia 
Y. enterocolitica and Y. pseudotuberculosis can be isolated from a wide range of wild 
birds [37-41], rodents [42-46], and domestic animals [45, 47-59] (Table 1.2). 
Table 1.2 Isolation of Yersinia species from faeces of various animals 
Animal Country 
Number of positive 
specimens Microorganism Ref 
Faeces Tonsils 
Wild Birds Japan 4.1% - Y. pseudotuberculosis* [40] 
Wild Birds Japan 0.8% - Y. pseudotuberculosis* [41] 
Wild Birds Japan 4.8% - Y. enterocolitica* [39] 
Wild Birds Norway 5.3% - Y. enterocolitica* [37] 
Rodents Japan 28.9% - Y. enterocolitica* [46] 
Rodents Sweden 5%** - Y. enterocolitica [45] 
Rodents Japan 32.1% - Y. enterocolitica* [42] 
Rodents USA 12.5% - Y. enterocolitica* [54] 
Goats Germany 3% - Y. enterocolitica: 
1A -100%  
[52] 
Goats China 8.7% - Y. enterocolitica: 
1A – 80% 
BT2 – 2.5% 
BT3 – 16.3% 
BT5 – 1.3% 
[53] 
Dogs China 6.7% - Y. enterocolitica: 
1A – 74% 
BT2 – 6% 
BT3 – 20% 
[53] 
Dogs Japan 19.8% - Y. enterocolitica: 
1A – 79.7% 
BT2 – 2.9% 
BT3 – 2.9% 
BT4 – 14.5% 
[49] 
Dogs Japan 6.3% - Y. pseudotuberculosis* [49] 
Dogs Italy 30.2% 
 
 
5.3% 
5.3% 
- Y. enterocolitica: 
1A – 10.5% 
BT4 – 78.9% 
Y. fredriksenii 
Y. intermedia 
[47] 
Dogs USA 3.4% - Y. enterocolitica* [54] 
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Animal Country 
Number of positive 
specimens Microorganism Ref 
Faeces Tonsils 
Cattle USA 6% - Y. enterocolitica* [54] 
Cattle UK 6.3% - Y. enterocolitica: 
3/O:5, 27- 3.5% 
1A – 96.5% 
[50] 
Cattle UK 4.5% - Y. enterocolitica: 
1A – 100% 
[51] 
Cattle China 5% - Y. enterocolitica: 
1A – 87% 
BT2 – 4.3% 
BT3 – 8.7% 
[53] 
Sheep UK 10.7% - Y. enterocolitica: 
3/O:5, 27- 38% 
1A – 62% 
[50] 
Sheep UK 8% - Y. enterocolitica: 
1A – 61% 
BT3 – 39% 
[51] 
Pigs USA 12% - Y. enterocolitica* [54] 
Pigs Japan - 24.3% Y. enterocolitica* [55] 
Pigs UK 29.1% 
 
 
 
 
8% 
1.1% 
1.6% 
- Y. enterocolitica: 
3/O:5, 27- 22% 
3/O:9 – 11% 
4/O:3 – 5% 
1A – 53.4% 
Y. frederiksenii 
Y.rohdei 
Y.intermediae 
[50] 
Pigs UK 10.2% - Y. enterocolitica: 
1A – 50% 
BT2 – 1% 
BT3 – 40% 
BT4 – 9% 
[51] 
Pigs China 11.3% - Y. enterocolitica: 
BT1A – 83.5% 
BT2 – 5.8% 
BT3 – 8.7% 
BT4 – 1% 
BT5 – 1% 
[53] 
Pigs Germany 16% 62% Y. enterocolitica [56] 
 20 
 
Animal Country 
Number of positive 
specimens Microorganism Ref 
Faeces Tonsils 
Pigs Belgium - 37.4% Y. enterocolitica [57] 
Pigs USA 22.1% 
46.8%** 
- Y. enterocolitica [58] 
Pigs Switzerland 88%** 34% Y. enterocolitica [59] 
Pigs Sweden 18%** - Y. enterocolitica [45] 
* Pathogenicity is unknown 
** Pathogenic Yersinia specific PCR detection 
Pulse Field Gel Electrophoresis (PFGE) and Enterobacterial Repeatetive Intergenic 
Consensus Polymerase Chain Reaction (ERIC-PCR) DNA profiling of pathogenic Y. 
enterocolitica isolates obtained from symptomatic patients and pigs has demonstrated 
an epidemiological link between yersiniosis in humans and pigs [60-62]. Consumption 
of contaminated pig products is a significant risk factor associated with sporadic cases 
of yersiniosis [16, 63-66] and has been linked to Y. enterocolitica gastroenteritis 
outbreaks among young children in several states of the USA [22, 28, 67] and a recent 
outbreak of yersiniosis in Norway [21]. Contamination of pig meat with pathogenic Y. 
enterocolitica occurs mainly during lairage and originates from pig tonsils as well as 
faecal material [68-72]. 
Contact with domestic animals is also linked to yersiniosis in humans [13, 14, 53, 73]. 
PFGE profiles of Y. enterocolitica strains isolated from pork, pigs, dogs and humans 
share similar patterns, hence transmission of pathogenic Yersinia to pets could also be 
due to consumption of contaminated pork [53, 73]. 
It has been suggetsted tha rodents may be possible vectors of pathogenic Yersinia 
transmission to pigs [45, 72] and in some cases directly to humans [41, 42]. Migratory 
birds [37, 38] as well as flies [74] could also become carriers of Yersinia through 
environmental faecal contamination and consequently transport bacteria over large 
distances. Drinking untreated water is a risk factor for yersiniosis in humans, 
contamination of which presumably linked to the prevalence of pathogenic Yersinia in 
animal faeces [13, 16, 65, 75-77]. 
 21 
 
1.2 Isolation and characterization of Y. enterocolitica and Y. 
pseudotuberculosis 
Isolation of pathogenic Yersinia spp. from stool specimens may require selection for 
Yersinia spp. in the presence of other background microflora. Thus, introduction of 
Yersinia selective procedures for faecal specimens screening may significantly increase 
Yersinia isolation rates [17, 78-80]. 
1.2.1 Yersinia selective enrichment procedures 
Proliferation of Y. enterocolitica at higher temperatures (32°C) can be inhibited by 
other faster growing gram-negative bacteria as a result of metabolic crowding [81]. 
However, lowering the incubation temperature to 15°C equalizes growth rates of Y. 
enterocolitica and other bacteria, and consequently eliminates such antagonism [81]. 
The mechanism underlying cold enrichment is presumably linked to the greater ability 
of Yersinia to grow at lower temperatures in comparison to other enteric bacteria [82, 
83]. 
Cold enrichment of specimens at refrigerated temperatures (2-8°C) for three weeks is 
an efficient procedure for isolation of Yersinia spp. from food [84, 85] and human stool 
samples especially when routine culture procedures fail to isolate Yersinia spp. [82, 86]. 
Phosphate Buffered Saline (PBS) is the most frequently used medium for the cold 
enrichment of clinical [17, 54, 82, 87-92] and non-clinical [50, 54] samples. Cold 
enrichment in PBS supplemented with 1% sorbitol and 0.15% bile salts gave better 
results for Yersinia isolation than cold enrichment in PBS alone [93] and currently PBS-
Sorbitol-Bile Salts broth is recommended by ISO10723:2003 [94] for the detection of 
pathogenic Y. enterocolitica in food. 
Cold enrichment may sometimes enhance recovery of pathogenic Y. enterocolitica from 
stool samples obtained from asymptomatic carriers or convalescing patients [87]. 
However, in most cases non-pathogenic Yersinia species are isolated from stool samples 
after cold enrichment [17, 78, 82, 86-89, 95]. A possible explanation for common 
isolation of non-pathogenic Yersinia biovars is that they produce bacteriocin-like 
substances that are active against pathogenic Y. enterocolitica biotypes [96]. Over 60 
percent (61.7%) of clinical Yersinia strains were susceptible to the bacteriocins 
produced by three bacteriocin producing non-pathogenic Y. enterocolitica strains [97]. 
Use of modified Salmonella selective Rappaport broth (MRB) (contains increased 
concentration of magnesium chlorate, decreased concentration of malachite green and 
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added carbenicillin) increased recovery of pathogenic Y. enterocolitica from stool 
samples [88, 98] and food products [99] in comparison to cold enrichment. MRB was 
excellent for recovery of Y. enterocolitica serotypes O:3 and O:9 but was not efficient for 
recovery of serotype O:8 [99-101]. Bile Oxalate Sorbose (BOS) broth used as part of 
two-step enrichment procedure was superior to MRB in the second step of enrichment 
for the isolation of pathogenic Y. enterocolitica O:8 serotype [101]. Further modification 
of MRB by the addition of irgazan, ticarcillin and potassium chlorate produced a  new 
enrichment broth ITC (Irgazan Ticarcillin potassium Chlorate) with increased 
selectivity for Yersinia [102]. However, isolation of Y. enterocolitica serotype O:9 from 
artificially contaminated minced pork was poor in comparison to recovery of serotype 
O:3 with ITC [103]. 
A combination of short enrichment of diarrhoeal stool samples at 16°C in the alkaline 
(pH 8.4 ± 0.1) Yersinia selective broth that contains 2% D-sorbitol, 0.15% bile salts and 
Yersinia selective supplement (Cefsulodin-Irgazan-Novobiocin) and subsequent 
inoculation onto Cefsulodin Irgazan Novobiocin (CIN) agar (YSE-CIN method) 
significantly increased isolation of pathogenic Y. enterocolitica from diarrhoeal stool 
samples in comparison to traditional culture methods used for Yersinia isolation [79]. 
1.2.2 Alkali treatment 
Y. enterocolitica and Y. pseudotuberculosis survive treatment with dilute alkali (O.5% 
KOH) which rapidly inactivates other Enterobacteriaceae [104]. Treatment of 
diarrhoeal stool samples [105], food [104, 106-108] and water [109] with dilute alkali 
(O.5% KOH) may eliminate competing microflora without prolonged cold enrichment 
and facilitate better isolation of pathogenic Yersinia. However, alkali treatment of 
experimentally inoculated stool samples did not consistently suppress other enteric 
microflora [110] and failed to increase the isolation rate of pathogenic Yersinia from 
clinical diarrhoeal stool samples [111]. External factors (peptones, bile salts, pH, 
bacterial growth phase, and temperature) influence alkalotolerance of Yersinia and 
therefore the reproducibility of alkali treatment [112]. Additionally, variable 
alkotolerance in different Y. enterocolitica [107, 108, 112], and Y. pseudotuberculosis 
[109] strains was detected. 
1.2.3 Yersinia selective agar medium 
Pathogenic Yersinia species can be isolated from stool samples using standard enteric 
media such as MacConkey (MAC) and Salmonella-Shigella (SS) agar [17, 87, 88, 113, 
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114]. SS agar is more selective for isolation of pathogenic Y. enterocolitica than MAC 
agar [88], however, neither MAC nor SS is very differential for Yersinia spp compared to 
other enterobacteria [114, 115]. In addition, not all Yersinia species can grow on SS agar 
[114, 116]. Cellobiose-Arginine-Lysine (CAL) [117] and Arabinose-Arginine-Lysine 
(DYS) agars [118] exploited the ability of Yersinia to ferment cellobiose and arabinose, 
and inability to utilize arginine or lysine in comparison with other enteric 
microorganisms [117, 118]. Yersinia resistance to deoxycholate in comparison to other 
enteric microorganisms was employed in the development of deoxycholate Salmonella-
Shigella (d-SS) agar [98] and YM (deoxycholate-citrate-D-mannitol) agar [119]. 
 
    
 
 
Figure 1.2 Y. enterocolitica colony morphology on CIN and MAC agar plates(adapted 
from www.fda.gov) 
 
 
Figure 1.3 Yersinia species on CIN agar (adapted from Hallanvuo et al [120]) 
Differentiating between Y. enterocolitica, Y. bercovieri, and Y. mollaretii on CIN agar 
(incubation at 30°C, 22 to 24 h) through a stereomicroscope (black bar, 1 mm). 
(a) Y. enterocolitica 4/O:3 (approximately <1 mm in diameter), typical bull's eye appereance 
(b) Y. enterocolitica BT 1A (approximately 2 mm in diameter) 
(c) Y. bercovieri (approximately 1.5 mm in diameter) 
(d and e) Y. mollaretii (approximately 1.5 mm in diameter); two types exist: mucoid, with a 
smoother and more convex appearance (d) and a flat, dry, more irregular- and erose-edged 
colony (e) 
(f) Y. enterocolitica O:5,27 (pathogenic serotype) (approximately 1 to 1.5 mm in diameter). 
A.  CIN agar B.  MAC agar 
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Cefsulodin Irgazan Novobiocin (CIN) agar containing sodium deoxycholate and sodium 
cholate, crystal violet and mannitol with a neutral red indicator was shown to be 
superior to MAC and SS agar media for selection and differentiation of Y. enterocolitica 
[114, 115] but not Y. pseudotuberculosis [55, 121] from other background microflora. 
Thus, CIN medium is comparable to blood agar for the recovery of Y. enterocolitica and 
the colony morphology of Y. enterocolitica on CIN agar is more distinctive when 
compared with the colony morphology on MAC agar plate (Figure 1.2 and 1.3) [114]. 
Additionally, CIN medium is also the most effective in the inhibition of other enteric 
bacteria [114, 115]. It is now the predominant commercially available Yersinia selective 
agar. However, some Y. pseudotuberculosis and Y. entercolitica biotype 3B strains (now 
speciated as Y. bercovieri [122]) are sensitive to cefsulodin 15mg/L but not 4mg/L 
[121]. Two formulations of the CIN agar are available commercially: BD™ Diagnostics, 
USA CIN formulation has cefsulodin concentration of 4mg/L and Oxoid Ltd., UK 
formulation has cefsulodin concentration of 15mg/L. Another minor weakness of CIN 
agar is that colony morphology of Citrobacter freundii, Serratia liquefaciens, Serratia 
marcescens, Serratia fonticola, Enterobacter agglomerans and Morganella morganii can 
resemble that of Yersinia species [114, 115, 123]. 
Efforts at producing an improved Yersinia selective agar continue with KV202 agar 
[84], chromogenic Yersinia selective agar (YeCM) [124] and VYE agar (virulent Y. 
enterocolitica agar) [125]. YeCM agar media allows differentiation of pathogenic Y. 
enterocolitica from non-pathogenic Yersinia species, however, it does not differentiate Y. 
pseudotuberculosis from other enteric microorganisms [124]. VYE, can differentiate 
pathogenic Y. enterocolitica from non-pathogenic Yersinia but it is also like YeCM, 
deficient in recovery of Y. pseudotuberculosis [125]. 
1.2.4 Biochemical identification of enteropathogenic Yersinia species 
Yersinia species are biochemically more active at 25-30°C than at 35-37°C [126, 127]. 
Several commercial biochemical test systems for the identification of 
Enterobacteriaceae have been evaluated for their ability to correctly assign a reference 
[128, 129] and clinical [129-132] panel of enteric Yersinia species strains previously 
identified by conventional biochemical reference methods to genus and species levels 
(Table 1.3). 
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Table 1.3 Performance of commercial identification systems 
Kit Manufacturer Incubation 
Genus level 
assignment 
Correct Species 
assignment 
Reference ID 
methods 
Ref 
API 20E BioMérieux, France 28°C, 18-24h ND 93% Bercovier 
biochemical tests 
[130] 
API 20E BioMérieux, France 28°C, 18-24 h ND 90% Ewing biochemical 
tests 
[131] 
API 20E BioMérieux, France 28°C, 18-24h 91% 79% ND [128] 
API Rapid ID 32E BioMérieux, France 37°C, 5h 86% 42% ND [128] 
Vitek GNI Card BioMérieux, France 37°C, 24h 96.3% 57.4% Bockemühl 
biochemical tests 
[129] 
BBL Crystal E/NF BD Diagnostics, USA 37°C, 24h 83.3% ND* CDC reference 
methods 
[132] 
Micronaut E Merlin Diagnostika GmbH, 
Germany 
37°C, 24h 92% 72% ND [128] 
*BBL Crystal E/NF identifies Yersinia species as Y. enterocolitica group (BBL Crystal E/NF package insert) 
ND :Not Determined 
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Incubation of API 20E strips at 28°C resulted in a higher percentage of correct 
identifications than at 37°C (Table 1.7) [128, 130, 131]. Excluding Voges-Proskauer 
(VP) reactions from scoring increased the percentage of correct Yersinia species 
identifications with the API20E [128, 130]. A high percentage (70-83%) of Y. intermedia 
strains are misidentified with the API 20E identification system [128, 131] because of 
slow or unreliable fermentation of rhamnose and melibiose. 
API Rapid ID 32E strips incubated at 37°C for 5h could not identify most non-
pathogenic Yersinia to species level, again because of weak metabolic activity [128]. 
Sensitivity of Micronaut E system for the identification of Yersinia is comparable with 
the API 20E at genus and species level [128]. 
1.2.5 Biotyping of Y. enterocolitica 
Currently six biovars of Y. enterocolitica are recognised: 1A, 1B and 2-5. Biotype of Y. 
enterocolitica correlates with the pathogenic potential of the organism: biotype 1A 
strains are traditionally considered as non-pathogenic, biotype 1B strains (so-called 
“American strains”) as highly pathogenic in animal models and moderately pathogenic 
strains placed into biotypes 2-5 (Table 1.4) [133]. 
Table 1.4 Wauters Y. enterocolitica biotyping scheme 
Tests 
Biotypes 
1A 1B 2 3 4 5 6 
Lipase (Tween-esterase) + + - - - - - 
Voges-Proskauer + + + + + (+) - 
Indole + + (+) - - - - 
Aesculin + - - - - - - 
Salicin + - - - - - - 
Xylose + + + + - V + 
Trehalose + + + + + - + 
Pyrazinamidase + - - - - - + 
Proline peptidase V - - - - - + 
β-D-Glucosidase + - - - - - - 
(+) :Delayed reaction; 
V  :Variable reaction 
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1.2.6 Biotyping of Y. pseudotuberculosis 
Y. pseudotuberculosis can be divided into 4 biovars by utilization of melibiose, citrate 
and raffinose (Table 1.5) [134]. 
Table 1.5 Y. pseudotuberculosis biotyping scheme 
Tests 
Biotypes 
1 2 3 4 
Melibiose + - - + 
Citrate - - + - 
Raffinose - - - + 
Melibiose-fermenting and melibiose non-fermenting Y. pseudotuberculosis respectively 
were shown to be virulent and avirulent, respectively, in intraperitoneally inoculated 
mice [135] and guinea pigs [136]. However, melibiose non-fermenting Y. 
pseudotuberculosis are able to cause mild infections in humans [137]. 
1.2.7 Serotyping of Y. enterocolitica and Y. pseudotuberculosis 
Seventy six O- and forty four H-antigens have been described for Y. enterocolitica [138]. 
Several O-antigens (O:3, O:8, O:9 and O:13) typical for pathogenic Y. enterocolitica are 
also shared with non-pathogenic Y. enterocolitica and Y. enterocolitica-like strains, but 
H antigens are always species-specific [138, 139]. 
Based on a combination of 26 O- and 5 H-antigens, the Y. pseudotuberculosis antigenic 
scheme comprises 14 O serogroups of which serogroups O:1 and O:2, and O:4 and O:5 
are divided into three (a, b, c) and two (a, b) subgroups respectively [134]. As with Y. 
enterocolitica, O antigens of Y. pseudotuberculosis can be shared with other 
Enterobacteriaceae while the H antigens are species-specific [134]. 
1.3 Molecular detection and characterization of Yersinia 
1.3.1 Molecular detection of pathogenic Yersinia species 
Culture methods for pathogenic Yersinia have various disadvantages. They have a 
sensitivity threshold of ≥103 CFU/ml [140], cannot select out pathogenic rather than 
non-pathogenic Yersinia species [70, 101], and are particularly poor at detecting Y. 
pseudotuberculosis in diarrhoeal stool samples [121, 141]. Moreover, bacteriocins 
secreted by non-pathogenic Yersinia species may be active against pathogenic Yersinia 
[96, 97, 142, 143] and prevent isolation of pathogenic Yersinia species from 
environmental samples such as soil and sewage [144-146] when they are in fact 
present. 
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PCR amplification is more sensitive in detection of pathogenic Y. enterocolitica and Y. 
pseudotuberculosis present in low numbers than bacteriological culture methods (Table 
1.6) and subsequently detection rates of pathogenic Yersinia are higher after 
application of PCR amplification in comparison to culture methods (Table 1.7). 
Table 1.6 Sensitivity of PCR methods in Y. enterocolitica and Y. pseudotuberculosis 
spiked environmental samples 
Source PCR Method 
Target 
gene 
Target 
m.o. 
Pre-PCR 
sample 
enrichment 
Sensitivity Ref 
Environmental 
water 
Simple ail YE - 60 CFU/ml [145] 
Environmental 
water 
Nested yadA YE TSBY, 
overnight, RT  
8 - 17 
CFU/100ml 
[147] 
Environmental 
water 
Nested yadA YE TSBY, 3h, RT 10 – 30 
CFU/100ml 
[148] 
Meat Nested yadA YE - 10 – 30 
CFU/gl 
[148] 
Meat Nested yadA YE TSBY, 
overnight, RT 
2 CFU/g [148] 
ITC broth Fluorogenic – 5’ 
nuclease 
ail YE - 10 CFU/ml* [149] 
Swine Faces Fluorogenic – 5’ 
nuclease 
ail YE ITC, RT, 12h, ≤1 CFU/g [149] 
Ground Pork Fluorogenic – 5’ 
nuclease 
ail YE ITC, RT, 12h, ≤1 CFU/g [149] 
Ground Pork TaqMan ystA YE PSBB, 35°C, 
12h 
>10 CFU/g [150] 
Carrots Real-Time PCR ail YP TSBY, 25°C, 18 
– 20h 
2.8 CFU/g [151] 
Ground Beef Real-Time PCR ail YP TSBY, 25°C, 18 
– 20h 
28 CFU/g [151] 
Carrots Real-Time PCR ail YP TSBY, 25°C, 18 
– 20h 
28 CFU/g** [151] 
Ground Beef Real-Time PCR ail YP TSBY, 25°C, 18 
– 20h 
2.8 CFU/g** [151] 
m.o.  :microorganism 
YE  :Y. enterocolitica 
YP  :Y. pseudotuberculosis 
RT :Room Temperature 
ITC :Irgazan Ticarcilin Chlorate broth 
PSBB :Peptone Sorbitol Bile broth 
TSBY  :Tryptone Soy broth supplementd with 
0.6% of yeast extract 
* Detection limit in the presence of 108 CFU/ml of 
background microflora 
** Detection limit in the presence of pathogenic Y. 
enterocolitica 
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Table 1.7 Comparison of the yield of bacteriological culture and PCR assays in 
detection of pathogenic Y. enterocolitica 
Source 
Culture 
Isolation rates 
Culture 
methods 
PCR  
Detection rates 
Target 
gene 
PCR 
method 
Ref 
Pig Faeces 22.1% ITC, 25°C, 
48h + CIN 
46.8% YE ail Real-
Time-PCR 
[58] 
Pig Tonsils 25% ITC, 25°C, 
48h + CIN 
88% YE ail Real-
Time-PCR 
[59] 
Human Faeces 6.2% YSE, 16°C, 
48h + CIN 
7.23% YE ystA Real-
Time-PCR 
[65] 
Environmental 
Water 
0% m-YE, 
25°C, 48h 
+ BABY-4 
4.6% ail PCR [145] 
YE  :Y. enterocolitica 
ITC :Irgazan Ticarcilin Chlorate broth 
m-YE :modified Yersinia enrichment broth 
BABY-Y  :Yersinia selective agar 
1.3.2 Molecular identification of Yersinia species 
Although API 20E is the current biochemical identification system recommended for 
the identification of Yersinia species [128], only Y. enterocolitica, Y. pseudotuberculosis, 
Y. kristensenii and Y. fredriksenii/intermedia identification profiles exist in the API 20E 
database. Moreover, only 17-30% of non-pathogenic Y. intermedia strains were 
correctly identified with API 20E strips incubated at 28°C [128, 131]. Sequencing of the 
Yersinia 16S rRNA gene and biochemical identification with API 20E in some cases are 
conflicting (Table 1.8) [3, 4, 120]. Thus, while API 20E strips identified nine Yersinia 
species strains as Y. enterocolitica with >90% confidence, 16S rDNA sequencing 
confirmed only one strain as Y. enterocolitica (Table 1.8) [120]. Additionally, 16S rRNA 
gene sequencing has contributed to the proposal of two new Yersinia species – Y. 
aleksiciae sp. nov. [4] and Y. similis sp. nov.[3] (Table 1.8), that were identified by API 
20E as Y. kristensenii [4] and Y. pseudotuberculosis [3], respectively. 
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Table 1.8 Comparison of API20E identification and 16S rDNA sequencing 
API 20E 
Profile 
API 20E ID  
16S rDNA 
sequencing 
Length of 
sequence 
Ref 
1114523  Y. enterocolitica (99.7%) Y. mollaretii  P [120] 
1014763  Y. enterocolitica (53%) Y. rohdei P [120] 
1114523  Y. enterocolitica (99.7%) Y. mollaretii P [120] 
0114523  Y. enterocolitica (99.9%) Y. bercovieri P [120] 
1114523  Y. enterocolitica (99.7%) Y. bercovieri P [120] 
1014522  Y. enterocolitica (93.9%) Y. mollaretii P [120] 
1114703 Y. enterocolitica (26.2%) 
Y. kristensenii (73.5%) 
Y. bercovieri P [120] 
0114523  Y. enterocolitica (99.9%) Y. bercovieri P [120] 
0014523  Y. enterocolitica (97.7%) Y. bercovieri P [120] 
1014522  Y. enterocolitica (93.9%) Y. mollaretii P [120] 
0154723  Y. enterocolitica (99.2%) Y. enterocolitica P [120] 
1014122  Y. enterocolitica (13.8%) 
Pantoea spp. (80.8%) 
Y. mollaretii P [120] 
1114703  Y. kristensenii (73.5%) Y. aleksiciae sp. 
nov. 
F [4] 
NG Y. pseudotuberculosis** Y. similis sp. nov. F [3] 
NG Y. pseudotuberculosis** Y. similis sp. nov. F [3] 
NG Y. pseudotuberculosis** Y. similis sp. nov. F [3] 
**Phenotyped by German Yersinia Reference Center, Hamburg [3] 
NG  :information not given 
P  :partial sequence 
F  :Full length sequence 
Comparison of 16S rDNA sequencing data for the type strains of eleven Yersinia species 
showed a range in interspecies similarity of 97.4 to 99.9%. Y. pseudotuberculosis and Y. 
pestis 16SrDNA sequences showed 99.9% similarity making them virtually 
indistinguishable [152]. As more 16S rDNA sequences have become available, it has 
been realised that the resolution of 16S rDNA sequence analysis is sufficient for 
differentiating distantly related Yersinia species, but insufficient to describe 
relationships of some species. Variability in gyrB gene sequences (encoding subunit B 
of DNA gyrase) is sufficient for discrimination of closely related Enterobacteriaceae 
genomo species [153]. Sequencing of gyrB allowed better discrimination of Y. 
frederiksenii [154] and Y. enterocolitica biovar 1A [155] in comparison to 16S rDNA 
sequencing, and has been successfuly combined with 16S rDNA sequences in 
establishing phylogenetic relationships within the genus Yersinia [156]. Sequencing of 
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the 16S rRNA gene from Yersinia strains 50640 and 823 isolated from fresh water in 
Marseille, France, revealed 1.3% divergence with 16S rRNA gene sequences of Y. 
bercovieri, 1.5% with that of Y.mollaretii and 1.6% with that of Y.frederiksenii. However, 
additional sequencing of four housekeeping genes hsp60, sodA, gyrB and rpoB, helped 
assign isolates 50640 and 823 to a novel Yersinia species – Y. massiliensis [2]. Multi 
locus sequence typing (MLST) has also been useful in uncovering phylogenetic 
relationships in Yersinia (see below). 
Y. enterocolitica strains of American (highly pathogenic biotype 1B) and of European 
(non-pathogenic bitype 1A and low pathogenic biotypes 2, 3, 4 and 5) origin 
demonstrate variability of 16S rRNA gene between 451nt and 480nt (Figure 1.4) [157, 
158]. Characteristic and distinct 16S rRNA sequences in type strains of American (ATCC 
9610 :GenBank/EMBL M59292) and European (Y11 DSMZ13030:GenBank/EMBL 
U63135) phenotype [158] allowed the description of two Y. enterocolitica subspecies. Y. 
enterocolitica subsp. enterocolitica are the highly pathogenic biotype 1B strains, and Y. 
enterocolitica subsp. palearctica are the non-pathogenic and low pathogenic biotypes 
1A, 2, 3, 4 and 5 [158]. 
 
Figure 1.4 BLASTN 2.2.18 alignment results for variable locus of 16S rRNA gene of 
Y.enterocolitica subsp. palearctica (U63135) and Y.enterocolitica subsp. 
enterocolitica (U59292) 
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1.4 Clinical manifestations of yersiniosis 
1.4.1 Gastrointestinal manifestations of yersiniosis 
Y. enterocolitica and Y. pseudotuberculosis infections mainly involve the gastrointestinal 
tract [17, 63, 65, 92, 159] and are usually manifest as acute enteritis [92, 160, 161]. 
Mild or even asymptomatic infections may also occur [17, 162-173]. Yersinia 
gastroenteritis incidence is highest in young children [13, 17, 65, 80, 92, 161]. There is 
one report of an increased incidence of enteric yersiniosis for adults over 60 years of 
age compared with adults under the age of 60 [65]. 
Diarrhoea and abdominal pain are the most common symptoms reported by the 
patients with Y. enterocolitica infections [63, 80, 92]. On the other hand, symptoms of Y. 
pseudotuberculosis enteric infection include abdominal pain without diarrhoea [18, 19, 
30, 32, 174-176]. Although diarrhoea due to Y. enterocolitica infection is reported in all 
age groups [63, 65, 80, 92, 161], abdominal pain is more often reported by adolescent 
and adults than younger children [65, 92, 160]. Other symptoms such as vomiting and 
fever are reported less frequently [65, 92, 161]. 
Patients with abdominal pain due to yersiniosis can be diagnosed with appendicitis [92, 
177-179], however, the surgically removed appendicitis in yersiniosis often appears to 
be non-inflamed [90, 178, 180-184]. Abdominal pain due to Yersinia infection that can 
be misdiagnosed as appendicular syndrome (pseudoappendicitis) usually is a result of 
the inflammation in the mesenteric lymph nodes (mesenteric lymphadenitis) or the 
terminal end of the small intestine (terminal ileitis) [160, 178, 180-182, 185-188]. 
Despite this, isolation rates of Yersinia from postoperative appendix swabs (2.7% to 
10%) [90, 183, 189] are often higher than from faeces (0.2% to 6.2%) [65, 78, 91, 190, 
191]. Moreover, molecular evidence with the Yersinia specific yadA probes has been 
obtained, hence pointing on the  possible involvement of Y. enterocolitica and Y. 
pseudotuberculosis in granulomatous appendicitis [186, 187]. However, this form of 
appendicitis is accountable for only a small percentage (0.38%-0.62%) of acute 
appendicitis cases world wide [192-194]. In the 1980s serological evidence 
(agglutinating antibodies) of yersiniosis was seen in 23% of patients presenting with 
acute abdominal pain in Dublin, Ireland in comparison to only 2% of Irish healthy 
control subjects [177]. The ratio of Y. pseudotuberculosis to Y. enterocolitica 
agglutination seropositivity was 5:1 [177]. 
Toxic megacolon due to Y. enterocolitica has been reported in a 17 year old girl. Culture 
did not yield pathogenic Yersinia species, but diagnosis of yersiniosis was made based 
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on the presence of an agglutinating Y. enterocolitica O:3 antibody titre of 2560 three 
weeks after the onset of illness. Combined therapy of corticosteroids and antibiotics 
was successful and in three months Y. enterocolitica antibody titre declined to 80 [195]. 
In Norway, serological evidence of current or recent Yersinia infection was detected in 
9.4% and 15% of patients with Ulcerative Colitis (UC) and Crohn’s Disease (CD), 
respectively [196]. Moreover, molecular evidence of the pathogenic Yersinia was 
detected in intestinal resections from 31% of patients with CD in a study from the USA 
[197]. 
1.4.2 Extraintestinal manifestations of yersiniosis 
Extraintestinal infections with Y. enterocolitica and Y. pseudotuberculosis mainly affect 
mature adults [65, 159, 198-205] and patients with various underlying conditions such 
as iron overload [206-218], immunosuppression [219-221], alcoholism [202, 222] and 
diabetes [210, 223, 224]. 
Yersinia demonstrate tropism to lymphoid tissue [225-228] and Yersinia tonsilar 
carriage is common in other mammals such as pigs [56, 71] and dogs [49, 229]. While 
infection with Y. enterocolitica and Y. pseudotuberculosis mainly involves the 
gastrointestinal tract with acute enteritis [92, 160, 161] and mesenteric lymphadenitis 
(mimicking appendicitis) [92, 177-179], in some outbreaks of yersiniosis pharyngitis 
not diarrhoea was a predominant symptom [198, 199]. Clinical manifestations of Y. 
enterocolitica pharyngitis mimic symptoms of streptococcal throat infection, infectious 
mononucleosis or viral pharyngitis and can only be diagnosed on throat swab culture 
[198]. Pneumonia due to Y. enterocolitica mainly occurs in patients with weakened 
immune status due to various predisposing factors and often co-manifested with 
enteric symptoms of yersiniosis [203, 221, 223, 230]. 
Multiple liver abscesses due to Y. enterocolitica infection are often reported in patients 
with iron overload and frequently require long term treatment [206-212]. 
Other extraintestinal manifestations of yersiniosis due to Y. enterocolitica include fatal 
cases of meningitis in patients suffering from alcoholism [202] and thalassemia [217], 
systemic Yersinia infections such as septic arthritis [231-233], osteomyelitis [224] were 
reported in patients with various predisposing factors. Transient bacteraemia [165, 
166, 170, 172, 173] or in some cases even septicaemia [234] was described for 
individuals without any underlying conditions and previous gastrointestinal 
yersiniosis. 
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Renal failure in children due to infection with Y. pseudotuberculosis is often reported in 
Japan [175, 235-238] and Korea [239, 240], but less frequently in Europe [241, 242]. 
Epidemics of Y. pseudotuberculosis systemic infection with clinical presentation similar 
to scarlet fever caused by Streptococcus pyogenes were experienced in the Far-Eastern 
region of Russia in the 1950s but were not described anywhere else [243-245]. 
1.4.3 Yersinia and blood transfusion 
Yersinia is a major cause of fatal blood transfusion septicaemia [246, 247]. Thus, 53.8% 
of 26 fatal blood transfusion cases reported to the U.S. FDA during 1976 - 1998 were 
due to Y. enterocolitica [246]. The overall worldwide mortality rate of Y. enterocolitica 
post-transfusion sepsis reported during 1975 – 2007 was 54.5% [247]. 
Most cases of transfusion transmitted Yersinia involves blood units older than 14 – 21 
days [247-249]. Yersinia may be present at undetected levels (<10 CFU/L) in blood 
donated by asymptomatic donors [173, 247-253], however, long-term storage of such 
blood units at 4°C enables Yersinia multiplication [254, 255]. The risk of post-
transfusion Yersinia sepsis is substantially decreased when blood components are 
leucodepleted before their storage [248, 256-259]. 
It has been difficult to devise a serological screening methodology to exclude blood 
donations at risk of Yersinia contamination because of poor predictivity. Thus, 34% of 
patients with recent culture-positive Yersinia infection were IgA and IgG seronegative 
against Yersinia O:3-LPS Ag and no Yersinia was recovered from their blood cultures 
[260]. Likewise, blood donors whose serum contained IgA antibody against Y. 
enterocolitica O:3 YOPs were not bacteraemic and their blood units did not grow 
Yersinia after long-term storage (35 days) at 4°C [261]. 
1.4.4 Post infectious complications 
Patients with persistent enteric Yersinia infection [228, 262, 263] and possessing the 
histocompatibility gene HLA-B27 [264-267] are at particular risk of developing post-
infectious sequelae. Reactive arthritis, erythema nodosum and acute anterior uveitis 
(AAU) are the most common post infectious complications that may develop after 
yersiniosis [204, 268-271]. A study undertaken in 1988 in St. James’s Hospital, Dublin 
which involved patients with AAU without any other underlying conditions 
demonstrated that 24% of them had serological evidence of Yersinia infection and 
additionally were HLA-B27 positive [204]. 
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1.5 Immunology of yersiniosis 
1.5.1 Immune response during Yersinia infection 
During the infective process and recovery, sequential secretion and subsequent 
disappearance of IgM, IgA and IgG class serum antibodies occurs. While IgM and IgA 
class antibodies reach peak levels at early stages of infection, IgG immunoglobulins are 
produced at later stages [272-275]. While young children and immunosuppressed 
patients show low levels of anti-Yersinia antibodies after infection, the serologic 
response to Yersinia gastrointestinal infection among adult and adolescent patients 
with normally functioning immune systems is profound [276]. Additionally, patients 
with extraintestinal systemic foci [276] and patients with persistent presence of 
pathogenic Yersinia in Gut Associated Lymphoid Tissue (GALT) experience extended 
antigenic stimulation [228] leading to a prolonged  immune response. 
1.5.2 Anti-Yersinia seroprevalence 
Anti-Yersinia antibody seroprevalence among healthy individuals is generally much 
higher than incidence rates of yersiniosis in the same population (Table 1.10) [76, 162-
164]. 
Normally, declining levels of anti-YOP and anti-LPS IgA immunoglobulins are detected 
for a few months after yersiniosis [272-275], however, in some patients with reactive 
arthritis, long term persistence of anti-YOP and anti-LPS IgA class antibodies occurs 
[274, 277-279]. Anti-LPS IgG class antibodies were found to be persistant for several 
years in patients after uncomplicated yersiniosis and appendicectomy [76, 179, 280]. 
Additionally, although the relationship between Yersinia infection and thyroid 
disorders is not clear, a high seroprevalence of anti-YOP and anti-LPS IgG antibodies in 
patients with thyroid disorders [281-288] and their relatives [289] has been reported. 
It has been suggested that relatives of patients with thyroid disorders may have a 
genetic predisposition for persistent Yersinia infection [289]. 
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Table 1.9 Anti-Yersinia antibody seroprevalence and incidence rates of yersiniosis 
Country Year 
Human 
population 
Age Range Methods Ag Ab 
Sero 
Prevalence 
Ref 
Yersiniosis 
per 100 000 
Norway 1993 Military 
recruits 
19-26 O3 Ag EIA O-Ag IgG 7.4% [76] 6.45* 
Finland 1997 Blood donors 18-63 (37)* O3 and O9 Ag 
EIA 
Whole cell IgG 10.6% [162] 14.1*5 
Immunoblot pYV 29.8% 
Germany 1997 Blood donors 20-65 (32)* O3 and O9 Ag 
EIA 
Whole cell IgG 24% [162] 8.7*5 
Hungary 1999-2000 Blood donors 39.4 Agglutination O-Ag IgA 2.6% [163] 1.4*5 
Mikrogen 
RecomWell 
pYV 15.1% 
Mikrogen 
RecomLine 
pYV 8% 
Greece 2000 Blood donors 49* Viramed 
ELISA 
pYV IgG 1.94% [283] NR*6 
Austria 2006 Military 
recruits 
19-58 Mikrogen 
RecomWell 
pYV IgG 41% [164] 1.9*6 
Mikrogen 
RecomLine 
pYV 29.7% 
Ireland 1987 Healthy 
individuals 
24.2 (m*2) 
23.3 (f*3) 
Agglutination O-Ag NA*4 2% [177] NA 
Patients with 
abdominal 
pain 
Agglutination O-Ag 23% 
* median age;  *2 male (m);  *3 female (f);  *4NA - Not Available;  *5 Data obtained from EpiNoth (http://www.epinorth.org); 6* Data obtained from European Centre for Disease 
Prevention and Control (http://www.ecdc.europa.eu), NR – Not Reported 
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Agglutinating anti-Yersinia antibodies (anti-O-Ag) quickly disappear after the acute 
phase of infection [276] whilst non-agglutinating antibodies (anti-YOP) have been 
shown to be more sensitive in the serodiagnosis of persistent, chronic or 
convalescent forms of yersiniosis [92, 205, 228, 262, 290, 291]. Western blot and 
ELISA immunoassays (both measuring anti-YOP antibodies) showed high sensitivity 
(95% both assays) and specificity (95% and 74% respectively) [292]. The highest 
levels of anti-Yersinia YOP seroprevalence in healthy individuals were found with an 
IgG ELISA assay (Table 1.11) [292]. 
Table 1.10 Comparison of Yersinia antibodies prevalence in the healthy population 
measured by various techniques (adapted from Rawlins et al [292]) 
Assay Manufacturer 
Antigens used in the 
assay 
Positive sera from healthy 
individuals 
IgG IgA IgM 
CF “In house ” Y. pseudotuberculosis 
and Y. enterocolitica O-
antigens 
2%* 
Western 
Blot 
Viralab Inc. YopH (51 kDa), YopM 
(44 kDa), YopB (41 
kDa), LcrV (37 kDa), 
YopD (35 kDa), YopN 
(33 kDa), YopE (23 kDa) 
6% 2% 2% 
ELISA Mikrogen 
Diagnostik 
YopH (51 kDa), YopM 
(44 kDa), YopB (41 
kDa), LcrV (37 kDa), 
YopD (35 kDa), YopN 
(33 kDa), YopE (23 kDa) 
18% 10% 4% 
* CF  :complement fixation, does not identify class of the immunoglobulin 
A significant cross reactivity in Yersinia ELISA and Western blot YOP assays was 
observed in a panel of sera known to be positive for Borrelia burgdorferi, Bartonella 
henselae, Brucella, Chlamydia pneumoniae and Rickettsia rickettsii antibodies [292]. 
The highest proportion of cross reactive samples were reported for sera known to 
contain anti-Brucella (4 out of 7) and anti-Borrelia burgdorferi (6 out of 11) 
antibodies in ELISA assays using recombinant YOP antigens [292-294]. 
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1.6 Virulence factors of enteropathogenic Yersinia species 
1.6.1 Chromosome encoded virulence factors 
1.6.1.1 Yersinia resistance to stomach acidity 
Gastrointestinal pathogens must withstand stomach acidity before colonising the 
intestinal mucosa [295, 296]. It is believed that urease production by 
enteropathogenic Yersinia species can assist bacteria to overcome stomach acidity 
by catalyzing the hydrolysis of urea to form carbon dioxide and ammonia, leading to 
a pH increase that promotes its survival [297]. 
1.6.1.2 Invasins 
During the next step of the host colonization, enteropathogenic Yersinia degrade 
mucins (glycoproteins of mucus) lining the epithelium of the intestine [298] and 
penetrate the intestinal barrier by passing through M cells associated with Peyer’s 
patches – lymphoid follicles lining the gastrointestinal tract [299-302]. Invasion of 
M-cells is mediated by the chromosomally-encoded invasin protein Inv that is 
exposed on the bacterial cell surface [303]. Inv promotes cell penetration by 
attaching to ß1 heterodimeric integrin receptors located on the apical end of the cell 
membrane of the M cell [301, 304, 305]. 
The Inv protein affinity for lymphoid tissue cells [301, 306, 307] enables 
dissemination of Inv-producing pathogenic Yersinia species via Peyer’s patches 
lining the gastrointestinal tract, while gene knock out of the Inv protein results in 
delayed systemic spread of orally or intraperitoneally inoculated pathogenic Y. 
enterocolitica [306, 308]. Y. pseudotuberculosis Inv mediates transcytosis of 
exogenous particles across the ileal mucosa via ß1-integrin binding [309]. Gene 
sequences similar to inv are detectable in all Y. enterocolitica strains (including non-
pathogens) by gene probe or PCR [310, 311]. However, expression of inv genes was 
not detectable as mRNA in non-pathogenic Y. enterocolitica, and functional 
expression of these inv-like genes was not detectable when cloned in E. coli [310]. 
Expression of the chromosomal Yersinia ail gene in E. coli HB101 [312] was able to 
induce bacterial attachment to, and invasion of, epithelial cells. A similar phenotype 
was conferred by cloning ail in an inv- and ail-deficient Y. enterocolitica 8081c strain 
[313]. While ail is present in pathogenic Y. enterocolitica and Y. pseudotuberculosis 
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strains associated with disease [314], this locus confers a capability for the 
attachment and invasion of host cells by Y. enterocolitica [312, 313], it does not 
contribute the same phenotype to Y. pseudotuberculosis [315]. However, ail does 
mediate short-term serum (complement) resistance [316] in both Y. enterocolitica 
[313, 315] and Y. pseudotuberculosis [315]. 
1.6.1.3 Enterotoxins 
Diarrhoea is usually a result of disturbances in water and electrolyte transport in the 
small or large intestine that may result in dehydration [317]. Production of 
enterotoxin resulting in net fluid secretion is an important virulence factor for many 
enteric pathogens. Y. enterocolitica was shown in 1978 to produce an exotoxin 
detectable in bioassays used for E. coli enterotoxins. Rabbits infected with Y. 
enterocolitica W1024 strain that encoded YstA enterotoxin suffered from diarrhoea 
and weight loss, and most of them died [318]. However, the role of the 71 amino acid 
YstA [319] in diarrhoeal disease remained controversial, due to its maximum 
expression in vitro at 30°C rather than at the body temperature of the mammalian 
host [264], until it was established that ystA gene transcription can be induced at 
37°C by incubation at osmolarity and pH values normally found in the ileal lumen, 
thus supporting the idea that ystA can be expressed in vivo [320]. Gene sequences 
similar to ystA are present in pathogenic Y. enterocolitica and Y. kristensenii strains 
but not in Y. pseudotuberculosis strains [319]. 
A homologue of YstA enterotoxin, YstB, was detected in non-pathogenic strains of Y. 
enterocolitica biovar 1A [311, 321-323]. Expression of ystB in vitro at 37°C only 
occurs when the pH of the culture medium is adjusted to 7.5, similar to that found in 
the ileum [322]. Enterotoxin activity of Y. enterocolitica 1A detected in an infant 
mice assay was not always observed in strains possessing ystB gene (Table 1.12) 
[321, 322]. 
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Table 1.11 Enterotoxin activity of non-pathogenic Y. enterocolitica biovar 1A isolates 
Source ystB+ve Enterotoxin Activity* Ref 
Clinical 87.3% 25.3% [321] 
Clinical 100% 77.7% [322] 
Non-clinical 81.3% 40.6% [321] 
Non-clinical 100% 0% [322] 
Non-clinical 96.3% 62.3% [322] 
* Percentage of Y. enterocolitica biovar 1A strains exhibiting enterotoxin activity in infant mice model 
This discrepancy between the presence of the ystB gene and detectable enterotoxin 
activity could be due to spontaneous mutations in ystB in some strains [321, 322]. 
However, all Y. enterocolitica biovar 1A strains containing ystB belong to the clonal 
group A that harbours potentially pathogenic strains that were differentiated from 
another clonal group based on REP-/ERIC-PCR genotyping [311]. 
1.6.1.4 Myf functionality 
Mucoid Yersinia Factor (Myf) of Y. enterocolitica is a fibrillar surface antigen 
expressed at 37°C in acidic conditions. It resembles the CS3 fimbriae of 
enteropathogenic E. coli, and is similar to the Y. pestis and Y. pseudotuberculosis pH6 
antigen encoded by the psa locus [324]. Myf is encoded by a 4.4kb locus that 
comprises three genes: myfA (encoding the major subunit), and myfB and mufC (both 
encoding the assembly mechanism) [325]. While pH6 antigen is responsible for 
thermoinducible adhesion to HEp-2 epithelial cells and hemagglutination in Y. 
pseudotuberculosis [315] there is no evidence for a similar Myf role in Y. 
enterocolitica adhesion to the host cells [326, 327]. Some non-pathogenic Y. 
enterocolitica biotype 1A strains possess myfA [321]. 
1.6.1.5 Role of Motility in Yersinia virulence 
A connection between motility and Yersinia invasiveness has been suggested in 
various studies because mutations in flhDC [328] and fliA [328, 329] abolished 
efficient bacterial invasion of epithelial cells. Additionally, expression of the inv gene 
is regulated by flagellar genes [328, 330]. It was also shown that the flagellar fliA 
gene is responsible for the inverse temperature regulation of plasmid-encoded 
Yersinia virulence genes (yadA, yomA, yscG, yscM, ISYen1, yopQ, and virF) [331]. 
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The inner and outer-membrane spanning flagella apparatus includes an export 
system for hook and filament components which can export other proteins. YplA is a 
phospholipase A that promotes lecithin-dependant haemolysis [332] and 
contributes to the Yersinia pathogenesis by disrupting host cell membranes [333]. 
The YplA protein is secreted via flagellar type III export system [334]. Expression of 
class II flagellar genes is sufficient as these encode the flagellum basal body and type 
III secretion machinery [333]. Mutations in class I flagellar genes abolish YplA 
secretion as class II flagellar genes expression cannot be activated [333]. 
1.6.1.6 Iron uptake 
Iron is an essential nutrient required for bacterial growth and forms one of the most 
limiting factors for microbial proliferation in the vertebrate host. Iron uptake by 
pathogenic Yersinia allows systemic dissemination of bacteria in animals and 
humans with iron overload [215, 335-340]. Highly pathogenic Y. enterocolitica 
subsp. enterocolitica are intrinsically mouse-lethal, but low-pathogenicity Y. 
enterocolitica subsp. palearctica can achieve the same levels of virulence in a mouse 
in the presence of an exogeneous siderophore or an excess of iron [341]. A variety of 
systems are present in bacteria for the synthesis of high-affinity iron-binding 
molecules (siderophores) [342]. 
Highly pathogenic Yersinia species (Y. pestis, Y. pseudotuberculosis serotype I and Y. 
enterocolitica subsp. enterocolitica) contain the yersiniabactin locus (ybt) [343] 
which encodes the capacity to synthesize the siderophore yersiniabactin. The 
chelating activity of yersiniabactin promotes uptake of iron essential for growth in 
the vertebrate host by pathogenic Yersinia, and its presence mediates lethality in 
mice [344-346]. Yersiniabactin is able to capture iron from host lactoferrin, present 
in the circulation and in the phagocytic vacuoles of neutrophil leucocytes [347]. 
Depletion of iron from host lactoferrin reduces the capacity of neutrophils, 
macrophages and monocytes to produce Reactive Oxygen Species (ROS), 
presumably by reducing activity of the Haber-Weiss reaction, which generates 
hydroxyl radicals and superoxide from hydrogen peroxide by Fe (II) catalysis [347]. 
Therefore yersiniabactin has a dual action, promoting bacterial growth in the host 
and reducing the effectiveness of the host innate immune response in bacterial 
killing. The ybt locus encodes proteins that are responsible for the biosynthesis 
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(high molecular weight proteins - HMWP 1 and 2, YbtT, YbtE and YbtS), transport 
(Psn/FyuA, YbtP and YbtQ) and regulation (YbtA) of the yersiniabactin (Ybt) (Table 
1.13) [343, 344, 348]. FyuA contains a region commonly present in TonB-dependent 
proteins and operates as the outer membrane yersiniabactin receptor [344]. 
Table 1.12 Yersiniabactin locus genes and their products (adapted from Carniel 
[343]) 
Gene designation in 
Y. pestis and Y. 
pseudotuberculosis 
Gene designation in 
Y. enterocolitica 
Product Function 
ybtS irp9 YbtS Ybt biosynthesis 
ybtX irp8 YbtX Unknown 
ybtQ irp7 YbtQ Ybt transport 
ybtP irp6 YbtP Ybt transport 
ybtA ybtA YbtA 
Regulator of ybt 
locus expression 
irp2 irp2 HMWP2 Ybt biosynthesis 
irp1 irp1 HMWP1 Ybt biosynthesis 
ybtU irp3 YbtU Unknown 
ybtT irp4 YbtT Ybt biosynthesis 
ybtE irp5 YbtE Ybt biosynthesis 
psn fyuA Psn/FyuA Ybt transport 
Similar to the first pathogenicity island described in uropathogenic E. coli [349] the 
ybt locus is bounded by an asn tRNA with an adjacent integrase gene on one side and 
a short direct repeat of part of the tRNA gene on the other [350]. Pathogenicity 
islands widely distributed in pathogenic Enterobacteriaceae [351]. In Yersinia it has 
been termed as High Pathogenicity Island (HPI) [350, 352, 353]. Two evolutionary 
lineages of HPI were identified among highly pathogenic Yersinia species: HPI of Y. 
pseudotuberculosis/Y. pestis (Yps HPI) and Y. enterocolitica HPI (Yen HPI) [354]. The 
part of the island that encodes yersiniabactin synthesis, receptor and regulator is 
highly conserved among Yersinia species, while the region downstream of the 
receptor (fyuA) gene is highly variable [350, 354, 355]. 
In addition to the ybt locus, Y. pestis also encodes a haemin storage locus (hms) 
[355]. The hms locus is not required for Y. pestis virulence in mammals [356], but it 
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mediates biofilm formation [357] and subsequently blockage of the flea foregut, and 
hence transmission of plague bacilli to mammals [358]. The hms locus is also 
present in Y. pseudotuberculosis, however, it does not cause blockage of the flea 
foregut [359]. 
Iron uptake systems that are not essential for mammalian virulence have been 
identified in pathogenic Yersinia: yfe, yfu, yin and a haemin uptake system [360-363]. 
Other iron uptake systems of unidentified functionality have been detected in Y. 
pestis and Y. pseudotuberculosis genomes by bioinformatic analysis (Table 1.14) 
[364]. 
Table 1.13 Y. pestis and Y. pseudotuberculosis iron/hemin uptake systems with 
unidentified functionality detetected by bioinformatics analysis of their 
genomes (adapted from Forman et al [364]) 
System Locus similarities* 
Siderophore-dependent systems 
Yersinia non-ribosomal peptide (Ypn) 6 patterns 
Ysu 2 patterns 
Aerobactin (Iuc; biosynthesis) 2 patterns 
ABC iron/siderophore transporters 
Fit 1 pattern 
Fiu 2 patterns 
Fhu and IutA 2 patterns 
FcuA 2 patterns 
Non-ABC transporters 
Feo 2 patterns 
Efe 2 patterns 
Fet 2 patterns 
FieF 1 pattern 
Hemin transporters 
Hmu 1 pattern 
Has 1 pattern 
* When relatively few amino acid residues changes and/or small deletions or insertions which maintain 
the ORF occur, they were classified as one pattern 
Non-pathogenic species Y. intermedia, Y. kristensenii, and Y. frederiksenii produce a 
hydroxamate siderophore, aerobactin, but are avirulent in mice, indicating that this 
particular siderophore does not contribute to virulence even when these species are 
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transformed with the virulence plasmid of Y. enterocolitica [264]. 
1.6.1.7 Y. pseudotuberculosis superantigen 
Y. pseudotuberculosis strains of Far Eastern origin but not of European origin 
produce a superantigenic toxin YPM (Y. pseudotuberculosis-derived mitogen) [245, 
365, 366]. Patients with extraintestinal manifestations of Y. pseudotuberculosis 
infection have higher levels of anti-YPM antibodies than patients with the 
gastrointestinal symptoms [367, 368]. 
The role of YPM superantigen in systemic Y. pseudotuberculosis illness is mediated 
by its ability to non-selectively stimulate T-cells resulting in development in acute 
renal failure, stimulation of PBMC cells leading to the production of IL-12 and 
subsequent expansion of the skin-homing receptor CLA+ T-cells that manifest as a 
erythematous skin rash in affected patients [369]. 
1.6.2 Plasmid encoded virulence factors 
Pathogenic strains of Y. enterocolitica [370], Y. pseudotuberculosis [371] and Y. pestis 
[372] possess a 64- to 75-kb plasmid designated as pYV [373-375]. Y. 
pseudotuberculosis and Y. pestis pYV plasmids were shown to be interchangeable 
[376]. The pYV encodes factors essential for Yersinia virulence such as: Yersinia 
Adhesin A (YadA), that mediates binding of bacteria to the host cell membrane [377-
379] and serum resistance [380-386], Yersinia Outer membrane Proteins (YOPs) 
that are secreted via the Ysc Type III Secretion System (TTSS) also encoded by pYV, 
which mediate inhibition of phagocytosis and inflammatory responses by the host 
[387]. 
Transcription of pYV genes is thermoregulated and in most cases depends on the 
presence of Ca2+ ions (low calcium response). Thus, in vitro transcription of YOPs is 
observed only in the absence of Ca2+ ions and at 37°C (proxy signals for host cell 
contact), but the secretion of YadA protein is calcium independent although it is still 
thermoregulated and expressed only at 37°C [388]. 
1.6.2.1 Function of the adhesin protein YadA 
The multiple functionality of YadA is attributed to its multidomain “lollipop-like” 
structure (Figure 1.5). The following domains and regions of YadA have been 
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functionally defined: N-terminal leader sequence, head domain, neck domain, stalk 
domain, linking region, and the C-terminal transmembrane region that consists of 
four β-strands [389]. 
 
Figure 1.5 YadA protein structure (adapted from Hoiczyk et al [389]) 
The C-terminal outer membrane anchor domain is responsible for stability, 
oligomerization and anchoring YadA to the bacterial cell surface [389, 390]. YadA-
dependent serum resistance [380-383, 386] has been linked to the stalk region but a 
specific stalk domain associated with serum resistance has not yet been identified 
[384, 385]. 
The N-terminal globular domain (head) is responsible for binding extracellular 
matrix molecules (ECM), adhesion to host cells, and agglutination [389-396]. 
Inactivation of yadA led to a significant reduction in the ability of Y. enterocolitica 
[377, 390, 395, 396], but not Y. pseudotuberculosis, to colonise the ileum of oro-
gastrically infected mice [377, 397]. The YadA of both Y. enterocolitica and Y. 
pseudotuberculosis enables bacterial adhesion to mammalian cells [377-379] and 
extracellular matrix molecules (ECM) [390, 398-400]. The Y. enterocolitica YadA 
mediates effective adhesion to but not invasion into epithelial cells in vitro [401], 
while Y. pseudotuberculosis YadA facilitates both effective bacterial adhesion and 
invasion of eukaryotic cells, independently of Inv [379, 402]. A unique motif of 31 
amino acids within the 53-83 AA region of the Y. pseudotuberculosis YadA head 
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domain (absent from Y. enterocolitica YadA), determines the ability to invade 
eukaryotic cells [391]. 
1.6.2.2 Ysc-YOP virulon 
The Yersinia Ysc-YOP virulon comprises the Type III secretion system (TTSS)/Ysc 
that mediates injection of Yersinia outer membrane proteins (YOPs) into 
mammalian cells [403, 404]. Eight core proteins from the injectisome share a 
significant similarity with the components of the flagellum (Figure 1.6) [404]. 
 
Figure 1.6 Structure of the flagellum and the injectisomes (adapted from Cornelis 
[404]) 
Schematic representation of the flagellum (a), Ysc injectisome (b), injectisome from 
EPECs (c) and the injectisome from plant pathogens (d). For the injectisomes, the C ring 
is represented by a dashed line as information on this component is still scarce. IM - 
inner membrane; OM - outer membrane; PG - peptidoglycan. 
Seven families of TTSS are recognised in free-living animal pathogens. The Ysc 
injectisome of Yersinia species is the prototype of one of these families, also seen for 
example in Pseudomonas aeruginosa. The injectisomes first found in Shigella flexneri 
and Salmonella typhimurium (encoded on the Salmonella SPI-1 pathogenicity island) 
are members of another family prevalent in animal pathogens. Another family is 
exemplified by injectisomes found in enteropathogenic E. coli (EPEC), 
enterohaemorrhagic E. coli (EHEC) and S. typhimurium (encoded on SPI-2) [404]. 
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Highly pathogenic Y. enterocolitica subsp. enterocolitica also encode a TTSS that is 
distinct from the Ysc/TTSS family and resembles the Mxi-Spa TTSS family of Shigella 
species and Salmonella typhimurium [405]. The Ysa/TTSS is encoded by the 
chromosomal pathogenicity island Ysa-PI that is part of a plasticity zone that also 
contains other virulence genes [406]. The Ysa/TTSS was shown to be involved in 
Yersinia colonization of gastrointestinal tissues by studies in a mouse model [407]. 
The Ysc/TTSS system is activated by close contact of pathogenic Yersinia with the 
eukaryotic cell surface [388] (Figure 1.7). After Ysc/TTSS activation a translocation 
of effector YOPs (YopE, YopH, YopO/YpkA, YopM, YopP/J and YopT) into the 
cytoplasm of eukaryotic cells occurs [388, 408]. Translocation of effector Yops into 
eukaryotic cell cytoplasm requires presence of translocator YOPs (YopB, YopD and 
LcrV) that form pores in the eukaryotic cell membrane [409-414]. The YopN protein 
forms a link between the Ysc/TTSS needle-like structure YscF and pore, thus, 
guiding the effector YOPs into eukaryotic cell cytoplasm [415]. 
 
Figure 1.7 Secretion of YOPs by the Ysc injectisome and translocation across the 
target cell membrane (adapted from Cornelis [403]) 
When Yersinia are placed at 37°C in a rich environment, the Ysc injectisome is installed 
and a stock of Yop proteins is synthesized. During their intrabacterial stage, some Yops 
are capped with their specific Syc chaperone. Upon contact with a eukaryotic target cell, 
the adhesins YadA or Inv interact with integrins and the bacterium docks at the cell's 
surface. Then, the secretion channel opens and Yops are exported. YopB and YopD form 
a pore in the target cell plasma membrane, and the effector Yops are translocated across 
this membrane into the eukaryotic cell cytosol. YopM migrates to the nucleus. EM - outer 
membrane; P - peptidoglycen; IM - plasma membrane. 
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Effector YOPs suppress phagocytosis [416, 417], modulate cytokine production 
[418-420] and cause apoptosis of dendritic cells [420] and macrophages [421-424] 
(Table 1.15). The outcome of this allows Yersinia to evade the host immune response 
and favours persistence and/or systemic dissemination [423, 425]. 
Table 1.14 Functionality of effector YOPs 
YOP Biological Activity 
Results of the 
biological activity 
Ref 
YopH Tyrosine phosphatase that acts 
on focal adhesion kinase 
(FAK), p130Cas and NADPH 
Disrupts actin 
cytoskeleton and inhibits 
phagocytosis 
[408, 416, 426, 
427] 
YopE GTPase activating protein 
(GAP) that acts on Rho family 
GTPases 
Disrupts actin 
cytoskeleton and inhibits 
phagocytosis and 
proinflammatory 
cytokine production 
[416, 428, 
429] 
YopM Leucin rich protein that binds 
to protein kinase C-like 
2(PRK2) and ribosomal S6 
protein kinase 1 (RSK1) in the 
eukaryotic cell nucleous  
Disrupts 
proinflammatory 
cytokine production 
[430-433] 
YopO/YpkA* Serine/Threonine kinase that 
binds  Rho and Rac-1 
Disrupts actin 
cytoskeleton and inhibits 
phagocytosis 
[434, 435] 
YopT Cystein protease that is 
cleaving CAAX box from Rho 
GTPases 
Disrupts actin 
cytoskeleton and inhibits 
phagocytosis 
[416, 428, 436-
439] 
YopP/YopJ* Acetyl transferase that 
disrupts NFkB and MAPK 
signalling pathways 
Disrupts actin 
cytoskeleton and inhibits 
phagocytosis by 
trigerring apoptosis 
[424, 440, 
441] 
* Y. pseudotuberculosis effector Yop 
 
1.6.3 Novel virulence factors 
Cytolethal Distending Toxins (CDTs) are bacterial heat-labile toxins with an 
ability to arrest the cell cycle of eukaryotic cells [442-445]. CDTs are produced by 
a number of bacterial pathogens including: Campylobacter species [446-448], 
Salmonella enterica Serovar Typhi [449], Shigella dysenteriae [450], E. coli [451-
454], Helicobacter species [455-460], Actinobacillus actinomycetemcomitans 
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[461-463] and Haemophilus ducreyi [464, 465]. A putative example was identified 
by sequence similarity in the genome sequence of the moderately pathogenic Y. 
enterocolitica O:3 strain Y11 [466] and has also been seen in other Y. 
enterocolitica genomes (N. Thomson, personal communication). 
CDT is an AB2 toxin and consists of a hetero-trimeric complex of three proteins: 
CdtA, CdtB and CdtC [467-470]. CdtA and CdtC subunits are required for delivery 
of CdtB into host cells. The CdtB subunit resembles type I mammalian DNases 
and enters the nucleus and binds host DNA, causing double strand breaks [471], 
leading to arrest of the cell cycle [445, 470, 472-476]. 
The role of CDT in the pathogenesis of enteropathogenic Yersinia is not yet 
established. Findings of relevance to CDT in Yersinia are discussed in Chapter 3 of 
this thesis, where the Insectidal Toxin Complex is also considered in detail. 
1.7 Genotyping of Yersinia species 
1.7.1 Multilocus Enzyme Electrophoresis (MLEE) 
Multi Locus Enzyme Electrophoresis (MLEE) is a molecular technique based on the 
electrophoretic mobility of the cellular enzymes that can be directly linked to the 
allelic variation at the corresponding gene [477]. MLEE enabled clustering of Y. 
enterocolitica-like species separately from Y. enterocolitica [478, 479]. Furthermore, 
Y. enterocolitica strains were separated in two distinct groups according to their 
pathogenic potential; moderately pathogenic Y. enterocolitica subsp. palearctica, and 
highly pathogenic Y. enterocolitica subsp. enterocolitica [478, 479]. Y. enterocolitica 
strains of biovar 1A were clustered into four separate groups showing high genetic 
diversity [480]. Also, MLEE typing demonstrated that Yersinia strains biochemically 
identified as Y. frederiksenii may be represented by more than one species [479]. 
This technique provided information about genetic heterogeneity of Yersinia species 
by clearly dividing them to the species and subspecies levels [478-480], however, 
did not provide clear geographical or source of isolation (host) distinction within 
clusters [478, 480]. MLEE has largely been replaced by Multi Locus Sequence Typing 
(MLST). 
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1.7.2 Multi Locus Sequence Typing (MLST) 
Multilocus Sequence Typing (MLST) was developed from MLEE [481]. 
Indistinguishable electromorphotypes can be encoded by very different nucleotide 
sequences and MLST typing allows discrimination of more alleles per locus by the 
amplification of internal fragments of approximately 400-600bp from multiple 
housekeeping genes that encode fundamental metabolic functions [481, 482]. MLST 
data can easily be made freely-accessible in curated databases [481] and used for 
epidemiological, evolutionary and population studies of bacteria regardless of their 
underlying diversity, population structure or evolution with some caveats given 
below [481, 482]. 
The level of discrimination afforded by MLST depends upon factors such as the 
number and type of genes used, the length of the sequenced gene fragment and the 
degree of diversity within the sample being characterized. The number of loci is 
generally minimised to 6-7 to meet the requirements for routine typing [482]. 
However, for clonal bacterial populations or for evolutionary young (recently 
diverged) species that have a single clonal lineage, MLST can be poorly 
discriminatory in some genera when based on the sequencing of 7 core 
housekeeping genes [483]. Sequencing of 20-30 core housekeeping genes can be 
useful in such cases but would require an initial genome screening procedure to 
identify polymorphic loci, an investment in funds and time which is becoming more 
achievable all the time with next generation sequencing [483, 484]. Variation in 
housekeeping genes provides basic clonal assignments, whereas sequences from 
hypervariable loci can be used to “zoom in” on specific clones and tease apart very 
recent patterns of descent [483, 484]. 
The intra- and interspecies genetic relationships of 58 strains representing almost 
all currently known species of the genus Yersinia were examined by 4-gene MLST, 
using sequence data from, glnA, gyrB, recA and Y-HSP60 loci in combination and in 
comparison with 16S RNA gene sequences [485]. MLST and 16S RNA data correlated 
well in most strains, and agreed with the species assignment based on biochemical 
tests. Y. aldovae, Y. bercovieri, Y. intermedia, Y. pestis, Y. pseudotuberculosis, Y. rohdei, 
and Y. ruckeri species groupings were genetically more homogeneous than Y. 
enterocolitica, Y. frederiksenii, Y. kristensenii, and Y. mollaretii. In instances where the 
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16S RNA and MLST data did not agree with each other, MLST data was more 
consistent with the species’ biochemical identification than 16S RNA results [485]. 
Four bacterial populations were identified by MLST analysis of 417 Yersinia strains 
biochemically identified as Y. pseudotuberculosis; these include Y. pseudotuberculosis 
sensu stricto, Y. pestis, Y. similis and new group of Y. pseudotuberculosis that is 
currently undergoing speciation [486]. 
1.7.3 Repetitive elements PCR 
Repetitive element PCR is a method for fingerprinting bacterial genomes by 
detecting repetitive DNA elements using PCR amplification [487]. Two main sets of 
repetitive elements are used for typing purposes: small (35bp) Repetitive 
Extragenomic Palindromic (REP) elements [488], and 126bp Enterobacterial 
Repetitive Intergenic Consensus (ERIC) sequences [489]. ERIC sequences are major 
genome components of pathogenic Yersinia, accounting for 0.7% and 0.45% of the 
total DNA of Y. enterocolitica subsp. enterocolitica strain 8081 and Y. pestis strain 
CO92 [490], respectively. 
Repetitive element PCR clearly distinguish clinical and environmental non-
pathogenic biovar 1A Y. enterocolitica strains [491]. However, biovar 1A Y. 
enterocolitica strains in general show limited genetic heterogeneity with this 
method [491]. REP-PCR was shown to be more discriminatory than ERIC-PCR or 
PCR-ribotyping for genomic profiling of Y. enterocolitica strains of various serotypes 
[492]. In another, study REP-PCR and especially ERIC-PCR provided effective 
discrimination between various Yersinia species, while 16SrDNA sequencing 
unsurprisingly failed to differentiate Y. pseudotuberculosis from Y. pestis [152]. Y. 
enterocolitica strains of bioserovar 4/O:3 showed high genomic similarity by ERIC-
PCR profiling that could be resolved by Pulse Field Gel Electrophoresis (PFGE) [493]. 
1.7.4 Ribotyping 
Ribotyping is a procedure that analyses the copy number, genomic location and 
nucleotide sequence variability of the ribosomal operon (rrn loci) and was first 
described by Grimont and Grimont [494]. Ribosomal operons are polycistronic 
transcriptional units that encode conserved 16S, 23S and 5S rRNA molecules and 
variable intragenic spacer region (ISR) located between 16S and 23S rDNA. 
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Conventional ribotyping is based on restriction endonuclease digestion of genomic 
DNA and subsequent electrophoretic separation followed by Southern blot 
hybridization to a labelled ribosomal operon probe [495]. 
Ribotyping provides a clear taxonomic and biotype differentiation of Yersinia 
species [496-499], however, the discrimination index of ribotyping depends on the 
combination of the restriction endonuclease enzyme used and Yersinia strain tested 
[155, 499-502]. Ribotyping of Y. enterocolitica strains of biovars 1-5 with HindIII and 
EcoRI restriction enzymes allowed clear differentiation of moderately pathogenic Y. 
enterocolitica biovars 2-5 from Y. enterocolitica of biovar 1. Biovar 1 strains could be 
further separated into highly pathogenic and non-pathogenic clusters [498]. These 
results were congruent with MLEE typing [478, 479]. 
Ribotyping of various Y. pseudotuberculosis isolates with EcoRV and EcoRI enzymes 
allowed subtyping of the strains within a given serotype, that is , the discriminatory 
power of ribotyping was superior to that of serotyping [503]. In contrast, ribotyping 
with EcoRI gave almost identical ribotypes for all Y. enterocolitica O:3 strains tested 
[496, 498, 501], but DNA digestion with NciI [499] and BglI-HindIII [501, 504] was 
efficient for subtyping of Y. enterocolitica O:3 strains. Ribotyping performed with the 
combination of BglI-NciI [155] and separate ribotyping with PvuII [500] restriction 
enzymes allowed the best discrimination of non-pathogenic Y. enterocolitica biovar 
1A strains. 
PCR ribotyping was first described by Kostman [505] and Gurtler [506] and is based 
on the variability of the PCR amplified internal spacer region (ISR) located between 
16S and 23S genes. PCR-ribotyping showed a higher discrimination index in 
comparison to conventional ribotyping for genotyping of non-pathogenic Y. 
enterocolitica biovar 1A strains [155, 507]. The combination of conventional and 
PCR-ribotyping significantly increases the discrimination power of the genotyping 
[504]. However , PCR-ribotyping has a lower discrimination index than PFGE [507]. 
1.7.5 Pulse Field Gel Electrophoresis (PFGE) 
Pulse Field Gel Electrophoresis (PFGE) is based on chromosomal DNA digestion with 
restriction enzymes and subsequent separation of large fragments on a gel with the 
assistance of an electric field which is switches periodically between two different 
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directions with various pulse times. 
Single enzyme PFGE with NotI [62, 508-510] or XbaI [507, 509] clearly differentiates 
Y. enterocolitica according to their bioserotypes into separate PFGE pulsotypes, and 
also shows genetic homogeneity of Y. enterocolitica bioserotype 4/O3 (Table 1.9). 
NotI PFGE pulsotypes for bioserotypes 3/O:3, 3/O:5 and 1A/O:5 are more closely 
associated with the biotype than serotype [508]. Digestion with more than one 
restriction enzyme enables fine discrimination of Yersinia strains making it a useful 
epidemiological tool [45, 61, 72, 509, 511-513]. 
Table 1.15 Y. enterocolitica pulsotypes obtained with different restriction enzymes 
Microorganism NotI, XbaI NotI+XbaI NotI+XhoI+ApaI Ref 
Y. enterocolitica O:3* 16 8 24 - [511] 
Y. enterocolitica 4/O:3 15 - - 30 [514] 
Y. enterocolitica 4/O:3 22 - - 126 [61] 
* Biotype information is not given 
PFGE is an excellent method for typing biochemically atypical Yersinia strains [496, 
508, 510] and superior to PCR ribotyping [507], ERIC-PCR typing [493], REAP, REAC 
and ribotyping [496] for epidemiological tracing of Y. enterocolitica strains. 
1.7.6 Amplified Fragment Length Polymorphism (AFLP) 
Amplified Fragment Length Polymorphism (AFLP) DNA fingerprinting is based on 
the detection of DNA restriction fragments by random PCR amplification without 
prior DNA sequence knowledge [515]. Double stranded adaptors containing 
restriction enzyme sites are ligated to DNA fragments cut with the corresponding 
frequent or rare-cutting restriction enzymes, and serve as primer binding sites for 
subsequent amplification of DNA restriction fragments [515]. 
The AFLP method has been applied to various bioserotypes of Y. enterocolitica 
isolated from a wide range of sources including human, domestic animals and food 
[516, 517]. AFLP DNA fingerprinting clearly separated pathogenic and non-
pathogenic Y. enterocolitica biotypes, and allowed further serotype associated 
subdivision of these strains [516, 517]. There was little correlation between the 
source of isolation and AFLP clustering. That is, some of the animal and human 
isolates clustered together and some strains of the same bioserotype clustered 
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separately [516, 517]. 
The AFLP technique is helpful in confirmation of Yersinia species identification. 
Thus, Y. enterocolitica strains were clearly separated from Y. enterocolitica-like 
species [516, 517]. 
1.7.7 Multiple Locus Variable number tandem repeat Analysis (MLVA) 
ShortSequence DNA Repeats (SSR), also known as variable number tandem repeats 
(VNTR), undergo frequent variation in the number of individual repeat units 
through slipped strand mispairing during DNA synthesis [518]. Variation in SSR is 
detected by PCR amplification with the primers for the regions flanking SSR [518]. 
VNTR typing, also known as MLVA typing, is widely used for epidemiological typing 
of human pathogens [519]. MLVA typing is less labour intensive than PFGE typing 
and does not require large culture volumes [520]. 
MLVA typing based on six VNTR loci identified in the draft of the Y. enterocolitica 
strain Y11 bioserotype 4/O:3 genome allowed better discrimination of Y. 
enterocolitica bioserovar 4/O:3 strains than PFGE [520, 521] or AFLP [521]. These 
VNTR loci were also detected in strains of serotypes O:5,27 and O:9 [521]. 
Although the six VNTR loci selected at the beginning of the study were stable during 
in vitro multiple passages in the laboratory, a comparison of the MLVA genotypes of 
epidemiologically linked isolates showed that they exhibited a single variation in the 
V2a locus and apparent hypermutability in V10 locus in vivo [521]. Recent 
examination of mutational events in VNTR loci in E.coli O157:H7 showed that the 
use of hypervariable loci may limit the validity of MLVA for long-term 
epidemiological investigations [522]. Thus each MLVA scheme used for 
epidemiological investigations must be validated with a control group of 
epidemiologically linked strains. 
1.7.8 Microarray Genotyping 
DNA microarrays allow whole-genome comparisons between a sequenced reference 
genome and genome of test strains without whole-genome sequencing of the 
comparator strains [523]. This technique is based on the competitive DNA-DNA 
hybridization between fluorescently labelled DNA from the test strain and a control 
strain to the reporter DNA elements on a microarray. After washing of the unbound 
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DNA, microarrays are scanned by a fluorescence scanner, and the obtained image is 
analysed by a specific software package. 
Two microarray technologies exist – the original Polymerase Chain Reaction 
product based microarrays (PCR-based) and now oligonucleotide-based DNA 
microarrays. Both technologies have their advantages and downsides [523]. The 
advantages of PCR-based microarrays were: flexibility in the design of the 
microarray; relative ease of production; and its relatively low cost. On the other 
hand PCR-based microarrays do not allow detection of single nucleotide 
polymorphism (SNP) and mutant alleles that can be detected by using 
oligonucleotide-based microarrays. Additionally oligonucleotide-based microarrays 
reduce cross-hybridization as more specifically designed oligonucleotides are 
employed and these have now largely replaced PCR product microarrays [523-527]. 
Microarray technology in combination with phylogenetic analysis is a sensitive and 
robust method for studying genetic relatedness bacterial populations [528-531]. 
The genome sequence of the highly pathogenic Y. enterocolitica subsp. enterocolitica 
strain 8081 [532] has allowed whole genome comparison using microarray 
technology between Y. enterocolitica strains of different origin in the same way that 
Y. pestis and Y. pseudotuberculosis strains have been analysed [533]. Comparative 
phylogenomic analysis of microarray data generated in Y. enterocolitica strains 
isolated in the Great Britain from humans with diarrhoea and domestic animals 
resulted in distribution of strains into the three clades: highly pathogenic, low 
pathogenic and non-pathogenic clades [531]. Strains isolated from humans and 
livestock were distributed throughout the clade and did not cluster together by the 
source host in both low-pathogenic and non-pathogenic clades [531]. Within the 
low-pathogenicity clade, isolates were partially separated according to the biotype 
and serotype; the distribution of isolates within non-pathogenic and highly 
pathogenic clades was more heterogeneous [531]. 
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1.8 Evolution of Yersinia species 
 
Figure 1.8 Schematic representation of a hypothesis of pathways for pathogenic 
Yersinia species evolution (adapted from Wren [534]) 
Molecular phylogenetics analyses evolutionary relationships among organisms by 
comparing molecular differences in their DNA and protein sequences [535]. The 
application of typing methods used in molecular epidemiology can also be extended 
to studying evolution of bacterial populations [484, 486, 528, 536, 537]. Based on 
genetic differences in housekeeping genes, the blood-borne pathogen Y. pestis was 
found to be a clone of the gastrointestinal pathogen Y. pseudotuberculosis. Using the 
“molecular clock” hypothesis the former was estimated to have evolved from the 
latter around 1,500-20,000 years ago (Figure 1.8) [538]. More extensive genomic 
comparisons using single nucleotide polymorphisms (SNPs) supported this 
relationship [529] and have allowed detailed phylogeographical studies placing the 
origin of all current Y. pestis strains in China [484]. Ancient DNA studies combined 
with this detailed SNP data have confirmed Y. pestis as the cause of the 14th century 
Black Death [539-541]. 
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This transition was accompanied by the combined acquisition and loss of a number 
of genes in the Y. pestis genome relative to Y. pseudotuberculosis [532, 533, 538, 542, 
543]. Y. pestis acquired two plasmids: a 100-110 kb pFra plasmid (also called pMT1 
[534]) that encodes a phospholipase D homologue Ymt that promotes colonization 
[544] and survival of Y. pestis in the flea midgut [545], and a 9.5 kb pPla plasmid 
(also termed pPCP1 or pPst [534]), that encodes plasminogen activator Pla and is 
required for systemic transmission of Y. pestis [546]. The pFra plasmid partially 
resembles the pHCM2 plasmid of Salmonella typhi and was probably acquired by the 
ancestral Y. pseudotuberculosis before the emergence of Y. pestis [547]. Both Y. pestis 
and Y. pseudotuberculosis encode hms loci [355, 358], however, the functionality of 
these loci differ in each microorganism. The Y. pestis hms locus mediates blockage of 
the flea foregut that instigates futile attempts to feed, hence the flea regurgitates 
infected blood back into the bite site [358]. In contrast, Y. pseudotuberculosis 
infected fleas do not show blockage of the foregut [359]. 
The virulence plasmid pYV is a consistent feature in pathogenic Y. pestis, Y. 
pseudotuberculosis and Y. enterocolitica and the most parsimonious explanation for 
this is a single acquisition event as shown in figure 1.8. 
In addition to the loss of methionine-salvage and osmoregulated periplasmic glucan 
(OPG) biosynthetic pathways that are essential for gut colonisation [532, 548] Y. 
pestis has undergone loss or inactivation by mutation of various proteins (YadA, Inv, 
Urease, flagellar operon) necessary for Yersinia gut colonisation or translocation 
across the intestinal barrier [542]. Although Y. pestis has apparently lost the ability 
to colonise the gastrointestinal tract, it can cause pharyngitis by infection of 
phayngeal lymphatic tissue [549]. 
Housekeeping genes and the “molecular clock” in turn suggest Y. enterocolitica and 
Y. pseudotuberculosis diverged within the past 200 million years [548]. Surprisingly, 
although both Y. enterocolitica and Y. pseudotuberculosis are enteric pathogens 
occupying a similar ecological niche, comparative genomics suggests Y. 
pseudotuberculosis lost or underwent significant changes in several metabolic 
pathways (cellulose biosynthesis and tetrathionate respiration pathways, and OPG 
cluster) presumably essential for gut colonisation [548]. Y. enterocolitica has 
acquired by lateral gene transfer hydrogenase gene clusters (hyf and hyb loci), 
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cobalamin (B12) synthesis cluster (cbi) and 1,2-propanediol utilisation (pdu) 
pathways that may enhance Y. enterocolitica ability to colonise the gastrointestinal 
tract [548, 550]. 
Y. enterocolitica species include microorganisms with a variable pathogenic 
potential (see 1.2.5 Biotyping of Y. enterocolitica). Comparative microarray analysis 
established that mildly and non-pathogenic Y. enterocolitica subsp. palearctica 
strains are closely related by gene content, however, non-pathogenic strains seem 
more related to highly pathogenic Y. enterocolitica subsp. enterocolitica strains than 
mildly pathogenic strains [531]. Biotype 1A strains generally show a high degree of 
genomic heterogeneity [516, 517, 531]. AFLP analysis indicated that some non-
pathogenic Y. enterocolitica 1A of human and animal origin were grouped together 
with pathogenic biovars [516].  
The presence of insecticidal toxin complex genes resembling loci in the insect 
pathogen Photorhabdus luminescens [551-553] in Y. pestis [542], Y. 
pseudotuberculosis, Y. mollaretii, Y. frederiksenii [554] and mildly pathogenic [555] 
and non-pathogenic [556] Y. enterocolitica subsp. palearctica isolates suggests 
ancestral Yersinia species were associated with insects or insect pathogens [538, 
542]. A baculoviral enhancin gene related to insect parasitism is also present in Y. 
pestis and Y. pseudotuberculosis.[533, 542]. 
It is thought that because of the numerical predominance of invertebrates and 
similarities of cellular and molecular immune responses of invertebrates and 
vertebrates, insects may act as a reservoir for emerging human pathogens [557]. 
Additionally, according to “eco-evo” perspectives on host-pathogen interactions, 
many bacterial virulence factors were initially evolutionary shaped for interactions 
with non-human hosts, and only subsequently due to accidental contacts with 
humans were these factors evolutionary adapted for interactions with humans 
[558]. Indeed, genomic comparisons of Y. enterocolitica and Ph. luminescens shows 
that many of Yersinia virulence factors such as Ail, urease, Inv and YplA have 
apparent homologues in Ph. luminescens [559]. 
 59 
 
1.9 Aims and Objectives 
Because of the low incidence rates of yersiniosis in Ireland and the high prevalence 
of pathogenic Y. enterocoloitica in slaughter pigs (unpublished Murphy et al.) the aim 
of this study is to investigate the reasons for such discreapancies. Low notifications 
of yersiniosis in the presence of high risk might represent a failure to detect 
pathogenic Yersinia in diarrhoeal stool samples or the prevalence of mild self-
limiting forms of yersiniosis in the Irish human population. The evidence of active 
forms of human yersiniosis was pursued through the examination of clinical 
samples with Yersinia selective culture, and substantiation of mild forms of 
yersiniosis was sought by a serological screening of asymptomatic healthy 
individuals as well as by molecular and culture screening of human sewage. 
Y. enterocolitica is a heterogeneous species that includes pathogenic and non-
pathogenic microorganisms. Pathogenic Y. enterocolitica biotypes are 
predominantly gastroenteric pathogens that possess chromosal (required for the 
initial stages of infection) and pYV plasmid encoded (required for systemic 
dissemination of Yersinia) virulence factors. Non-pathogenic biovar 1A Y. 
enterocolitica do not encode conventional virulence factors. However, their 
predominance in the collections of Y. enterocolitica strains isolated from humans 
(gifts of Prof. M. Cormican (University College Galway) and Dr. J. Moore (Queen’s 
University Belfast)) and retail meat samples (unpublished Murphy et al.) incited 
investigation of their pathogenic potential towards humans. Clinical and non-clinical 
Y. enterocolitica strains of various biovars were screened for the presence of novel 
virulence factors and their pathogenic potential was compared in a Galleria 
mellonella model. 
Because of the extensive human, animal and food exchange between Ireland and 
United Kindom, investigation of the genetic relationships between clinical and non-
clinical Y. enterocolitica strains isolated in Ireland and United Kindom is required. 
Many Yersinia genotyping techniques described in section 1.7 are based on  
knowledge about limited set of genes and often require additional validation for the 
discrimination of closely related bacterial populations. On the other hand, 
microarray technology allows comparative genomics without the need for full 
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genome sequencing for all test microorganisms and was shown to be sensitive and 
robust. Therefore, genetic relationships between clinical and non-clinical Y. 
enterocolitica strains isolated in Ireland and United Kindom were investiagted by 
comparative microarray analysis. 
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Chapter 2 Current evidence for human 
yersiniosis in Ireland 
 
 
 
 
 
 
 
 
Ringwood T, Murphy BP, Drummond N, Buckley JF, Coveney AP, Redmond HP, 
Power JP, Fanning S, Prentice MB: Current evidence for human yersiniosis in 
Ireland. Eur J Clin Microbiol Infect Dis 2012. (see Appendix) 
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2.1 Introduction 
Y. enterocolitica and to a lesser extent Y. pseudotuberculosis are the leading causes of 
yersiniosis in Europe and worldwide [12, 13, 560]. Most gastrointestinal Yersinia 
infection cases are sporadic [12, 13, 17, 560] but recent outbreaks of Y. 
pseudotuberculosis [19, 174] and Y. enterocolitica [21, 25] infections involving food 
have been reported. The association of yersiniosis with the consumption of 
contaminated pork meat is consistent worldwide [14, 16, 22, 61, 66]. Pig tonsils as 
well as faecal material are the main sources of the pig meat contamination with 
pathogenic Y. enterocolitica [69, 70]. In Ireland tonsillar carriage of pathogenic Y. 
enterocolitica in 31% of pigs at slaughter level has recently been recorded 
(unpublished Murphy et al.), a figure very similar to carriage seen in recent surveys 
of slaughter pigs in Finland (35%) [561] and Belgium (37.4%) [57] However, the 
annual incidence of human yersiniosis notified from 2006-8 inclusive in Ireland was 
the lowest in Europe and did not exceed 10 cases per year (≤0.1 per 100,000 
population) [12]. In comparison, in Finland and Belgium, an average of 12.03 and 2.5 
yersiniosis cases per 100,000 of population respectively were reported during the 
same period [12]. 
In contrast, in the 1980s, a serological survey of agglutinating antibodies reported 
that 23% of patients with a clinical diagnosis of appendicitis in two hospitals in 
Dublin had active yersiniosis [177]. Based on the high current prevalence of 
pathogenic Y. enterocolitica in pigs in Ireland, we hypothesized that the current low 
yersiniosis notification rates might represent a failure to detect Yersinia infection in 
humans, possibly due to the requirement for specific culture methodology to isolate 
Yersinia species from faeces [65, 78]. 
Isolation of pathogenic Yersinia species from stool specimens may require selection 
for the bacterium in the presence of other background microflora [17, 82, 86]. Cold 
enrichment of specimens at refrigerator temperatures (2-8°C) for up to three weeks 
is an effective procedure for isolation of Yersinia species from food [84, 85] and 
human stool samples [82, 86]. Alternatively, alkali shock may rapidly eliminate 
competing microflora without prolonged cold enrichment for the selective isolation 
of pathogenic Yersinia from stool samples [105] and food [104, 106, 107]. A short 
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enrichment period in respect of diarrhoeal stool samples in Yersinia selective broth 
at 16°C and subsequent inoculation onto Cefsulodin Irgazan Novobiocin (CIN) agar 
(YSE-CIN method) significantly increased the isolation of pathogenic Y. 
enterocolitica from diarrhoeal stool samples in comparison to traditional culture 
methods [79]. Specific enrichment or selective culture for Yersinia is not currently 
routinely practised in most diagnostic laboratories in Ireland. 
While infection with Y. enterocolitica and Y. pseudotuberculosis mainly involves the 
gastrointestinal tract with acute enteritis [12, 13, 17, 80, 92, 560] and mesenteric 
lymphadenitis (mimicking appendicitis) [92, 178, 179], in some outbreaks of 
yersiniosis, pharyngitis and not diarrhoea was a common symptom [198, 199]. 
Although enteritis is the most common clinical form of yersiniosis [12, 13, 17, 80, 92, 
560], isolation rates of Yersinia species from postoperative appendix swabs (2.7% to 
10%) [90, 183, 189] are often higher than from faeces (0.2% to 6.2%) [65, 78, 91, 
190, 191]. 
Therefore, evidence of Yersinia infection in humans in Ireland was sought by 
carrying out Yersinia selective culture of diarrhoeal stool samples with different 
modes of enrichment, as well as culture screening of throat swabs from patients 
with pharyngitis and swabs from resected appendix fossae. Furthermore, because 
subclinical forms of yersiniosis [17, 162-164, 562] do not result in submission of 
stool samples for culture, a molecular and culture screening of human sewage as 
well as a serological survey of asymptomatic healthy individuals were carried out. 
2.2 Materials and methods 
2.2.1 Clinical specimens screening methodology 
2.2.1.1 Clinical specimens selection 
Yersinia selective culture was carried out on anonymised clinical specimens 
collected at the Microbiology Department of Cork University Hospital (CUH) during 
five collection periods (Table 2.3). Diarrhoeal stool samples were obtained from 601 
(50.5%) children and 588 (49.5%) adults (≥18 years). Outpatients were prioritised 
to exclude nosocomial diarrhoea. However, 17.8% of all screened stool samples 
were acquired from inpatients admitted to the hospital with diarrhoea. Formed 
stools were excluded from the survey. 
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All throat swabs from patients with a clinical diagnosis of pharyngitis available 
during collection period 4 (Table 2.3) and appendix swabs from surgical patients 
with a clinical diagnosis of appendicitis available during collection period 5 were 
cultured for the presence of Yersinia species. Demographic information was not 
available for patients with pharyngitis. Appendix swabs were obtained from eleven 
children and twelve adults (>18 years), for two specimens information about age of 
patients was not provided. Fifteen (65.2%) surgical patients received pre-operative 
antibiotic treatment with the amoxicillin/clavulanic acid. 
2.2.1.2 Yersinia isolation methodology 
During each collection period different isolation procedures were used in 
progressive order (Table 2.3). Various liquid enrichment procedures were carried 
out over the course of the study; final incubation was on CIN (LIP, Galway, Ireland) 
agar plates for three of four of these, and for one period direct plating of faeces onto 
CIN agar plates was applied. Inoculated agar plates were incubated at 30°C for 18–
24 h [127], if no bacterial growth was observed after this period of incubation plates 
were incubated for an additional 24 hours at 30°C with a maximum incubation time 
of 48 hours. MacConkey (MAC) (Merck Chemicals) agar plates were used for 
inoculation of diarrhoeal stool samples following cold enrichment during collection 
period 1 only. 
Cold enrichment (CE) procedure. A loop full (approx. 10 µl) of each stool sample 
was inoculated into 5 ml of phosphate buffered saline (PBS) (Sigma-Aldrich) and 
placed into a refrigerator (2-8°C) for cold enrichment (CE) over a 3-week period 
[127]. CE procedures were used for 375 specimens collected during periods 1 and 2 
only (Table 2.3). Stool enrichments were plated onto MAC agar plates [88] during 
collection period 1 and onto CIN agar plates [91, 563] during collection period 2. 
Alkali treatment procedure. Alkali treatment to remove contaminating faecal flora 
was applied to stool specimens during period 1 only. Prior to alkali treatment PBS 
suspensions of stool samples (5 ml) were incubated at 30°C for 48 h (warm 
enrichment, WE) [104, 107]. Three methods of alkali treatment were applied. 
Method A (0.25% KOH, 2 min) [105, 110]: equal parts of stool sample after WE and 
0.5% KOH solution were mixed for 2 min. Method B (0.25% KOH, 15 sec): equal parts 
of stool sample after WE and 0.5% KOH solution were mixed for 15 sec. Method C 
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(0.5% KOH, 15 sec): equal parts of stool sample after WE and 1.0% KOH solution 
were mixed for 15 sec. One portion of PBS stool suspensions were alkali treated and 
inoculated onto MAC agar plates [104, 105, 107], and another portion was plated 
onto MAC agar plates without prior alkali treatment. 
YSE-CIN procedure. During collection periods 4 and 5 all clinical specimens (faeces 
and swabs) were enriched in Yersinia selective (YSE) broth and inoculated onto CIN 
agar plates. YSE broth was prepared as described [79, 564]: 10 g tryptone (Merck 
Chemicals), 2.75 g 3-N-morpholino propanesulfonic acid (MOPs) (Sigma-Aldrich), 
2.75 g Tris-HCl [pH 8.4] (Sigma-Aldrich), 20 g D-sorbitol (Sigma-Aldrich), 1.5 g Bile 
salts (Sigma-Aldrich) were dissolved in 1 L of distilled H2O and autoclaved at 121°C 
for 15 min. Two vials of Yersinia selective supplement (OXOID, UK) containing 
cefsulodin, irgasan and novobiocin antimicrobials, and 5 ml of sterile 0.8 M KClO3 
(potassium chlorate) (Sigma-Aldrich), were added to 983 ml of autoclaved base 
broth and pH adjusted to pH 8.4. 
In period 4, pooled stool samples (5 samples for each 20 ml of enrichment broth) 
were enriched in YSE broth at 16°C for 48 h [79]. Throat swabs were enriched in 
YSE broth in pools of 5 for each 20 ml of broth and incubated at 30°C for 96 h. 
In period 5 pooled stool samples (10-15 samples for each 35 ml of enrichment 
broth) were enriched in YSE broth at 2-8°C for 10-12 days. Each appendix swab was 
enriched in 10 ml of YSE broth and incubated at 2-8°C for period of 3 weeks. 
2.2.2 Recovery of Y. enterocolitica from experimentally inoculated faecal 
specimens 
Diarrhoeal faeces from 13 individuals known to be negative for enteric pathogens 
were homogenized (1:1) in sterile PBS solution. Each homogenized faecal specimen 
was divided into six sterile containers (0.9 ml per container) and spiked with 0.1 ml 
of six ten-fold serial dilutions of 1.0 OD600 nm Y. enterocolitica IP383 (B2/O:9) to 
achieve final concentrations in aliquoted spiked stool samples ranging from 1.8x106 
to 1.8x10 CFU/ml of faecal homogenate. Thoroughly mixed spiked faeces were 
processed accordingly to the Yersinia selective procedures in Table 2.3 with the 
exception of YSE-CIN used in periods 4 and 5 for which individual stool samples 
rather than pooled samples were spiked. 
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2.2.3 Yersinia identification procedures 
Biochemical identification of Yersinia. Presumptive Yersinia species colonies 
(small lactose-negative on MAC agar plates [113], and small red bull-eye appearance 
colonies on CIN agar [114]) were further identified with API 20E biochemical 
galleries (BioMérieux), incubated overnight at 30°C [130, 131]. Isolates identified as 
Y. enterocolitica were biotyped according to the Wauters schema [133] and screened 
for the presence of Yersinia virulence plasmid (pYV) on Congo Red-Magnesium 
Oxalate (CR-MOX) agar [565]. 
CR-MOX agar was prepared as described [565]: 40 g of tryptic soy agar (Merck 
Chemicals) was mixed with 825 ml of distilled water and autoclaved for 15 min at 
121°C. The molten medium was cooled to 55°C, and the following solutions were 
added: 80 ml 0.25 M sodium oxalate (Sigma-Aldrich), 80 ml 0.25 M magnesium 
chloride (Sigma-Aldrich), 10 ml 20% D-galactose (Sigma-Aldrich), and 5 ml 1% 
Congo Red (Sigma-Aldrich). The D-galactose solution was sterilized by autoclaving 
for 10 min at 115°C. All other solutions were autoclaved for 15 min at 121°C. 
Yersinia strains forming small pinpoint bright red colonies on CR-MOX agar after 
overnight incubation at 37°C were deemed pYV positive. The positive control 
organism was pYV-positive Y. enterocolitica 8081 sourced from D. Portnoy, 
University of California. 
Molecular identification of Yersinia. 16S rDNA from isolates was amplified with 
the following primers: 16S-27F (5’-aga gtt tga tcc tgg ctc ag-3’) [566] 
and 16S-1435R (5’-ctt ctt ttg caa ccc act cc-3’) and the sequences 
were initially assigned to a taxonomic group with the Ribosomal Database Project 
Classifier [567] and an RDP Seqmatch search carried out [568, 569]. 
2.2.4 Human sewage and pig slurry screening for pathogenic Yersinia 
2.2.4.1 Separation of bacterial cells from the faecal matter 
Human sewage samples (500 ml) from five sewage treatment plants (STP) and pig 
slurry (PS) (500 ml) from six pig farms were collected in county Cork, Ireland. 
Sewage samples were concentrated by centrifugation at 4300 x g for 5min. For pig 
slurry the concentration protocol was omitted due to the high concentration of the 
faecal material. Bacterial cells were separated from concentrated raw sewage and 
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pig slurry by Nycodenz (Axis Shield) gradient centrifugation as described [570, 571]. 
Briefly, a 1 ml sample of concentrated sewage was centrifuged with 650 µl of 
Nycodenz (1.3 g/ml in 10 mM Tris-HCl (pH 8.0) containing 1 mM EDTA) at 10,000 x 
g for 6 min at 4°C [571]. 25 ml of neat pig slurry was centrifuged with 9 ml of 
Nycodenz (1.3 g/ml in 10mM Tris-HCl (pH 8.0) containing 1 mM EDTA) at 10,000 x 
g for 20 min at 4°C [570]. Separated bacterial cells from Nycodenz first were washed 
in 5 ml of sterile PBS by centrifugation at 10,000 x g for 10 min and then the washed 
bacterial pellet was inoculated into 5 ml of YSE broth [79, 564] and incubated with 
shaking at 200 rpm overnight at 30°C [564]. YSE enrichments were streaked onto 
CIN agar plates, and 1 ml of each broth was aliquoted for DNA extraction with a 
Promega Total DNA kit (Promega UK, Southampton). Inoculated CIN agar plates 
were incubated overnight at 30°C for 18–24h [127]. Presumptive Yersinia spp. 
colonies were identified as described above. 
2.2.4.2 Molecular detection of Yersinia contamination 
Molecular screening for pathogenic Yersinia species in sewage and pig slurry used a 
modified yadA nested PCR protocol [148]. Additionally, the presence of Y. 
pseudotuberculosis specific ail and Y. enterocolitica specific ystA genes were 
identified using published PCR primers [151, 572] (Table 2.1). PCR master mix for 
each reaction was prepared with GoTaq Green Polymerase kit (Promega UK, 
Southampton) according to the manufacturer’s recommendations; total volume of 
the PCR reaction for each protocol was 50 µl. PCR was performed on a PTC-200 
Peltier Thermocycler with the following conditions: denaturation at 94°C for 5 min; 
followed by 29 cycles of each: denaturation at 94°C for 30 sec, annealing depending 
on Tm of primers ranged from 55°C to 65°C for 30sec, elongation at 72°C for 40 sec, 
and final elongation at 72°C for 7 min. Amplicons were maintained at 4°C. The first 
round of yadA PCR consisted of 40 cycles, the second round of yadA nested PCR 
consisted of 20 cycles. Because the yadA PCR products were of variable size their 
identity was confirmed by commercial sequencing (GATC, Germany). To confirm the 
absence of PCR inhibitory substances co-purified from faecal material, 
environmental DNA samples were spiked with control DNA isolated from Y. 
enterocolitica 8081 in a ratio of 4:1 (Environmental DNA : Control DNA). 
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Table 2.1 Primers used for environmental screening for Yersinia species 
Target  Primer Sequence Product size (bp) PCR Method Ref 
Y. enterocolitica ystA F 5’-aatgctgtcttcatttggagc-3’ 145 Simple [572] 
R 5’-atcccaatcactactgacttc-3’ 
Y. pseudotuberculosis ail F 5’-cgtctgttaatgtgtatgccgaag-3’ 157 Simple [151] 
R 5’-gaacctatcactccccagtcattatt-3’ 
Y. enterocolitica yadA F 5’-taagatcagtgtctctgcggca-3’ 747 Nested [148, 573] 
R 5’-tagttatttgcgatccctagcac-3’ 
F 5’-gcgttgttctcatctccatatgc-3’ 529 
R 5’-ggctttcatgaccaatggatacac-3’ 
F  :Forward primer 
R  :Reverse primer 
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2.2.5 Serological screening 
Anonymised blood plasma samples from 200 Irish blood donors were obtained from 
the Munster Regional Blood Transfusion Centre, St. Finbarr’s Hospital, Cork in April 
2009 together with 17 blood plasma samples obtained from surgical patients 
diagnosed with appendicitis, who were admitted to CUH. Blood plasma samples 
were stored at -20°C for one week before analysing and then transferred for long 
term storage at -80°C. The nationality of the individual blood donors was not known. 
All samples were initially tested for anti-Yersinia antibodies with the quantitative in 
vitro recomWell Yersinia IgG ELISA (Mikrogen Diagnostik, Germany). The 
immunoassay was performed and interpreted according to the manufacturer’s 
guidelines. Samples with measured antibody activity levels below 20 U/ml were 
considered as negative, samples with measured antibody activity levels between 20 
and 24 U/ml were assigned as borderline, and samples with the antibody activity 
levels above 24 U/ml were recorded as positive. Samples with equivocal results 
were retested. Positive samples in recomWell Yersinia IgG ELISA assay were tested 
with the recomLine Yersinia IgG strip immunoassay. This is a qualitative in vitro 
assay that allows specific detection of anti-Yersinia antibodies against pYV plasmid 
encoded virulence factors: YopM, YopH, V-Ag, YopD, YopN and YopE applied to a 
nitrocellulose membrane strips. Each strip also contains a reaction control, an IgG 
conjugate control and a cut off control band. All tests were performed and 
interpreted according to the manufacturer’s guidelines. Samples were considered as 
anti-Yersinia IgG positive when the reaction control and IgG conjugate controls were 
positive for YopD or at least two other bands displayed the same (+) or a stronger 
(++/+++) intensity (as judged by the un-aided eye) than the cut off control. If no 
YopD-band (-) or weak YopD-band (+/-) but at least two other bands with the same 
(+) or a stronger (++/+++) intensity than the cut off control was seen then results 
were interpreted as borderline. 
Blood plasma collected from 17 patients with appendicitis was tested with 
RecomWell Yersinia IgG kit only. 
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2.2.5.1 Cross reactivity screening 
Blood plasma positive for Yersinia IgG and gender/age matched anti-Yersinia IgG 
negative blood plasma were screened with a recomBead Borrelia IgG assay 
(Mikrogen Diagnostik, Germany) [574]. This is a semi-quantitative in vitro 
immunoassay based on Luminex xMAP® technology enabling detection of anti-
Borrelia antibodies against four Borrelia species pathogenic for humans: B. 
burgdorferi sensu stricto, B. garinii, B. afzelii and B. spielmanii. Results were 
interpreted using specifically designed Excel-based software supplied by Mikrogen 
Diagnostik (Germany). 
2.2.6 Statistical analysis 
Linear regression with significance level of 0.05 and χ2 (Chi-square) were used to 
model relationships between serological variables in MiniTab® 16 statistical 
software. P values for spiked cultures were calculated using GraphPad QuickCalcs 
Web site: http://www.graphpad.com/quickcalcs/Contingency1.cfm (accessed November 
2011). Power calculations for the sample size of the faeces and throat swab culture 
studies were carried out as described [575] based on an inability to falsify the null 
hypothesis that pathogenic Yersinia are not responsible for diarrhoea/throat 
infection in our population, using a binomial model with an assumed population size 
of >100,000 and an expected true prevalence of pathogenic Yersinia causing 
diarrhoea requiring samples to be sent for culture (threshold of concern) of 0.005, 
and an expected prevalence of pathogenic Yersinia throat carriage of 0.02. 
2.3 Results 
2.3.1 Clinical specimens screening 
Pathogenic Yersinia species were not detected in the 1,189 faeces samples, 297 
throat swabs and 23 appendix swabs cultured in this study with the procedures 
summurised in Table 2.3. Three non-pathogenic biovar 1A Y. enterocolitica strains 
(pYV negative on CR-MOX agar and by PCR for yadA) were isolated from pooled 
faeces cold enriched in YSE broth in period 5. Each isolate was cultured from a 
separate pool: adults (11 samples), children 5 to 9 years old (6 samples) and 
children 0 to 4 years old (14 samples). 
 71 
 
Table 2.2 Clinical and demographic distribution of patients with diarrhoea 
 
Table 2.3 Isolation procedures 
* Different liquid enrichment methods employed but all specimens sub cultured on CIN agar, apart 
from period 1 (MAC agar). 
If the true prevalence of Y. enterocolitica causing diarrhoea with faecal samples 
submitted for culture in our population was 0.005 (0.5%), a minimum sample size of 
919 would be required to detect the presence of this disease with 99% confidence 
[575]. This number is exceeded in the current study, even excluding samples 
processed in period 1 using MacConkey agar, which was inferior in detection of 
Patients age groups All patients Inpatients Blood in stool 
Abdominal 
pain 
Children (0-14 yo) 601 (50.5%) 115 (19.1%) 10 (1.7%) 12 (2.0%) 
Adolescents (15-17 yo) 4 (0.3%) 0 (0%) 0 (0%) 1 (25%) 
Adults (≥18 yo) 584 (49.1%) 97 (16.6%) 16 (2.7%) 15 (2.6%) 
Total 1189 (100%) 212 (17.8%) 26 (2.2%) 28 (2.3%) 
Period Duration 
Sample Numbers Isolation 
Procedures* Stool Throat Appendix 
1 27th March’07 - 27th 
April’07 
191 - - CE, alkali treatment, 
MAC agar  
2 14th January’08 - 12th 
February’08 
184 - - CE 
3 9th - 18th December’08 97 - - Direct plating 
4 10th November’09 –  
13th April’10 
122 297 - Stool Samples (pools 
of 5) – YSE broth 
(16°C, 48 h) 
Throat swabs (pools 
of 5) – YSE broth 
(30°C, 96 h)  
5 13th May’11 –  
21st June’11 
595 - 23 Stool samples (pools 
of 10-15) – YSE broth 
(2-8°C, 10-12 days) 
Appendix swabs – YSE 
broth (2-8°C, 21 days) 
Total  1189 297 23  
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spiked faeces samples to the culture methods used in periods 2-5 (see below). 
Similarly, the negative throat swabs exceed the minimal sample size of 228 to 
exclude 2% pharyngitis caused by culturable Y. enterocolitica with 99% power. 
2.3.1.1 Recovery of Y. enterocolitica from experimentally inoculated faecal 
specimens 
Prolonged cold enrichment in PBS and subsequent inoculation onto CIN agar 
resulted in the highest recovery rates of Y. enterocolitica IP383 (Table 2.4). Culture 
on MacConkey plates was less likely to result in recovery than other methods 
(1.8x106 CFU two-tailed P < 0.0001, Fisher’s exact test). Inferiority of MAC agar 
plates was stool-specific (only shown with some stools) and failure to isolate 
Yersinia was because of overgrowth of background enteric microflora. 
Table 2.4 Recovery of Y. enterocolitica from experimentally inoculated faecal 
samples 
Isolation Procedure 
Y. enterocolitica IP383 inoculums, CFU/ml of faeces 
Period 1.8x106 1.8x105 
PBS CE + MAC 1 46.2% 
(6/13)* 
46.2% 
(6/13)** 
PBS CE + CIN 2 100% 
(13/13) 
100% 
(13/13) 
CIN direct plating 3 100% 
(13/13) 
92.3% 
(12/13) 
YSE broth 16°C, 48h 4 92.3% 
(12/13) 
84.6% 
(11/13) 
YSE broth CE 5 100% 
(13/13) 
92.3% 
(12/13) 
* P < 0.0001 
** P = 0.006 
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2.3.2 Human sewage and pig slurry screening for pathogenic Yersinia 
Screening of human sewage and pig slurry detected a Yersinia specific yadA gene 
fragment in three out of six pig slurry samples and in four out of five human sewage 
samples (Figure 2.1), ystA sequences were detected in two pig slurry samples, but 
not in human sewage (Table 2.5). Pathogenic Yersinia species were not isolated from 
either pig slurry or human sewage (Table 2.5). Four Yersinia isolates were recovered 
from three (60%) human sewage samples (Table 2.5). These strains did not contain 
the pYV plasmid as determined by CR-MOX and yadA PCR and their 16S rDNA 
sequences did not match Yersinia species pathogenic for humans. Although 16S 
rDNA is insufficient as sole criterion to separate all Yersinia species, Y. enterocolitica 
and Y. pseudotuberculosis 16S rDNA sequences are distinct [156, 485] and were not 
found in these cultures. 
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Table 2.5 Environmental detection of Yersinia species by culture and PCR 
Source Culture Results RDP Classifier* RDP Seqmatch*2 
Environmental PCR on sewage/pig slurry 
YPT ail ystA yadA Simple yadA Nested 
PS1 - NT NT - - - - 
PS2 - NT NT - - - - 
PS3 - NT NT - + + + 
PS4 - NT NT - + + + 
PS5 - NT NT - - - - 
PS6 - NT NT NT NT - + 
STP1 - NT NT - - - + 
STP2 M1 – API 20E 1105723 
Y. enterocolitica 93.9% 
 
M3 - API 20E 1014522 
Y. enterocolitica 1.2%*3 
Yersinia 
 
 
Yersinia  
Y. intermedia ATCC 29909 
 
 
Y. kristensenii ATCC 33638 
NT NT - - 
STP3 API 20E 1115773  
Enterobacter gergoviae 83% 
Yersinia Y. frederiksenii ATCC 33641  NT NT - + 
STP4 - NT NT - - - + 
STP5 API 20E 1115563  
Y. enterocolitica 83.5% 
Yersinia  Y. aldovae ATCC 35236  - - - + 
PS1 - PS6:Pig slurry samples; STP1 – STP5:Human sewage samples; YPT:Y. pseudotuberculosis specific PCR; 
“-“:Negative results; “+”:Positive results; NT:Not Tested; *  16S rDNA RDP culture assignment; * 2 Type strain with maximal similarity score to culture 
16S rDNA with RDP Seqmatch; * 3 Biochemically biotype 3 but lacking pYV and ystA 
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Figure 2.1 yadA nested PCR 
Expected PCR product 529bp 
PS1 - PS6  :Pig slurry samples 
STP1 – STP5  :Human sewage samples 
8081  :Y. enterocolitica subsp. enterocolitica strain 8081 
NEG  :Negative control 
M   :Low molecular weight marker (NE BioLabs, UK) 
 
 
Figure 2.2 ClustalW2 alignment of the Yersinia spp. YadA head domain sequences 
*In blue boxes YadA head domain degenerate repeat sequences; 
** In multicolored boxes N-terminal 32aa insert seen in Y. pseudotuberculosis and PS3 
Alignment of translated yadA PCR fragments from pig slurry and human sewage 
showed amino acid (aa) repeats characteristic of the Yersinia pYV-specific YadA 
head domain (Figure 2.2, denoted in colour) [389]. The PCR product from PS3 was 
larger than the expected size (Figure 2.1) and encoded a 32 residue N-terminal 
insert (Figure 2.2) resembling a spacer domain found in Y. pseudotuberculosis YadA 
[391]. Although the best BLASTX hit for the whole PCR product PS3 was Y. 
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pseudotuberculosis YadA (Table 2.6), molecular phylogenetic analysis of a multiple 
alignment of the yadA fragment nucleotide sequences grouped all PS and STP 
sequences with Y. enterocolitica yadA sequences rather than Y. pseudotuberculosis 
(Figure 2.3). Moreover, a Y. pseudotuberculosis-specific ail gene fragment [151] was 
not amplified from the PS3 sample but the Y. enterocolitica specific ystA [572] was 
detected (Table 2.5). 
 
Figure 2.3 Neighbor-Joining tree showing relationship of the yadA sequences 
The tree was constructed using the Neighbor-Joining method [8]. The optimal tree with 
the sum of branch length = 0.07758621 is shown. The percentage of replicate trees in 
which the associated taxa clustered together in the bootstrap test (500 replicates) are 
shown next to the branches [9]. The tree is drawn to scale, with branch lengths in the 
same units as those of the evolutionary distances used to infer the phylogenetic tree. The 
evolutionary distances were computed using the p-distance method [10] and are in the 
units of the number of amino acid differences per site. The analysis involved 14 amino 
acid sequences. All positions containing gaps and missing data were eliminated. There 
were a total of 377 positions in the final dataset. Evolutionary analyses were conducted 
in MEGA5 [11]. 
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Table 2.6 BLASTX yadA gene fragments results 
Source AA 
BLASTX results 
Bacterial strain providing 
best hit 
Database Hit 
gene/ORF 
Sequence reference 
number 
Max. Identity Query coverage E-value 
PS3 181 Y. pseudotuberculosis IP32953 pYV0013 emb CAF253561.1 82% 100% 4e-71 
PS4 151 
Y. enterocolitica subsp. 
palearctica 105.5R 
YadA gb ADZ44497.1 97% 99% 2e-59 
PS6 149 
Y. enterocolitica subsp. 
palearctica Y11 
Y11_p0221 emb CBY78119.1 100% 99% 9e-73 
STP1 154 
Y. enterocolitica subsp. 
palearctica Y11 
Y11_p0221 emb CBY78119.1 100% 96% 7e-65 
STP3 151 
Y. enterocolitica subsp. 
enterocolitica 8081 
YadA emb CAL10087.1 100% 97% 3e-77 
STP4 152 
Y. enterocolitica subsp. 
enterocolitica 8081 
YadA emb CAL10087.1 100% 94% 4e-74 
STP5 150 
Y. enterocolitica subsp. 
enterocolitica 8081 
YadA emb CAL10087.1 100% 98% 2e-77 
AA  :length of translated amino acid sequence 
PS1 - PS6 :Pig slurry samples 
STP1 – STP5 :Human sewage samples 
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2.3.3 Serology 
Anti-Yop Yersinia IgG was detected in 57 (28.5%) of Irish blood donors after initial 
screening with the recomWell (ELISA) assay. The presence of anti-Yersinia YopD IgG 
antibodies was confirmed in 50 of these blood plasma samples (25 % of the total) 
with the RecomLine strip immunoassay. One sample was borderline positive in the 
RecomLine assay. 
 
Figure 2.4 Anti-Yersinia IgG seroprevalence 
A linear regression model analysis (Figure 2.4) showed an age-related increase of 
anti-Yersinia IgG antibodies among healthy individuals: seroprevalence increased 
from 13.3% in 18- to 25-year old donors to 38.1% in 56-66 year old donors (P-value 
= 0.001). Anti-YOP Yersinia IgG seropositivity showed no significant sex difference. 
Cross-reactivity between YopD and Borrelia burgdorferi antigens has been reported 
[292, 293] and the estimated minimum notification rate of Lyme borreliosis in 
Ireland is 1.67/100,000 [576] and is higher than the notification rates for 
yersiniosis. However, no anti-Borrelia antibodies were detected using the 
RecomBead Borrelia IgG assay (Mikrogen) in the 50 Yersinia antibody-positive 
specimens or 43 Yersinia antibody-negative age and gender matched blood donor 
plasma controls. No relationship between the presence of anti-Yersinia IgG antibody 
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and appendicitis was observed as 25% of healthy blood donors and 17.6% of 
patients who underwent appendectomy were anti-Yersinia seropositive. 
2.4 Discussion 
No isolates of pathogenic Yersinia were recovered from 1,189 diarrhoeal stool 
samples processed at CUH, despite the use of standard Yersinia selective culture 
techniques. Three non-pathogenic Y. enterocolitica biovar 1A strains were isolated 
following cold enrichment of diarrhoeal stool samples in YSE broth and subsequent 
inoculation onto CIN agar plates. Y. enterocolitica biovar 1A are frequently isolated 
from diarrhoeal stool samples [63, 78, 577], but their pathogenicity towards humans 
remains unclear [556, 578]. Prospective faecal culture studies in other countries 
where yersiniosis is common reported 1.1% (Finland) [78], 4.1% (Belgium) [89], 
and 6.2 % (China) [65] of samples positive for pathogenic Y. enterocolitica. Tests 
with spiked samples (Table 2.4) indicated faecal culture methods used in this study 
(derived from previous published prospective surveys) could detect Y. enterocolitica 
at counts of 105-108 CFU/g typically found in culture positive stools by real time PCR 
[65]. Our negative result excluded a true yield of 0.5% or more of diarrhoeal stools 
containing Y. enterocolitica in our study population with 99% power, suggesting Y. 
enterocolitica is a much less common cause of diarrhoea in Ireland than in the above 
countries, consistent with current notification rates. 
Because of the associated presentation of yersiniosis with pharyngitis [198, 199], 
297 throat swabs from patients with pharyngitis were also cultured using a 
sensitive selective enrichment method for Yersinia [79], with similarly negative 
results, excluding a true 2% yield of culturable Y. enterocolitica in pharyngitis with 
99% power. In contrast pathogenic Y. enterocolitica has been cultured from tonsil 
swabs with CIN agar direct plating from 31% of local slaughtered pigs in Ireland 
(unpublished Murphy et al.), a similar rate to that reported in other countries [57, 
561, 579]. These results are further evidence for a low current rate of Y. 
enterocolitica infection in the human population in Ireland, although the positive pig 
swabs suggest exposure from the local food chain is potentially similar to other 
countries where isolation rates from humans are higher. Therefore, variations in 
food preparation methods (including popular raw pork dishes in Germany [80], 
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Belgium [66] and Norway [16]) may be important determinants in the observed 
variation in incidence of human yersiniosis between different countries in Europe. 
Yersinia selective culture of 23 appendix swabs from surgical patients did not yield 
any Yersinia isolates. The reported isolation rates of Yersinia species from 
postoperative appendix swabs are 2.7% to 10% [90, 183, 189]. 
Following initial negative faeces cultures from patients with diarrhoea, molecular 
investigation of different human sewage and pig slurry samples was carried out as a 
means by which to identify pathogenic Yersinia species in a wider sample of human 
and animal excreta. The PCR targets for pathogenic Y. enterocolitica chromosomal 
target ystA and plasmid-located yadA were detected in pig slurry and not in human 
sewage by simple PCR. Nested PCR was required to detect yadA in human sewage, 
consistent with a low level of intestinal excretion of pathogenic Y. enterocolitica in 
humans locally compared with pigs. There was little evidence of Y. 
pseudotuberculosis-specific DNA in either pig slurry or human sewage samples: the 
Y. pseudotuberculosis chromosomal ail gene was not detected. pYV-located yadA 
DNA was found in both pig slurry and human sewage samples. Multiple alignment of 
deduced amino acid sequences suggested these were more likely to represent 
Y.enterocolitica yadA than Y. pseudotuberculosis yadA. A single yadA sequence 
amplified from pig slurry encoded a 31 aa N-terminal insert (Figure 2.2) resembling 
a spacer domain found in Y. pseudotuberculosis YadA that is responsible for bacterial 
uptake by epithelial cells [391], but the remaining sequence of the amplicon more 
closely resembled Y. enterocolitica yadA. The significance of this chimaeric sequence 
is uncertain. 
Negative sewage and pig slurry culture results in the light of molecular detection of 
pathogenic Yersinia could arise from inter-bacterial competition in a complex 
environment. Bacteriocins secreted by non-pathogenic Yersinia species may be 
active against pathogenic Yersinia [96, 97, 142, 143] and may reduce isolation of 
pathogenic Yersinia from environmental samples such as soil and sewage [144-146] 
while still allowing molecular detection at a low level. 
The overall seroprevalence of anti-Yersinia YOP IgG antibody in healthy blood 
donors was 25% and is similar to that recorded in other countries such as Austria 
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(employing the same detection protocol) [164] and Finland [162], where reported 
rates of yersiniosis are much higher than in Ireland [12]. Cross-reactivity between 
anti-Borrelia antibodies and Yersinia antigens has been reported [292, 293]. 
However, no blood plasma specimens tested in this study, reacted with Borrelia 
antigens. If the seropositivity in blood donors reflected current or recent infection, 
we would expect to see a high incidence of transfusion-related Yersinia septicaemia 
in Ireland similar to other countries where yersiniosis is common such as New 
Zealand [248]. However, there have been no reports of Yersinia sepsis following 
blood transfusion in Ireland, in keeping with the low incidence of yersiniosis. 
However, it should be noted that all blood components used in Ireland have been 
leuco-depleted since October 1999 [580], thereby reducing the potential risk of 
transfusion-related Yersinia sepsis [248, 256-259]. 
There was a significant association between increasing age and the presence of anti-
Yersinia YOP antibodies, compatible with a cohort effect of increased risk of 
infection with pathogenic Yersinia in Ireland. In Ireland in the 1980s acute anterior 
uveitis was commonly associated with positive Yersinia serology [204], and a 
serological survey detecting agglutinating antibodies reported that 23% of patients 
with a clinical diagnosis of appendicitis, and 2% of healthy controls in two hospitals 
in Dublin had active yersiniosis [177]. The ratio of Y. pseudotuberculosis to Y. 
enterocolitica agglutination seropositivity was 5:1 [177], but infections with either 
species would result in anti-YOP antibodies in the assay used in the current study. 
Pathogenic Y. enterocolitica were present in retail raw and cooked meat samples in 
Ireland in the mid 1990s [106]. 
IgG immunoglubulins are secreted at latter stages of an infection cycle, and the 
presence of anti-Yersinia IgG is commonly used to detect past infections [262]. The 
duration of detectability of anti-YOP antibodies following Yersinia infection is not 
well documented, but there is evidence for anti-somatic Yersinia IgG persistence for 
several years after occurrence of uncomplicated (untreated) yersiniosis [280], 
appendicectomy [76], and in relatives of patients with thyroid disorders [289]. Y. 
pseudotuberculosis is notoriously difficult to culture from faeces [121, 141] and was 
not isolated in the current study or the unpublished pig abbatoir study (unpublished 
Murphy et al.). Y. pseudotuberculosis infection has been associated with 
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contaminated water supplies [75, 581, 582]. In Ireland the quality of drinking water 
has been recently improved in many areas in response to European legislation 
[583], and a decreasing level of Y. pseudotuberculosis infection since the 1980s could 
have accompanied this change, contributing to the age-related cohort serology.  
However, it seems unlikely that over 25% of healthy blood donors have been 
infected with Y. pseudotuberculosis alone, as this organism is generally a rarer cause 
of yersiniosis than Y. enterocolitica even in countries with a high incidence of 
yersiniosis [12]. 
The absence of Y. enterocolitica as a culturable cause of diarrhoea in this prospective 
study is compatible with the current low national yersiniosis notification rate and 
the lack of reports of Yersinia associated blood transfusion contamination in Ireland. 
We suggest the most probable explanation linking absence of culturable Y. 
enterocolitica, with a high seroprevalence of anti-Yersinia Yop antibodies in older 
blood donors, and molecular evidence of the presence of pathogenic Y. enterocolitica 
in human sewage, is a combination of a higher incidence of yersiniosis in Ireland in 
the past (caused by both Y. pseudotuberculosis and Y. enterocolitica) and a continuing 
low incidence of mild self-limited Y. enterocolitica infection which does not result in 
diarrhoea specimens being sent for culture [17, 162-164]. 
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Chapter 3 Yersinia insect toxicity
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3.1 Introduction 
It has been suggested that ancestral Yersinia species were associated with insects or 
insect pathogens [529, 533, 534, 538, 542, 559]. One current Yersinia subspecies, 
Yersinia pestis, is a well known insect and mammalian pathogen, which has to infect 
fleas to be transmitted between mammals. Genome sequences of various Yersinia 
species have demonstrated the presence of several loci found in insect pathogens. 
For example, baculoviral enhancin has been detected in Y. pestis and Y. 
pseudotuberculosis [533, 542] and toxin genes resembling the Insecticidal Toxin 
Complex (ITC) encoded by the insect pathogen Ph. luminescens [551, 552] were 
found in Y. pestis [542], Y. pseudotuberculosis, Y. mollaretii, Y. frederiksenii [554] and 
in mildly pathogenic [555] and non-pathogenic [556] Y. enterocolitica subsp. 
palearctica (but not in the highly pathogenic Y. enterocolitica subsp. enterocolitica 
[532]). There are also bioinformatically identified toxin genes in Y. enterocolitica for 
which activity and targets are at present unidentified, for example apparent 
cytolethal distending toxin (CDT) genes. In this chapter the toxicity of different ITC 
and CDT genotypes of Y. enterocolitica is investigated in an insect model, G. 
mellonella. 
3.1.1 Genetic organisation of Yersinia insecticidal toxin complexes 
Ph. luminescens is part of the gut flora of entomopathogenic nematodes and an insect 
pathogen belonging to the family Enterobacteriaceae [551, 552]. It was the first 
bacterium shown to contain ITC genes and the archetypal description of the 
insecticidal toxin complex operons was established in Ph. luminescens. The 
insecticidal toxin complex (Tc) of Ph. luminescens strain W14 comprises four loci 
(tca, tcb, tcc and tcd) [551, 552]. Each locus contains multiple tca (tcaA, tcaB, tcaC 
and tcaZ), tcb (tcbA), tcc (tccA, tccB, tccC and tccZ) and tcd (tcdA1, tcdB1 and tcc2) 
genes [551, 553]. Based on sequence identity between insecticidal toxin complex 
genes, they can be grouped into three types: type A - tcdA/tcaAB/tcbA/tccAB, type B 
- tcdB/tcaC and type C - tccC [584]. Consequently, tca loci encode type A and type B, 
tcd – type A, B and C and tcc- type A and C genes [554]. 
Yersinia insecticidal toxin complex genes are encoded by tc-PAIYe genomic islands 
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and in all cases are inserted into the same location between YE3797 (tcaR1) and 
YE3798 (tldD) genes with respect to the chromosome of the Y. enterocolitica 8081 
strain [554-556] (Figure 3.1). The tc-PAIYe of pathogenic Y. enterocolitica W22703 
(2/O:9) [555], Y. pseudotuberculosis and Y. pestis [553, 554] contains tca like operon 
structures, non-pathogenic Y. enterocolitica T83 (1A) have tcd like insecticidal toxin 
complex loci [554, 585]. Thus, type A homology genes in Y. enterocolitica W22703, Y. 
pseudotuberculosis and Y. pestis split into tcaA and tcaB genes, unlike in non-
pathogenic Y. enterocolitica T83 in which the type A gene is encoded as a single 
continuous ORF (tcdA [554, 585] or tcbA [556]). The tcaB gene in Y. enterocolitica 
W22703 split into separate ORFs (tcaB1 and tcaB2) [555]. 
 
 
Figure 3.1 Yersinia species insecticidal toxin complexes (adapted from Fuchs et al 
[585]) 
Three homology groups tcaAB/tcdA, tcaC/tcdB, and tccC are shown. Identically coloured 
arrows mark homologous genes. tcaR1 (left) encoding a regulator and tldD encoding a 
putative DNA gyrase modulator (right, checkered) mark the island insertion site 
common for all Yersinia strains that harbour tc homologues. A transposase-like gene 
(tnp) is present in the genome of Y. pestis Angola (red arrow). The overall gene 
organisation is similar for all strains harbouring insecticidal determinants, but 
differences with respect to gene homology, hypothetical ORFs, the presence of 
transposase-like elements and the number of tccC genes are also visible. Gene lengths 
and intergenic regions are in scale. Asterisks mark frameshifts. With the exception of 
tcaC, all frameshifts result in two ORFs. tcaB split into tcaB1 and tcaB2  in Y. 
enterocolitica W22703 not shown.Y. ptb. - Y. pseudotuberculosis 
biovar 1A 
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3.1.2 Insect models 
Insects have been suggested as a model for studying microbial pathogenicity 
towards humans [586-589]. M. sexta (tobacco horn worm) is a moth of the family 
Sphingidae and G. mellonella (Greater Wax Moth) is a moth of the family Pyralidae, 
both belong to order Lepidoptera of class Insecta. Both G. mellonella [590] and M. 
sexta [591] larvae can be kept at 37°C, the optimum temperature for many human 
pathogens, and constitute a cost-effective non-mammalian model for studying 
microbial pathogenesis [592, 593]. A M. sexta larva is an established model for 
studying insect pathogenicity of Ph. luminescens [551, 552, 594-597]. However, a 
good correlation between virulence of human pathogens such as Pseudomonas 
aeruginosa [598], Burkholderia cepacea Complex [599], Y. pseudotuberculosis [600] 
and Candida albicans [601] has been obtained in mammalian and G. mellonella 
infection models. G. mellonella larvae also provide an excellent infection model of 
Listeria septic infection that enables clear differentiation of pathogenic and non-
pathogenic Listeria species, and between virulent and attenuated strains of normally 
pathogenic Listeria monocytogenes [592]. 
3.1.3 Biological activity of insecticidal toxins 
Ph. luminescens insecticidal toxin complex toxin complex (Tc) protein shows clear 
oral toxicity against M. sexta larvae [551, 552, 595-597, 602] and injectable toxicity 
against G. mellonella larvae [603]. There is evidence of differential toxicity of 
individual proteins and of interaction between different Ph. luminescens Tc proteins. 
Deletion of tca or tcd loci in Ph. luminescens reduced its oral toxicity in M. sexta 
larvae and simultaneous deletion of both loci in a single strain completely abolished 
oral insecticidal toxicity of M. sexta larvae [551]. On the other hand, deletion of 
either tcb or tcc loci alone insignificantly reduced mortality of orogastrically infected 
M. sexta [551]. Co-expression of Ph. luminescens tccC and tcdAB in E. coli was 
required for high levels of oral toxicity to M. sexta larvae [596]. Potentiation of TcdA 
oral toxicity was achieved when TcdB and TccC were expressed in the same 
bacterial cytoplasm [597]. When the same potentiators were expressed separately 
in different bacterial cytoplasms, and then mixed with TcdA prior feeding to 
caterpillars, the toxicity of TcdA was not enhanced. Close examination of co-
expressed TcdB and TccC revealed a reduction in TcdB molecular weight suggesting 
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that TccC may modify TcdB when co-expressed [597]. The same potentiators may 
increase toxicity of TcaA and TcaB, which unlike TcdA shows little or no activity 
when fed to caterpillars on its own [597]. The highest biological activity of Ph. 
luminescens W14 insecticidal toxins (TcdA and TcaAB) was achieved in E.coli BL21 – 
a protease deficient strain in comparison with other E.coli hosts EC100 and DH5α 
[602]. Significant levels of biologically active soluble insecticidal toxins were 
obtained after incubation of bacteria at 15°C for 24 hours, and high levels but 
biologically inert and insoluble insecticidal toxins were obtained after bacterial 
incubation at 37°C for 3 hours [602]. Once again, soluble expression of TcaA and 
TcaB was only achieved when these were simultaneously co-expressed in the same 
bacterial cytoplasm [602]. 
To summarise, Ph. luminescens type A toxins (TcaAB and TcdA) require potentiation 
by type B (TcdB) and type C (TccC) proteins for full oral toxicity to M. sexta larvae 
[596, 597]. Moreover, toxins must be co-expressed in the same bacterial cytoplasm 
[596, 597, 602]. Additionally, insecticidal activity of Ph. luminescens Tcs is 
expression host and temperature-dependent, with maximum biological activity 
being obtained when insecticidal toxins are expressed in a protease deficient host at 
15°C for 24h [602]. 
In contrast to Ph. luminescens, Y. pseudotuberculosis toxins TcaC and TccC (TcbB- and 
TccC-like) are substantially less potent combinations with TcaAB [602]. In fact, some 
researchers have not found any M. sexta oral toxicity of Y. pestis or Y. 
pseudotuberculosis TcaAB and TcaC-TccC insecticidal toxin proteins expressed in 
E.coli BL21 [604]. 
While Ph. luminescens TcdA or TcdB-TccC proteins expressed in E. coli BL21 are 
toxic for the rat flea Xenopsylla cheopis, neither Y. pestis nor Y. pseudotuberculosis 
TcaAB and TcaC-TccC toxins expressed in E. coli BL21 mediate acute flea toxicity 
[359]. In fact, live wild-type Y. pseudotuberculosis and isogenic mutants lacking the 
tcaAB locus or the entire tcaA-tccC region were equally toxic for Xenopsylla cheopis 
[359]. Moreover, tcdB-tccC encoding Y. enterocolitica strain CS080 and insecticidal 
toxins non-encoding Y. enterocolitica 8081 were equally toxic to the flea [359]. 
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Also in contrast to Ph. luminescens Tcs (TcaAB and TcdBC), Y. pseudotuberculosis and 
Y. pestis Tcs (TcaAB and TcaCTccC) expressed in E. coli BL21 were not toxic when 
applied as cell lysates to Sf9 insect cells [604]. However, Y. pseudotuberculosis 
caused membrane ruffles, actin vacuoles, multinucleation, and actin condensation 
when applied to human gut cells (Caco-2), and cell lysates of E. coli expressing Y. 
pseudotuberculosis insecticidal toxins reproduced this phenotype. Cell lysates of E. 
coli-expressed Y. pestis and Ph. luminescens Tcs did not affect Caco-2 cells. In 
contrast, cell lysates of E. coli-expressingY. pestis and Ph. luminescens Tcs caused 
actin condensation and nuclear fragmentation in mouse fibroblast NIH3T3 cells 
which were unaffected by Y. pseudotuberculosis Tcs [604]. Transient intracellular 
expression of Y. pseudotuberculosis and Y. pestis Tc proteins in these respective cell 
lines reproduced these phenotypes. 
It has been hypothesized that these phenotypes reflect co-option of insecticidal 
toxins by Y. pseudotuberculosis for activity against mammalian intestinal cells to aid 
enteric pathogenicity, and a similar adaptation by Y. pestis for systemic 
pathogenicity [604]. Interestingly, inactivation of clinical Y. enterocolitica biovar 1A 
insecticidal toxin complex resulted in attenuation of the ability to colonise the 
intestinal tract of orally inoculated BALB/c mice [556]. Moreover, tcbA, tcaC and 
tccC toxin proteins of non-pathogenic biovar 1A Y. enterocolitica strain T83 [556], 
and tcaC, tccC of Y. pseudotuberculosis and Y. pestis [604] are preferentially 
expressed at temperatures of 30°C and 37°C (mammalian body temperature). 
However, it should be noted that tcaA and tcaB of moderately pathogenic Y. 
enterocolitica W22703 are highly expressed at 10°C [555]. No insecticidal activity in 
M. sexta was observed when Y. enterocolitica W22703 was grown at 30°C , but cell 
extracts (not culture supernatants) obtained from grown at 10°C for 48 hours were 
orally toxic towards M. sexta [555]. Cell extracts of highly pathogenic Y. 
enterocolitica subsp. enterocolitica strain 8081v (which does not contain insecticidal 
toxin complex loci [532]) cultured at 10°C were not orally toxic towards M. sexta 
larvae [555]. Insertional knock out of W22703 tcaA, but not tcaB1 resulted in the 
loss of oral insecticidal activity against M. sexta larvae when cell extracts from 
bacterial cultures incubated at 10°C were used [555]. 
However, the presence or absence of an insecticidal toxin complex did not affect the 
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outcome of the subcutaneous infection of G. mellonella at 15°C with different 
pathogenic Y. enterocolitica strains (Table 3.1) [585]. This study did not include 
biovar IA Y.enterocolitica strains. 
Table 3.1 Mortality rates of G. mellonella larvae incubated at 15°C after 
subcutaneous infection with Y. enterocolitica (adapted from Fuchs et al 
[585]) 
Microorganism Strain 
ITC 
presence 
G. mellonella Mortality rates* 
5-7.5x105 
CFU** 
5-7.5x104 
CFU** 
Total Dead, 
% ± SD 
Y. enterocolitica 
2/O:9 
2594 +ve 90% 
(36/40) 
87% 
(34/39) 
90 ± 9% 
(70/79) 
Y. enterocolitica 
2/O:9 
W22703 +ve 56% 
(32/57) 
36% 
(20/57) 
41 ± 17% 
(52/114) 
Y. enterocolitica 
2/O:9 
W22703 
tca::Tn5lux 
tca 
knockout 
55% 
(30/55) 
47% 
(18/380 
51 ± 13% 
(48/93) 
Y. mollaretii NA +ve 94% 
(30/32) 
75% 
(24/32) 
84 ± 5% 
(54/62) 
Y. enterocolitica 
1B:O21 
4466 -ve 98% 
(47/48) 
71% 
(34/48) 
88 ± 11% 
(81/96) 
*Results calculated from the table provided in the reference [585] 
** CFU of bacteria subcutaneously injected into G. mellonella larvae 
NA :Not Applicable 
 
3.1.4 Cytolethal distending toxin 
Putative Cytolethal Distending Toxins (CDT) have been identified in the genome 
sequence of pathogenic Y. enterocolitica strain Y11 [466] and in the genome 
sequences of non-pathogenic Y. enterocolitica (N.Thomson, personal 
communication). CDT are able to cause cell cycle arrest and apoptosis in various 
eukaryotic cells [442-445] including immune cells that may subsequently lead to the 
inhibition of the adequate immune response towards pathogen [605, 606]. CDT are 
produced by a number of bacterial pathogens including: Campylobacter spp. [446-
448], Salmonella enterica Serovar Typhi [449], Shigella dysenteriae [450], Escherichia 
coli [451-454], Helicobacter spp. [455-460], Actinobacillus actinomycetemcomitans 
[461-463], and Haemophilus ducreyi [464, 465]. CDT in Actinobacillus 
actinomycetemcomitans [607] and Haemophilus ducreyi [608, 609] affect 
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lymphocytes in a way that may lead to impairment of the immune response and 
persistent infection. CDT producing Campylobacter jejuni [446] and Shigella 
dysenteria cdtA, cdtB and cdtC cloned in an E. coli JM109 strain [606] can cause 
diarrhoea in a suckling mice model. 
3.1.5 Toxicity of Y. enterocolitica strains isolated in Ireland for G. mellonella 
The predominance of non-pathogenic biovar 1A strains in Y. enterocolitica isolated 
from humans and retail meat samples in Ireland prompted investigation of their 
pathogenic potential in comparison with pathogenic strains in a Galleria model. 
Because the presence of an insecticidal toxin complex in non-pathogenic Y. 
enterocolitica biovar 1A strains has been shown to be linked to an enhanced ability 
for colonisation of the mammalian gastrointestinal tract [556] we screened for the 
presence of insecticidal toxin complex genes in clinical and non-clinical Y. 
enterocolitica biovar 1A strains to be studied in the Galleria model. Because the 
insecticidal toxin complex operon differs in mildly pathogenic biovar 2 - 5 Y. 
enterocolitica and biovar 1A strains (Figure 3.1), two sets of PCR assays were 
required for this. Because the newly demonstrated CDT locus might also play a role 
in toxicity in the Galleria model, we also sought the CDT genotypes among 
pathogenic and non-pathogenic biovars of Y. enterocolitica and Y. enterocolitica-like 
species tested and looked for evidence of expression of CDT toxins in G. mellonella 
larvae incubated at 15 and 37°C. 
Thus, to demonstrate potential pathogenicity of pathogenic and supposedly non-
pathogenic Y. enterocolitica strains isolated in Ireland we compared their virulence 
towards G. mellonella with the virulence of highly and mildly pathogenic Y. 
enterocolitica strains. 
3.2 Materials and Methods 
3.2.1 Yersinia strains 
Culture collections of 64 strains of Yersinia species were obtained from University 
College Galway (gift of Professor Martin Cormican) and 25 strains from Queen’s 
University Belfast (gift of Dr. John Moore), identification of strains was confirmed by 
API 20E BioMérieux incubated at 30°C overnight [130, 131]. Y. enterocolitica and Y. 
enterocolitica like species from retail meat samples (51), dogs (25) and slaughtered 
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pigs (287) were obtained from Niall Drummond and Dr. Brenda Murphy in the 
Veterinary Food Safety Laboratory Cork Council Inniscarra, Co. Cork, Ireland. 
Reference strains of the main biovars were obtained as shown in Table 3.2. 
Table 3.2 Y. enterocolitica reference strains 
Microorganism Reference# Source 
Y. enterocolitica 1B/O:8 8081  
D. Portnoy, University of 
California 
Y. enterocolitica 1A/O:6,30 IP102 E. Carniel, Institute Pasteur 
Y. enterocolitica 2/O:9 IP383 E. Carniel, Institute Pasteur 
Y. enterocolitica 2/O:5, 27 IP885 E. Carniel, Institute Pasteur 
Y. enterocolitica 3/O:5 IP22228 E. Carniel, Institute Pasteur 
Y. enterocolitica 4/O:3 IP134 E. Carniel, Institute Pasteur 
All strains were biotyped according to the simplified Wauter’s Biotyping Scheme 
(Table 3.3) and serotyped with MAST Group Yersinia enterocolitica Antisera that 
included one poly antisera – O:1,O:2 and four mono antisera – O:3; O:5; O:8; O:9. All 
isolates were checked for possible autoagglutination in a drop of sterile 0.85% 
saline solution. 
Table 3.3 Simplified Wauters Y. enterocolitica biotyping scheme 
Tests 
Biotypes 
1A 1B 2 3 4 5 6 
Lipase (Tween-esterase) + + - - - - - 
Voges-Proskauer + + + + + (+) - 
Indole + + (+) - - - - 
Esculin + - - - - - - 
Salicin + - - - - - - 
Xylose + + + + - V + 
Trehalose + + + + + - + 
(+) :Delayed reaction 
V :Variable reaction 
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3.2.2 DNA isolation 
A loopful of overnight bacterial culture grown on tryptic soy agar (TSA) plates at 
30°C was gently resuspended with 600µl of Nuclei Lysis solution (Promega Wizard 
Genomic DNA purification protocol, Promega UK, Southhampton) in 1.5ml tubes. 
After bacterial culture was fully homogenized in nuclei lysis solution they were 
incubated at 80°C for 5min, then cooled to room temperature. RNA was removed by 
adding 3µl of RNAse solution into the cell lysate, inverting tubes 2-5 times to mix 
and following incubation at 37°C for 60min. Protein precipitation was achieved by 
adding 200µl of protein precipitation solution into the cooled down to room 
temperature RNAse-treated cell lysate and following incubation on ice for 5min. 
Protein was removed from DNA samples by series of washes in isopropanol and in 
70% ethanol. DNA samples were rehydrated by adding 100µl of rehydration 
solution and overnight incubation at 4°C. DNA samples were stored at -80°C. DNA 
quality was assessed by Nanodrop NT1000. 
3.2.3 PCR Protocols 
PCR master mix for each reaction was prepared with GoTaq Green Polymerase kit 
(Promega UK, Southampton) according to the manufacturer’s recommendations; 
total volume of the PCR reaction for each protocol was 50 µl. PCR was performed on 
a PTC-200 Peltier Thermocycler with the following conditions: denaturation at 94°C 
for 5 min; followed by 29 cycles of each: denaturation at 94°C for 30 sec, annealing 
temperature depending on Tm of primers ranged from 52°C to 55°C for 30sec, 
depending from the expected product size duration of elongation at 72°C lasted 
from 40sec to 3min, and final elongation at 72°C for 7 - 10min. Amplicons were 
maintained at 4°C. 
All primers (Table 3.4) were designed with Primer 3 [610] based on publically 
available reference sequences (Table 3.4). Two sets of primers were designed to 
detect a putative Cytolethal Distending Toxin (CDT) in Yersinia based on the genome 
sequence of non-pathogenic Y. enterocolitica subsp. palearctica (N. Thomson, 
Welcome Trust Sanger Institute, unpublished). One set of primers was designed to 
amplify the entire CDT locus (CDT Flanking primers) and another set was designed 
to amplify targets within CDT genes (CDT Internal primers). 
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Table 3.4 PCR primers 
PCR protocol Primers Sequences Product size, bp Reference sequence 
Insecticidal Toxin Complex of 
non-pathogenic Y. 
enterocolitica 
tcbA F 
tcbA R 
5’-aacgcttcccagtggtattg-3’ 
5’-gagggtagacgcagtcgaag-3’ 
473 AY647257  
tcaC F 
tcaC R 
5’-atcaatttattggccccaca-3’ 
5’-aatggtaactggccttgtcg-3 
580 
tccC F 
tccC R 
5’-aaaactgtgcgttattccgg-3’ 
5’-tagtccgggtactcctgtgg-3’ 
217 
Insecticidal Toxin Complex PCR 
of pathogenic Y. enterocolitica 
(W22703-TC) 
tcaC2 F 
tcaC2 R 
5’-ccgggtatgctttaccaaga-3’ 
5’-gattaacgccagatcggaaa–3’ 
330 AJ920332 
tcaA F 
tcaA R 
5’–cacatggttggaaagtcacg–3’ 
5’–aattgcagcggttcttcact–3’ 
240 
tcaB2 F 
tcaB2 R 
5’–agcctaaaagagaccgcaca–3’ 
5’–atgctggcgctgtagttctt–3’ 
192 
Flanking Cytolethal Toxin 
Complex PCR 
CDT-F F 
CDT-F R 
5’-aaacttgccagcgatgatct-3’ 
5’-ggcttggttcatggtgactt-3’ 
1461* 
3009** 
NA 
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PCR protocol Primers Sequences Product size, bp Reference sequence 
Internal Cytolethal Toxin 
Complex PCR 
CDT-I F 
CDT-I-v2 R 
5’-atgaaattattgcggccaac-3’ 
5’-tcgatggttctgttcgactg-3’ 
1461** NA 
16S rDNA PCR 16S F 
16S R 
5’-cagccacactggaactgaga-3’ 
5’-gttagccggtgcttcttctg-3’ 
204 M59292, U63135, 
X75273, X75275-X75281 
* PCR product expected for CDT negative strains;  
** PCR product expected for CDT positive strains;  
NA  :Not applicable
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PCR protocols were validated with the available reference Y. enterocolitica strains 
(Table 3.2). The expected PCR products were detected by gel electrophoresis. All 
products of partial 16S rRNA gene PCR protocol were sequenced at GATC Biotech 
(Germany, Konstanz). 
Insecticidal Toxin Complex of non-pathogenic Y. enterocolitica PCR protocol was 
validated with Y. enterocolitica IP102 (positive control) and Y. enterocolitica 8081 
(negative control), PCR products amplified from DNA of Y. enterocolitica IP102 were 
sequenced at GATC Biotech (Germany, Konstanz). 
Insecticidal Toxin Complex PCR of pathogenic Y. enterocolitica (W22703-TC) PCR 
protocol was validated with Y. enterocolitica IP134, IP383, IP885, IP22228 strains 
(positive controls). tcaA, tcaB2 and tcaC PCR products amplified from DNA of test 
strain 5618 (biotype 2) were sequenced at GATC Biotech (Germany, Konstanz). 
Flanking and Internal Cytholethal Distending Toxin Complex PCR protocols were 
validated with Y. enterocolitica IP102, IP134, IP383, IP885, IP22228 and 8081 
strains. Flanking Cytholethal Distending Toxin Complex PCR products amplified 
from DNA of all reference strains and some test strains (RS-156 D14, Y/02/02) were 
sequenced at GATC Biotech (Germany, Konstanz). Internal Cytolethal Distending 
Toxin Complex PCR products amplified from DNA of Y. enterocolitica IP102 strain 
was sequenced at GATC Biotech (Germany, Konstanz). 
3.2.4 G. mellonella death assay 
G. mellonella death assay was performed as described by Joyce et al [611]. 
Selected Y. enterocolitica strains were plated on Luria Bertani (LB) agar plates and 
incubated at 30°C overnight. A loop full of cultured bacteria was inoculated into 5ml 
of Luria Bertani broth and incubated overnight at 15°C. After overnight incubation 
in LB broth bacterial inoculums were centrifuged in a Beckman centrifuge using 
rotor JS-5.3 at 5000 rpm for 5 min at temperature of 4°C. LB supernatant was 
removed and the bacterial pellet was washed with 1ml of sterile Phosphate Buffered 
Saline (PBS) and centrifuged as above. After centrifugation the bacterial pellet was 
re-suspended in 1ml of sterile PBS. 
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The density of bacterial inoculums in PBS was adjusted to 1.0 OD600. Eight ten-fold 
serial dilutions of bacterial inoculums were made with PBS. 10µl of each dilution 
was plated onto LB agar plates for CFU determination by viable counts. 10µl of neat 
1.0 OD600 suspension and the first two serial dilutions corresponding to 
approximately 1.8x107, 1.8x106 and 1.8x105 CFU, respectively, were subcutaneously 
injected into G. mellonella larvae that were obtained from Livefood, UK, and stored 
in the dark until use (not longer than 1 week). 
For each bacterial inoculum twenty larvae were injected using a single use sterile 
BD insulin syringe (cat. No. 324884) as described by S. Joyce [611]. Larvae (ten per 
each plate) were placed in sterile petri dishes lined with Whatman paper discs and 
incubated in parallel at 15°C and 37°C. As a control ten larvae per each temperature 
regime were also injected with 10 µl of sterile PBS. The numbers of the killed larvae 
(nonresponsive to the touch) were counted on a daily basis up to 5 days. The assay 
was repeated three times on different occasions for each Yersinia strain. 
3.2.5 Bacterial gene expression assay in G. mellonella 
Bacterial inoculums were prepared as mentioned above for the G. mellonella death 
assay. After injection, larvae were incubated for 4 hours at 37°C and for 24 hours at 
15°C [602]. Larvae were then chilled on ice for 30 min and aseptically bled into pre-
chilled Rnase-free sterile 1.5 ml tubes (Ambion). Microcentrifuge tubes with 100 µl 
of haemolymph were kept on ice at all times. To inactivate RNases in larval 
haemolymph 1 ml of TRI reagent (Sigma) for RNA extraction was added 
immediately into microcentrifuge tubes with haemolymph and followed by 
immediate homogenisation. The homogenate was incubated at room temperature 
for 5 min to allow nucleoprotein complexes to completely dissolve. 
To remove insoluble material including DNA from the homogenate it was 
centrifuged at 12,000 x g for 10 min at 4°C. The supernatant was transferred to a 
fresh RNase-free microcentrifuge tube. Next, 100 µl of BCP reagent (Sigma) was 
added and mixed well with the supernatant. Supernatant with BCP reagent (Sigma) 
was incubated for 15 min at room temperature and then centrifuged at 12,000 g at 
4°C for 10 min. The resulting aqueous phase (colourless top layer) was transferred 
into a fresh RNase-free microcentrifuge tube. 
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RNA was precipitated by the addition of 500 µl of molecular grade isopropanol 
(Sigma) followed by incubation at room temperature for 10 min and centrifugation 
at 12,000 g for 8 min at 4°C. The pellet was washed with 1 ml 75% molecular grade 
ethanol (Sigma) followed by centrifugation at 7,500 x g for 5 min and then re-
suspended in Ambion RNA storage solution and kept at -70°C until needed. 
Multiplex single step Reverse-Transcriptase PCR (RT-PCR) for insecticidal toxins 
was performed with One Step RT-PCR kit (QIAGEN). Master mix was prepared as 
follows: Qiagen One-Step RT-PCR Buffer 5x -5 µl, Q-Solution 5x - 5 µl, dNTP 10mM -
1µl, of each forward primer 20 pmole/µl - 0.75 µl, of each reverse primer 20 
pmole/µl - 0.75 µl, Qiagen RT-PCR enzyme mix – 1 µl, RNase free H2O – 9.5 µl, RNA 
template – 0.5 µl. Total RT-PCR reaction volume was 25 µl. 
RT-PCR was performed on the PTC-200 Peltier Thermocycler with the following 
conditions: reverse transcription at 50°C for 30 min, initial denaturation at 95°C for 
15 min; followed by 39 cycles of each: denaturation at 94°C for 30 sec, annealing at 
55°C for 30sec, elongation at 72°C for 1 min; and final elongation at 72°C for 10 min. 
As control for the DNA contamination RNA samples were submitted to PCR run with 
the reverse transcription step (50°, 30 min) omitted. 
Primers were designed using Primer 3 [610] from the reference sequences 
AJ920332 (Y. enterocolitica subsp. palearctica W22703) and AY647257 (Y. 
enterocolitica subsp. palearctica T83) respectively for tcaC2 and tcaC genes and from 
the conserved regions identified in putative cdtB2 and cdtB3genes detected 
respectively in non-pathogenic and pathogenic Y. enterocolitica strains: 
 cdtB2 Forward   5’-ttccgagcagaagaggtcat-3’ 
 cdtB2 Reverse   5’-ctgagtgagtgacgggttca-3’ 
 tcaC Forward   5’-gcaccagacagcattgaaga-3’ 
 tcaC Reverse   5’-tgttgctgttctttcgcatc-3’ 
 cdtB3 Forward   5’-ggatagccggtgttactgga-3’ 
 cdtB3 Reverse   5’-ttgtcggtctgcatgaggta-3’ 
 tcaC2 Forward   5’-ccgggtatgctttaccaaga-3’ 
 tcaC2 Reverse   5’-gattaacgccagatcggaaa–3’ 
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The expected products of 330bp - tcaC2 gene and 155bp – cdtB3 of pathogenic Y. 
enterocolitica and 341bp – tcaC3 and 282bp – cdtB2 for non-pathogenic Y. 
enterocolitica biovar 1A were detected by gel electrophoresis. PCR protocol was 
validated with Y. enterocolitica IP102, IP134, IP383, IP885, IP22228 and 8081 
strains. Amplified PCR products from some of the reference strains (IP102 and 
IP22228) were sequenced at GATC Biotech (Germany, Konstanz). 
3.2.6 Statistical analysis 
Statistical comparison was performed using χ2 test, one-way ANOVA comparison of 
the means with Tukey’s error rate (multiple comparisons) or 2-sample t-test 
(pairwise comparison) in MiniTab 16 software. Cramér’s V2 coefficient was used to 
establish the strength of association between two variables by the following criteria: 
Cramér’s V2 >0.5 – high association, 0.3-0.5 – moderate association, 0.1-0.3 – low 
association, 0-0.1 – little if any association 
(http://www.acastat.com/Statbook/chisqassoc.htm). Statistical analysis of the 
differences in the outcome of Yersinia infection in G. mellonella larvae between 
different bacterial strains was applied to pooled data from all experimental 
replicates for each test strain. Pairwise comparison was applied to establish 
statistical difference between outcomes of Yersinia infection in insect larvae 
observed at 15°C and 37°C. LD50 for Yersinia strains was estimated by the Reed-
Muench method where possible [612]. Hierarchical cluster analysis was performed 
by Dr Ian Jeffery using the Heatplus software package (Bioconductor) in the 
statistical environment R [613, 614]. 
3.2.7 Cell culture assay 
Cell culture protocols were adapted from Scott et al [469] and Fabris et al [615]. 
3.2.7.1 Yersina cell lysates 
Bacterial cultures were grown on tryptic soy agar with 0.6% of yeast extract at 37°C 
and 22°C for 48h. Harvested bacterial cultures were suspended in 10ml of PBS and 
washed twice. Optical density of bacterial inoculums measured at 600nm was 
around 3.0 OD. Bacterial inoculums were then sonicated for 1 min at maximum 
speed of 16,000 x g on ice. To remove cell debris sonicates were centrifuged for 20 
min at 3500 rpm at 4°C. Supernatants were further filter sterilized through 0.22µm 
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impact filters (Millipore) and stored overnight at 4-8°C. Protein concentrations of 
bacterial cell extracts were measured by NanoDrop. 
3.2.7.2 Cell culture 
Next day cell lysates (12µl) were inoculated into 120µl (2.4 x104 cells/ml) of Chinese 
Hamster Ovaries (CHO) cell cultures in HAMs’ F12 culture medium supplemented 
with 10% foetal bovine serum, 1% glutamine and penicillin (100 U/ml) and 
streptomycin (100 µl.ml). Cell cultures were incubated for 120h. Cell cultures were 
“fed” with 100 µl of fresh HAMs’ F12 cell culture medium with all above mentioned 
supplements after 72h of incubation. At the end of the incubation cycle (120 h) cell 
cultures were fixed and stained with 0.2% crystal violet. Morphology of CHO cells 
was examined using an inverted microscope. All experiments were performed in 
triplicate twice. PBS and E. coli strain DHα5 were used as negative controls. 
3.3 Results 
3.3.1 Identification and biotyping of Yersinia strains 
Sequencing of the 16S rRNA gene variable locus (204bp) for some Yersinia strains 
that were identified as Y. enterocolitica with API 20E strips revealed that these 
isolates in fact are not Y. enterocolitica but other Yersinia species (Table 3.5). 
Table 3.5 API20E and 16s rDNA identification of Y. enterocolitica-like species 
Strain 
Number 
Source 
API20E 
Profile 
API 20E Identification 16S rRNA 
RS-42 D21 Retail meat 1155723 Y.enterocolitica 99.7%  Y. frederiksenii* 
29869 Human 1155723 Y.enterocolitica 99.7%  Y. frederiksenii** 
58735 Human 1055723 Y.enterocolitica 94.4% Y.intermedia** 
24070 Human 1054723 Y.enterocolitica 95.4% Y.massiliensis* 
26931 Human 1014523 
Y.enterocolitica 96.4%  
VP+Ind neg 
Y.bercovieri* 
3343 Human 1114563 
Y.enterocolitica 94.5% 
Melibiose pos 
Y.rohdei* 
VP :Voges-Proskauer reaction 
Ind :indole production 
* Confirmed by full 16S rDNA sequencing (see protocol in Chapter 2) 
** Identified by full 16S rDNA sequencing (see protocol in Chapter 2) 
 
 100 
 
Table 3.6 Biotyping results of Yersinia strains 
Source 
Y. enterocolitica biotype Y. ent. 
like sp. 
Total 
1A B2 B3 B4 
Human 72 
(80.9%) 
3 
(3.4%) 
3 (3.4%) 4 
(4.5%) 
7 (7.9%) 89 
(100%) 
Pig 50 
(17.1%) 
0 218 
(74.7%) 
15 
(5.1%) 
9 (3.1%) 292 
(100%) 
Retail Meat 36 
(70.6%) 
0 0 0 15 
(29.4%) 
51 
(100%) 
Dog 25 
(100%) 
0 0 0 0 25 
(100%) 
Total 
183 
(40%) 
3 
(0.7%) 
221 
(48.4%) 
19 
(4.2%) 
31 
(6.8%) 
457 
(100%) 
79 Yersinia enterocolitica isolates obtained from UCG and QUB have been serotyped 
with the MAST Group Yersinia enterocolitica Antisera (commercial panel containing 
common pathogenic serogroups) (Table 3.7). Only pathogenic bioserotypes of Y. 
enterocolitica isolated from slaughter pigs, culled dogs and retail meat samples were 
serotyped (Dr. B. Murphy and N. Drummond), data summarised in Table 3.8. 
Table 3.7 Serotyping of Y. enterocolitica strains isolated from humans only 
Biotype/Serotype Number 
1A/O:5 17/69 (24.6%) 
1A/O:8 11/69 (15.9%) 
1A/O:9 1/69 (1.4%) 
1A/O:8;O:5 1/69 (1.4%) 
1A/O:9;O:5 1/69 (1.4%) 
1A/O:9;O:5;O:8 4/69 (5.8%) 
1A/NEG 33/69 (47.8%) 
1A/Autoagglutination 1/69 (1.4%) 
2/O:9 2/3 (66.7%) 
2/Autoagglutination 1/3 (33.3%) 
3/Autoagglutination 2/3 (66.7%) 
3/O:9 1/3 (33.3%) 
4/O:3 4/4 (100%) 
Total 79 
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Table 3.8 Serotyping results for pathogenic Y. enterocolitica isolated from slaughter 
pigs only 
Biotype/Serotype Number 
3/O:5 3/218 (1.4%) 
3/O:9 215/218 (98.6%) 
4/O:3 10/15 (66.7%) 
4/O:9 4/15 (26.7%) 
4/NEG 1/15 (6.6%) 
Total 233 
 
3.3.2 PCR screening Y. enterocolitica for insecticidal toxin complex genes 
All pathogenic Y. enterocolitica contained insecticidal toxin complex PCR targets 
resembling those identified in pathogenic Y. enterocolitica bioserovar 2/O:9 strain 
W22703 (EMBL/GenBank Accession number AJ920332) but only 24.8% of non-
pathogenic (that is not apparently pathogenic for mammals) Y. enterocolitica 
contained insecticidal toxin complex PCR targets resembling that identified in non-
pathogenic Y. enterocolitica bioserovar 1A/O:5 strain T83 (EMBL/GenBank 
Accession number AY647257). 
Four types of insecticidal toxin complex toxin operons were detected among Y. 
enterocolitica strains (Table 3.9). 
Table 3.9 Insecticidal toxin complex genotypes detected in Y. enterocolitica strains 
ITC loci type ITC genes detected 
tcd-like tcaC, tcbA and tccC 
tcbA-like tcbA 
tca-like tcaA, tcaB2 and tcaC2 
tcaA-tcaC2-like tcaA and tcaC2 
The tcd ITC locus, previously reported in non-pathogenic Y. enterocolitica [556], and 
tcbA ITC locus were mainly encoded by the non-pathogenic biovar 1A Y. 
enterocolitica strains, while the tca and tcaA-tcaC2 insecticidal toxin complex loci 
were encoded by mildly pathogenic biovars (Table 3.10). Chi-square test for 
association indicated that there is a strong relationship between the insecticidal 
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toxin complex locus encoded by Yersinia strains and their biotype (Cramer’s V2 
=0.63, P-Value <0.05, Table 3.10). Thus, the tcd-like locus was predominantly 
encoded by biovar 1A Y. enterocolitica strains, tca-like and tcaA-tcac2-like loci were 
predominantly encoded by mildly pathogenic biovars 2 and 3, and 4, respectively 
(Table 3.10). 
Table 3.10 Biotype dependent distribution of insecticidal toxin complex loci in Y. 
enterocolitica strains isolated from humans, pigs, dogs and retail meat 
samples 
A weak statistical association was detected between insecticidal toxin complex locus 
type and the source of Yersinia isolates (Cramer’s V2 =0.26, P-Value < 0.05, Table 
3.11). 
Table 3.11 Source dependent distribution of insecticidal toxin complex loci in Y. 
enterocolitica strains isolated from humans, pigs, dogs and retail meat 
samples 
Biotype 
Tested 
strains 
ITC +ve 
strains 
ITC type 
tcd tcbA tca 
tcaA-
tcaC2 
tcaC2 
1A 149 37  
(24.8%) 
33 
(22.1%) 
4 
(2.7%) 
- -  
2 3 3     
(100%) 
- - 3 
(100%) 
-  
3 64 64 
(100%) 
- - 63 
(98.4%) 
- 1 
(1.6%) 
4 10 10 
(100%) 
- - - 10 
(100%) 
 
Cramer’s V2 =0.63 
P-value <0.05 
Source 
Tested 
strains 
ITC+ve 
strains 
ITC type 
tcd tcbA tca tcaA-tcaC2 
Human 80 22 (27.5%) 12 (15%) - 6 (7.5%) 4 (5%) 
Pig 86 75 (87.2%) 7 (8.1%) - 61 (73.3%) 4 (4.7%) 
Retail 
meat 
35 5 (14.3%) 1 (2.9%) 4 (11.4%) - - 
Dog 25 13 (52%) 13 (52%) - - - 
Cramer’s V2 =0.26 
P-value <0.05 
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A moderate statistical association was established between the serotype and the 
insecticidal toxin complex locus encoded by Yersinia strains (Cramer’s V2 =0.38, P-
value <0.05, Table 3.12). 
Table 3.12 Serotype dependent distribution of insecticidal toxin complex loci in Y. 
enterocolitica strains isolated from humans, pigs, dogs and retail meat 
samples 
Serotype 
Tested 
strains 
ITC+ve 
strains 
ITC type 
tcd tcbA tca 
tcaA-
tcaC2 
tcaC2 
O:3 10 9 (90%) - - - 
9 
(90%) 
 
O:5 19 
2 
(10.6%) 
1 
(5.3%) 
- 
1 
(5.3%) 
-  
O:8 10 1 (10%) 
1 
(10%) 
- - -  
O:9 65 
65 
(100%) 
- - 
63 
(96.9%) 
1 
(1.5%) 
1 
(1.5%) 
O:5, O:8 1 0      
O:5, O:9 1 
1 
(100%) 
1 
(100%) 
- - -  
O:5, O:8, O:9 4 0      
Autoagglutinated 4 
3 
(75%) 
- - 
3 
(75%) 
  
Unserotypable* 112 
34 
(30.4%) 
31 
(26.8%) 
4 
(3.6%) 
- -  
Cramer’s V2 =0.38 
P-value <0.05 
* Unserotypable strains represented by biovar 1A recovered from slaughter pigs, culled dogs and retail 
meat samples for which serotyping was not done and biovar 1A isolated from humans for which 
serotyping results were negative 
3.3.3 Cytolethal distending toxins in Yersinia strains 
CDT loci encoded by pathogenic and non-pathogenic Y. enterocolitica were inserted 
into a similar location between the genes YE1746 and YE1747 of the Y. enterocolitica 
subsp. enterocolitica 8081 genome (EMBL/GenBank Accession number AM286415). 
BLASTP analysis of open reading frames (ORFs) of the inserts amplified from 
pathogenic and non-pathogenic Y. enterocolitica strains identified similarity with 
CdtA and CdtB toxins (Table 3.13, Figure 3.3). Six distinct CDT loci designated in this 
thesis as A, B, C, D, E and F were identified in 90.5% (239/264) Y. enterocolitica and 
Y. enterocolitica-like species strains (Table 3.13). CDT loci F encode only CDT locus 
flanking genes homologous to YE1746 and YE1747 (Table 3.13, Figure 3.3). 
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Table 3.13 BLASTP hits of open reading frames detected in flanking PCR amplicons of CDT loci 
CDT loci 
(size) 
ORF in 
flanking 
amplicon 
Position (bp) 
in amplicon 
ORF length 
(amino acids) 
First BLASTP GenBank 
hit 
Accession number 
Amino acid 
identity, (%) 
ORF 
designation 
A (3kb) Orf1 2-739 245 hypothetical protein 
YE1746 Y. enterocolitica 
subsp. enterocolitica  
8081 
CAL11819 233/245 (95%) YE1746 
Orf2 555-1187 210 Cdt A Haemophilus 
ducreyi 35000HP 
AAP95786 41/154 (27%) CdtA 
Orf3 1180-1626 148 CdtB Escherichia coli EGW63159 26/62 (42%) CdtB1 
Orf4 1451-2641 396 Cdt B Campylobacter 
lari 
BAJ52736 115/316 (36%) CdtB2 
Orf5 2757-3119 120 hypothetical protein 
YE1747 Y. enterocolitica 
subsp. enterocolitica  
8081 
CAL11820 120/120 
(100%) 
 
YE1747 
B* (4kb) Orf1 3-452 148 Cdt A Haemophilus 
ducreyi 35000HP 
AAP95786 38/136 (28%) CdtA1 
Orf2 551-916 121 Hypothetical protein 
PUUH_pUUH2392p0167 
[Klebsiella pneumoniae] 
AET17237 65/92 (71%) HP** 
Orf3 810-1780 323 Cdt B Campylobacter 
lari 
BAJ52736 95/270 (35%) CdtB2 
 
C (2kb) Orf1 76-612 178 Cdt A Haemophilus AAP95786 40/154 (26%) CdtA1 
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CDT loci 
(size) 
ORF in 
flanking 
amplicon 
Position (bp) 
in amplicon 
ORF length 
(amino acids) 
First BLASTP GenBank 
hit 
Accession number 
Amino acid 
identity, (%) 
ORF 
designation 
ducreyi 35000HP  
Orf2 605-1600 331 Cdt B Campylobacter 
lari 
BAJ52745 111/320 (35%) CdtB2 
Orf3 1717-2079 120 hypothetical protein 
YE1747 Y. enterocolitica 
subsp. enterocolitica  
8081 
CAL11820 120/120 
(100%) 
YE1747 
D (4.5kb) Orf1 1-507 329 hypothetical protein 
YE1746 Y. enterocolitica 
subsp. enterocolitica  
8081 
CAL11819 97/100 (97%) 
 
YE1746 
Orf2 392-1441 349 putative transposase for 
IS1667 
Y. enterocolitica subsp. 
enterocolitica 8081  
CAL13100 334/339 (99%) TnIS1667 
Orf3 1587-2306 239 hypothetical protein 
YE1746 Y. enterocolitica 
subsp. enterocolitica  
8081 
CAL11819 176/195 (90%) YE1746 
Orf4 2384-2995 203 Cdt A Escherichia coli BAH78157 56/187 (30%) CdtA2 
Orf5 2989-3576 195 Cdt B Campylobacter 
coli 
ABJ98315 74/192 (39%) CdtB3 
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CDT loci 
(size) 
ORF in 
flanking 
amplicon 
Position (bp) 
in amplicon 
ORF length 
(amino acids) 
First BLASTP GenBank 
hit 
Accession number 
Amino acid 
identity, (%) 
ORF 
designation 
Orf6 3515-3946 143 Cdt B subunit 
Helicobacter cinaedi 
CCUG 18818 
BAM12443 55/126 (44%) CdtB4 
Orf7 4072-4458 128 hypothetical protein 
YE1747 Y. enterocolitica 
subsp. enterocolitica  
8081 
CAL11820 120/128 (94%) YE1747 
E (3kb) Orf1 5-961 318 hypothetical protein 
YE1746 Y. enterocolitica 
subsp. enterocolitica  
8081 
CAL11819 270/294 (92%) YE1746 
Orf2 1039-1650 203 Cdt A Escherichia coli BAH78157 56/187 (30%) CdtA2 
Orf3 1644-2231 195 Cdt B Campylobacter 
coli 
ABJ98315 75/192 (39%) CdtB3 
Orf4 2170-2601 143 Cdt B subunit 
Helicobacter cinaedi 
CCUG 18818 
BAM12443 55/126 (44%) CdtB4 
Orf5 2727-3140 137 hypothetical protein 
YE1747 Y. enterocolitica 
subsp. enterocolitica  
8081 
CAL11820 121/126 (96%) YE1747 
* Internal locus was only sequenced 
** HP :Hypothetical protein
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Figure 3.2 Cytolethal Distending Toxin loci amplified from reference Y. enterocolitica 
strains 
M :Molecular Marker 1kb (NE BioLabs Inc.) 
1 :Y. enterocolitica subsp. palearctica biovar 1A/O:6,30 strain IP102 (CDT Type A) 
2 :Y. enterocolitica subsp. palearctica biovar 4/O:3 strain IP 134 (CDT Type D) 
3 :Y. enterocolitica subsp. palearctica biovar 2/O:9 strain IP383 (CDT Type E.) 
4 :Y. enterocolitica subsp. palearctica biovar 2/O:5,27 strain IP885 (CDT Type D) 
5 :Y. enterocolitica subsp. enterocolitica biovar 1B/O:8 strain 8081 (CDT Type F) 
6 :Y. enterocolitica subsp. palearctica biovar 3/O:5 strain IP 22228 (CDT Type D) 
N :Negative control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Schematic representation of the Cytolethal Distending Toxin loci of Yersinia 
species 
All loci were shown by sequencing to be flanked by YE1746 and YE1747 with the exception 
of; CDT locus B – CDT internal PCR amplicon was sequenced only, the presence of YE1746 
and YE1747 is hypothetical based on the non-sequenced CDT flanking PCR amplicon; CDT 
locus C does not apparently encode YE1746 but a binding site for CDT-Flanking Forward 
primer only was present. Red boxes indicate binding regions for flanking forward and 
reverse primers respectively; white boxes indicate binding regions forinternal forward and 
reverse primers respectively. 
M M M 
CDT Internal PCR CDT Flanking PCR 
1 2 3 4 5 6 N 1 2 3 4 5 6 N 
10.0 kb 
 
5kb 
3kb 
4kb 
2kb 
1.5kb 
1kb 
0.5kb 
Non-pathogenic 
CDT locus type A (3/1.4 kb) 
CDT locus type B (4/2 kb) 
CDT locus type C (2/1.4 kb) 
Pathogenic 
CDT locus type F (1.4/N kb) 
CDT locus type E (3/N kb) 
CDT locus type D (4.5/N kb) 
YE1746 YE1747 CdtA1 CdtB1 CdtB2 
HP 
CdtA2 TnIS CdtB3 CdtB4 
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3.3.4 Distribution of CDT loci in Yersinia strains 
The CDT locus was amplified from 264 Yersinia strains from our collection and six 
reference Y. enterocolitica strains (Table 3.14). 
Table 3.14 CDT loci present in reference Y. enterocolitica strains 
Yersinia strain Bioserotype CDT Type 
Flanking PCR 
Band 
Internal PCR 
Band 
Reference strain IP102 1A/O:6, 30 A 3kb 1.4kb 
Reference strain IP885 2/O:5, 27 D 4.5kb NEG 
Reference strain IP22228 3/O:5 D 4.5kb NEG 
Reference IP134 4/O:3 D 4.5kb NEG 
Reference strain IP383 2/O:9 E 3kb NEG 
Reference strain 8081 1B/O:8 F 1.4kb NEG 
Only a weak statistical association was established between the source of Yersinia 
strains and the type of CDT locus encoded (Cramér’s V2 =0.24, P-Value <0.05, Table 
3.15). 
CDT locus A was predominant among non-pathogenic Y. enterocolitica biovar 1A 
(83.3%) and was encoded by isolates recovered from humans, pigs, dogs and porcine 
retail meat samples (Table 3.16, Figure 3.4). CDT locus B was detected in Y. 
enterocolitica biovar 1A strains isolated from retail meat samples and pigs, and locus C 
was only detected in Y. enterocolitica biovar 1A strains isolated from humans (Table 
3.15, Table 3.16, Fig 3.4). CDT loci D and E were most common among pathogenic Y. 
enterocolitica biovars which were mainly from pigs (Table 3.15). Biovar 4 Y. 
enterocolitica mainly encoded loci E (80%), and biovars 2 and 3 – loci D (100% and 
90.1% respectively) (Table 3.16, Figure 3.4). Y. enterocolitica-like species were mostly 
negative for the CDT toxins with the primers used in this study (Table 3.16, Figure 3.4). 
There was a strong statistical relationship between the biotype of Yersinia and the CDT 
locus encoded (Cramér’s V2 =0.51, P-value <0.05, Table 3.16). 
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Table 3.15 Source-dependent distribution of CDT loci in Yersinia strains isolated from humans, pigs, dogs and retail meat samples 
Source 
Number of 
strains 
CDT type 
A B C D E F NEG 
Human 86 64 (74.4%) 6 (7.0%) - 6 (7.0%) 4 (4.7%) 2 (2.3%) 4 (4.7%) 
Pig 131 15 (11.5%) - 6 (4.6%) 88 (67.2%) 4 (3.1%) 2 (1.5%) 16 (12.2%) 
Retail meat 33 15 (45.5%) - 4 (12.1%) - - 4 (12.1%) 10 (30.3%) 
Dog 14 14 (100%) - - - - - - 
Cramér’s V2 =0.24 
P-value <0.05 
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Table 3.16 Biotype dependent distribution of CDT loci in Yersinia strains isolated from humans, pigs, dogs and retail meat samples 
Biotype 
Number 
of strains 
CDT type 
A B C D E F N* 
1A 132 110 (83.3%) 6 (4.5%) 11 (8.3%) - - 2 (1.5%) 3 (2.3%) 
2 3 - - - 3 (100%) - - - 
3 101 - - - 91 (90.1%) - - 10 (9.9%) 
4 10 1 (10%) - - 1 (10%) 8 (80%) - - 
Y.enterocolitica-like 18 - - - - 1 (5.6%) 5 (27.8%) 12 (66.7%) 
Cramér’s V2 =0.51 
P-value <0.05 
* No PCR bands obtained 
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Figure 3.4 Biotype-dependent distribution of CDT loci in Yersinia strains isolated from 
humans, pigs, dogs and retail meat samples 
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Table 3.17 Serotype dependent distribution of CDT loci in Yersinia strains isolated from humans, pigs, dogs and retail meat samples 
Serotype 
Number of 
strains 
CDT type 
A B C D E F N** 
O:3 9 1 (11.1%) - - - 8 (88.9%) - - 
O:5 19 17 (89.5%) - - 2 (10.5%) - - - 
O:8 10 10 (100%) - - - - - - 
O:9 
101 
1 
(0.99 %) 
- - 100 (99.01%) - - - 
O:5, O:8 1 1 (100%) - - - - - - 
O:5, O:9 1 1 (100%) - - - - - - 
O:5, O:8, O:9 4 4 (100%) - - - - - - 
Auto agglutinated 3 - - - 3 (100%) - - - 
Unserotypable* 98 76 (77.6%) 11 (11.2%) 6 (6.1%) - - 2 (2.0%) 3 (3.1%) 
Y.enterocolitica-like 18 - - - - 1/18 (5.6%) 5 (27.8%) 12 (66.7%) 
Cramér’s V2=0.36 
P-value <0.05 
* Unserotypable strains represented by biovar 1A recovered from slaughter pigs, culled dogs and retail meat samples for which serotyping was not done and 33 biovar 1A strains 
isolated from humans for which serotyping results were negative 
** Negative, no PCR bands obtained 
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Figure 3.5 Serotype-dependent distribution of CDT loci in Yersinia strains isolated 
from humans, pigs, dogs and retail meat samples 
CDT locus A was represented in the majority of Y. enterocolitica serotypes, while 
CDT loci D were mostly encoded by Y. enterocolitica serotype O:9 strains (100/105 
or 95%) autogglutinating Y. enterocolitica strains (3/105, 2.9%) and O:5 strains 
(2/105,2%); CDT loci E were predominantly encoded by Y. enterocolitica serotype 
O:3 (8/9, 88.9%) (Table 3.17, Figure 3.5). Chi-square test for the association 
estimated a moderate statistical association between the serotype of Yersinia strain 
and CDT locus type encoded (Cramér’s V2 =0.36, P-Value <0.05, Table 3.17). 
3.3.5 Expression of Yersinia CDT and insecticidal toxin complexes in G. 
mellonella larvae 
Two different multiplex Reverse-Transcriptase PCR protocols were used for 
pathogenic and non-pathogenic Yersinia, respectively, to simultaneously detect 
expression of CDT and insecticidal toxin complex genes in both groups. The cdtB2 
and cdtB3 subunits were expressed by non-pathogenic and pathogenic Y. 
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enterocolitica strains, respectively, in the G. mellonella infection model equally at 
both 15°C and 37°C (Table 3.18, Figure 3.6, Figure 3.7). Expression of other Cdt 
toxins was not examined. tcaC2 and tcaC were also expressed at 15°C and 37°C in 
both pathogenic and non-pathogenic Y. enterocolitica (Table 3.18, Figure 3.6, Figure 
3.7). However increased expression of tcaC at 15°C was apparent for strains IP102, 
and 2850 (Figure 3.6), and increased expression of tcaC2 at 15°C by IP22228 (Figure 
3.7). Highly pathogenic Y. enterocolitica strain 8081 lacks genes for both insecticidal 
toxin complex and CDT loci, consequently their expression was not detected by the 
RT-PCR assay (Table 3.18, Figure 3.7). 
Table 3.18 Expression of cdtB and tcaC of pathogenic and non-pathogenic Yersinia in 
G. mellonella larvae 
Strain Bioserotype CDT type ITC type 
Expression 
Gene 37°C 15°C 
IP102 1A/O:6,30 A tcd-like cdtB2 + + 
tcaC + + 
2850 1A/NEG B tcd-like cdtB2 + + 
tcaC + + 
3/C/86 CS D7 1A/O:9 C NEG cdtB2 + + 
tcaC - - 
IP22228 3/O:5 D tca-like cdtB3 + + 
tcaC2 + + 
Y/00/01(1) 4/O:3 E tcaA-tcaC2 like cdtB3 + + 
tcaC2 + + 
8081 1B/O:8 F (NEG) NEG cdtB3 - - 
tcaC2 - - 
5618 2/AUTO D tca-like cdtB3 + + 
tcaC2 + + 
RS-42 D21 YF F NEG cdtB3 - - 
tcaC2 - - 
YF :Y. frederiksenii 
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Figure 3.6 RT-PCR for simultaneous expression of non-pathogenic Y. enterocolitica 
biovar 1A ctdB2 and tcaC toxin genes in G. mellonella larvae 
M :Low Weight Molecular DNA marker (NE BioLabs Inc.) 
1 :CDT type A, tcd-like (IP102) 37°C 
2 :CDT type A, tcd-like (IP102) 15°C 
3 :CDT type B, tcd-like (2850) 37°C 
4 :CDT type B, tcd-like (2850) 15°C 
5 :CDT type C, ITC negative (3/C/86 CSD7) 37°C 
 
6 :CDT type C, ITC negative (3/C/86 CSD7) 15°C 
7 :PBS 37°C (expression negative control) 
8 :PBS 15°C (expression negative control) 
N :PCR negative control 
tcaC – 341 bp, cdtB2-282 bp 
 
 
 
Figure 3.7 RT-PCR for simultaneous expression of ctdB3 and tcaC2 toxins of 
pathogenic biovars of Y. enterocolitica in G. mellonella larva 
M :Low Weight Molecular DNA marker (NE BioLabs Inc.) 
1 :CDT type D, tca-like (IP22228) 37°C 
2 :CDT type D, tca-like (IP22228) 15°C 
3 :CDT type F, ITC negative (8081) 37°C 
4 :CDT type F, ITC negative (8081) 15°C 
5 :CDT type negative, ITC negative (3343 Y. rohdei) 37°C 
6 :CDT type negative, ITC-negative (3343 Y. rohdei) 15°C 
7 :CDT type negative, ITC negative (26931 Y. bercovieri) 37°C 
8 :CDT type negative, ITC negative (26931 Y. bercovieri 15°C 
9 :CDT type D, tca-like (5618) 37°C 
10 :CDT type D, tca-like (5618) 15°C 
11 :CDT type F, ITC negative (RS-42 Y. frederiksenii) 37°C 
12 :CDT type F, ITC negative (RS-42 Y. frederiksenii) 15°C 
13 :CDT type E, tcaA-tcaC2-like (Y/00/01(1)) 37°C 
14 :CDT type E, tcaA-tcaC2-like (Y/00/01(1)) 15°C 
15 :PBS 37°C (expression negative control) 
16 :PBS 15°C (expression negative control) 
N :PCR negative control 
tcaC2 - 330bp, cdtB3 – 155bp
 
 300bp - 
500b 
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 350bp 
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M M 1 2 3 4 5 6 7 8 N 
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Figure 3.8 Hierarchical clustering of the G. mellonella larvae mortality rates incubated at 37°C and 15°C after subcutaneous infection with 
Yersinia  
*CFU refer to viable counts per ml of suspensions, of which 10 l was injected per larva 
* * * 
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3.3.6 Yersinia infection in G. mellonella larvae 
Yersinia infection in G. mellonella larvae at 15°C and 37°C caused by pathogenic and 
non-pathogenic strains was accompanied by pigmentation indicating activation of the 
PPO (ProPhenolOxidase) system causing melanisation [589, 616-619] (data not 
shown). 
Hierarchical clustering of the experimental mortality data obtained after Yersinia 
subcutaneous infection in G. mellonella larvae incubated at 15°C and 37°C for 120h 
grouped strains into two major phenotypic clusters 1 and 2, cluster 1 is further 
divisible into subclusters 1A and 1B (Figure 3.8). Cluster 2 (comprising only Y. 
enterocolitica strains of Biovar 1A and one Y. rohdei strain) is characterised by 
enhanced killing at 37°C (fast killing) compared to Cluster 1, and subcluster 1B shows 
even lower mortality at 37°C than cluster 1A. All negative controls for each experiment 
(10 G. mellonella injected with 10µl of the same sterile PBS used for the preparation of 
the Yersinia inocula in experiments) survived after incubation for 120h at 15°C and 
37°C. 
The chi-square test for association shows that there is a statistically significant strong 
association between hierarchical mortality cluster type and type of CDT locus encoded 
by the isolate (Cramér’s V2 =0.65, P-Value < 0.05 , Table 3.19), moderate association 
between serotype (Cramér’s V2 =0.48, P-Value < 0.05, Table 3.19), source (Cramér’s V2 
=0.36, P-Value < 0.05, Table 3.19), ITC locus encoded by microorganism (Cramér’s V2 
=0.33, P-Value < 0.05, Table 3.19) and biotype (Cramér’s V2 =0.31, P-Value < 0.05, Table 
3.19). A weak association was found for the presence of the pYV and hierarchical 
mortality cluster type (Cramer’s V2=0.27, P-value < 0.05, Table 3.19).  
Overall, subcluster 1A grouped mildly pathogenic Y. enterocolitica strains (isolated 
from humans) of serotype O:3 and O:5, encoding CDT type E and tcaA-tcaC2-like 
insecticidal toxins. Cluster 1B shows over-representation of the mildly pathogenic Y. 
enterocolitica serotype O:9 strains isolated from pigs which encode CDT type D and tca-
like insecticidal toxins. Cluster 2 mostly includes non-pathogenic Y. enterocolitica 
strains of biovar 1A that encode CDT type A and tcd-like insecticidal toxins. All biovar 
1A Y. enterocolitica strains from cluster 1A encode CDT type B and contain an ITC, and 
all biovar 1A Y. enterocolitica strains from cluster 1B encode CDT type C but are ITC 
negative. Not all biovar 1A Y. enterocolitica strains in cluster 2 are ITC positive but most 
of them encode CDT type A, except strain 2850 which encodes CDT type B (Table 3.19). 
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Table 3.19 Outcome of subcutaneous Yersinia infection in G. mellonella larvae incubated at 37°C and 15°C for up to 120h 
Strain Bioserovar Source 
CDT 
type 
ITC type pYV 
Average Dead Gm larvae 
±SD per group of 10*10 P-value *4 
LD50, CFU/ml 
15°C, 120h 37°C, 120h 15°C, 72h 37°C, 24h 
Cluster 1A 
Y/00/02 4/O:3 Human E tcaA-tcaC2-like pos 10 ± 0.0 3.5 ± 5.1 <0.001 2.30x107 (96h) *5 7.94x108 
Y/00/01 (1) 4/O:3 Human E tcaA-tcaC2-like neg 9.8 ± 0.4 5.2 ± 4.5 <0.001 3.24x108 4.27x108 
IP22228 3/O:5 Ref** D tca-like pos 9.5 ± 1.2 2.8 ± 3.3 <0.001 6.03x108 1.05x109 
IP383 2/O:9 Ref E tca-like pos 8.0 ± 3.2 3 ± 4.1 <0.001 8.51x107 (96h) *5 9.33x108 (96h) *7 
IP134 4/O:3 Ref D tcaA-tcaC2-like neg 9.2 ± 1.2 2.3 ± 2.9 <0.001 1.12x109 1.67x109 (120h) *7 
IP885 2/O:5,27 Ref D tca-like pos 10 ± 0.0 3.8 ± 3.7 <0.001 3.47x108 1.07x109 
Y/02/08 4/O:3 Human E tcaA-tcaC2-like pos 8.7 ± 2.4 5.2 ± 4.8 <0.001 1.45x109 1.40x108 
8081 QC 1B/O:8 Ref F neg pos 10 ± 0.0 1 ± 1.3 <0.001 2.19x108 (48h) *6 no above 50% *8 
Y/00/01 (2) 1A/NEG Human B tcd-like NT*3 6.8 ± 3.1 3.8 ± 3.5 0.001 5.01x108 (96h) *5 7.94x108 
Y/02/02 1A/NEG Human B tcd-like NT 5.7 ± 3.8 4.0 ± 4.4 0.068 7.24x108 (96h) *5 8.13x108 
2484 3/O:9 Human D tca-like neg 6.2 ± 4.5 3.7 ± 4.2 <0.001 7.08x108 (96h) *5 8.32x108 
26931 Y. bercovieri Human neg neg NT 6.2 ± 3.2 3.8 ± 4.2 0.011 2.10x109 5.50x107 
2/A/40 NAS D7 4/O:3 Pig E tcaA-tcaC2-like neg 6.7 ± 2.2 5.3 ± 4.3 0.136  no above 50% at 96h 
and no below 50% at 
120h 
 
 
3.02x108 
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Strain Bioserovar Source 
CDT 
type 
ITC type pYV 
Average Dead Gm larvae 
±SD per group of 10*10 P-value *4 
LD50, CFU/ml 
15°C, 120h 37°C, 120h 15°C, 72h 37°C, 24h 
Cluster 1B 
3/B/71 NAS D14 4/O:9 Pig D tca-like pos 7.0 ±3.0 1.8 ± 2.8 <0.001 2.95x107 (120h) *5 1.57x109 (120h) 
*7 
2/A/36 TB D14 3/O:9 Pig D tca-like pos 8.5 ± 3.2 1.8 ± 2.4 <0.001 3.55x108 (96h) *5 1.70x109 (120h) 
*7 
2/B/49 TB D7 3/O:9 Pig D tca-like pos 6.0 ± 4.0 1.5 ± 2.1 <0.001 2.10x109 (96h) *5 no above 50% *8 
5618 2/Autoaggl Human D tca-like pos 6.7 ± 4.1 1.2 ± 1.5 <0.001 1.60x109 (96h) *5 no above 50% *8 
RS-42 D21 Y. frederiksenii Retail 
meat 
F neg NT 8.0 ± 2.9 0.3 ± 0.5 <0.001 1.23x108 (96h) *5 no above 50% *8 
3/C/87 CS D7 1A/Autoaggl Pig C neg NT 3.5 ± 3.9 1 ± 1.3 <0.001 5.13x108 (120h) *5 no above 50% *8 
3/C/86 CS D7 1A/O:9 Pig C neg NT 3.7 ± 3.7 0.7 ± 0.8 <0.001 1.23x109 (96h) *5 no above 50% *8 
RS-156 D14 Y. frederiksenii Retail 
meat 
C neg NT 4.2 ± 3.7 1.2 ± 1.2 <0.001 2.25x109 no above 50% *8 
Cluster 2 
2850 1A/NEG Human B tcd-like NT 6.8 ± 3.5 7 ± 3.2 0.843 3.24x108 (96h) *5 1.38x108 
2/A/31NM D14 1A/NST* Pig A neg NT 7.7 ± 2.7 8.3 ± 2.3 0.361 1.05x109 6.31x107 
DOG T43 D21 1A/NST Dog A neg NT 9.2 ± 1.2 7.3 ± 3.8 0.008 8.32x108 6.46x107 
1045 1A/O:8 Human A neg NT 8.3 ± 2.7 7.7 ± 3.4 0.361 7.76x108 6.76x107 
Y/01/05 1A/Autoggl Human A tcd-like NT 9.8 ± 0.5 6.5 ± 4.7 <0.001 4.17x108 7.08x107 
3343 Y. rohdei Human neg neg NT 7.7 ± 3.4 7.5 ± 3.2 0.831 9.55x108 2.82x107 
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Strain Bioserovar Source 
CDT 
type 
ITC type pYV 
Average Dead Gm larvae 
±SD per group of 10*10 P-value *4 
LD50, CFU/ml 
15°C, 120h 37°C, 120h 15°C, 72h 37°C, 24h 
19639 (2) 1A/NEG Human A tcd-like NT 10 ± 0.0 7.2 ± 2.7 <0.001 6.17x108 8.32x107 
19639 (1) 1A/NEG Human A neg NT 7.7 ± 2.0 6.3 ± 3.6 0.111 7.76x108 9.55x107 
DOG T50 D14 1A/NST Dog A tcd-like NT 7.5 ± 3.2 7.7 ± 2.7 0.831 4.57x108 2.19x107 
1/A/1 TB 1A/NST Pig A tcd-like NT 7.3 ±2.5 8.5 ± 1.6 0.116 8.51x108 <1.9x107 *9 
IP102 1A/O:6,30 Ref A tcd-like NT 9.2 ± 1.3 8.3 ± 2.4 0.168 4.47x108 <1.83x107 *9 
*NST – not serotyped 
** Reference strain  
*3NT – not tested   
*4 Statistical difference between G. mellonella larvae mortality rates observed after their incubation for 120h at 37°C and 15°C 
*5 50% mortality was not achieved at the specified time (72h) 
*6 LD50 was achieved after incubation for 48h 
*7 50% mortality was not achieved at the specified time (24h) 
*8 Mortality rate of 50% was never achieved  
*9 More than 50% of G. mellonella larvae were killed at the lowest CFU/ml injected 
*10 Mean number of dead insect larvae observed for all three different bacterial inocula 
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One-way ANOVA analysis with Tukey’s error of the mortality rates observed for 
Yersinia strains encoding different CDT loci revealed that strains encoding CDT type 
A locus were the most virulent towards insect larvae at 37°C but not at 15°C (Table 
3.20). 
Y. enterocolitica strains encoding a tcd-like ITC locus were the most virulent towards 
insect larvae at 37°C, at 15°C all strains encoding different ITC loci were equally 
pathogenic towards G. mellonella (Table 3.21). However, insecticidal activity of 
Yersinia strains encoding tca- and tcaA-tcaC2-like ITC loci as well as of ITC non-
encoding bacteria significantly increased at 15°C (Table 3.21). Y. enterocolitica 
strains encoding a tcd-like ITC locus were equally virulent at 15°C and 37°C (Table 
3.21). 
Presence of the Yersinia virulence plasmid pYV did not enhance insecticidal activity 
of Yersinia strains at 37°C, on the contrary pYV encoding strains were the least 
virulent towards insect larvae at 37°C (Table 3.22). At 15°C virulence of all strains 
irrespective of pYV presence significantly increased, moreover all strains were 
equally virulent at 15°C (Table 3.22). 
According to Tukey’s grouping all Yersinia strains were equally virulent at 15°C and 
37°C irrespective of their biotype (that reflects pathogenicity) (Table 3.23). While, 
mildly pathogenic biovar 2-4 and highly pathogenic biovar 1B Y. enterocolitica 
strains demonstrated significantly increased virulence towards G. mellonella larvae 
at 15°C than at 37°C, non-pathogenic biovar 1A Y. enterocolitica and Y. 
enterocolitica-like strains were similarly virulent at both 15°C and 37°C (Table 3.23).  
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Table 3.20 One-way ANOVA comparison of the G. mellonella larvae mortality rates caused by Yersinia strains encoding different CDT loci 
CDT locus 
Number of 
strains 
Average Dead 
Gm larvae ±SD 
per group of 10, 
37°C, 120h* 
95% CI** 
Tukey’s 
Grouping *3 
Average Dead Gm 
larvae ±SD per 
group of 10, 15°C, 
120h* 
95% CI** 
Tukey’s 
Grouping *3 
P-value *4 
A 9 7.5 ± 0.8 6.93, 8.14 A 8.5 ± 1.04 7.72, 9.32 A < 0.05 
B 3 4.9 ± 1.9 0.52, 9.37 B 6.4 ± 0.7 4.77, 8.12 AB 0.306 
C 3 0.9 ± 0.3 0.31, 1.58 C 3.8 ± 0.4 2.92, 4.64 B < 0.05 
D 8 2.4 ± 1.0 1.55, 3.20 C 7.9 ± 1.6 6.54, 9.21 A 0.000 
E 5 4.4 ± 1.1 3.07, 5.80 B 8.6 ± 1.4 6.92, 10.34 A < 0.05 
F 2 0.7 ± 0.5 -3.57, 4.90 C 9.0 ± 1.4 -3.71, 21.76 A 0.08 
N 2 5.7 ± 2.6 -17.63, 28.96 AB 6.9 ± 1.06 -2.61, 16.45 AB 0.642 
P-value *5 NA < 0.05 NA NA < 0.05    NA NA NA 
* Average numbers of dead insect larvae observed for all bacterial inocula 
**Confidence Interval 
*3 Means that do not share a letter are significantly different (p < 0.05), (pairwise differences between means not significant for means with the same letter)  
*4 Comparison of mortality rates observed at 15°C against those observed at 37°C 
*5 Comparison of mortality rates in different clusters at the same temperature 
NA :Not applicable 
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Table 3.21 One-way ANOVA comparison of the G. mellonella larvae mortality rates caused by Yersinia strains encoding different ITC loci 
ITC locus 
Number of 
strains 
Average Dead 
Gm larvae ±SD 
per group of 
10, 37°C, 120h* 
95% CI** 
Tukey’s 
Grouping *3 
Average Dead 
Gm larvae ±SD 
per group of 10, 
15°C, 120h* 
95% CI** 
Tukey’s 
Grouping *3 
P-value *4 
NEG 11 4.1 ± 3.3 1.86, 6.35 AB 6.9 ± 2.2 5.41, 8.41 A < 0.05 
tca-like 8 2.5 ± 1.01 1.61, 3.30 B 7.7 ± 1.5 6.46, 9.00 A < 0.05 
tcaA-tcaC2-
like 
5 4.3 ± 1.3 2.65, 5.95 AB 8.9 ± 1.3 7.20, 10.53 A < 0.05 
tcd-like 8 6.6 ± 1.8 5.12, 8.13 A 7.9 ± 1.6 6.57, 9.22 A 0.157 
P-value *5 NA < 0.05 NA NA 0.252 NA NA NA 
* Average numbers of dead insect larvae observed for all bacterial inocula 
**Confidence Interval 
*3 Means that do not share a letter are significantly different (p < 0.05), (pairwise differences between means not significant for means with the same letter) 
*4 Comparison of mortality rates observed at 15°C against those observed at 37°C 
*5 Comparison of mortality rates in different clusters at the same temperature 
NA :Not applicable 
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Table 3.22 One-way ANOVA comparison of the G. mellonella larvae mortality rates caused by pYV positive and pYV negative Yersinia strains 
pYV 
Number 
of strains 
Average Dead Gm 
larvae ±SD per group 
of 10, 37°C, 120h* 
95% CI** 
Tukey’s 
Grouping *3 
Average Dead Gm 
larvae ±SD per group 
of 10, 15°C, 120h* 
95% CI** 
Tukey’s 
Grouping *3 
P-value *4 
pYV +ve 10 2.6 ± 1.3 1.61, 3.52 B 8.4 ± 1.5 7.37, 950 A < 0.05 
pYV -ve 4 4.1 ± 1.4 1.88, 6.37 AB 8.0 ± 1.8 5.07, 
10.84 
A < 0.05 
Non-path 18 5.4 ± 2.9 3.95, 6.85 A 7.2 ± 1.9 6.21, 8.14 A < 0.05 
P-value *5 NA < 0.05 NA NA 0.214 NA NA NA 
* Average numbers of dead insect larvae observed for all bacterial inocula 
**Confidence Interval 
*3 Means that do not share a letter are significantly different (p < 0.05), (pairwise differences between means not significant for means with the same letter) 
*4 Comparison of mortality rates observed at 15°C against those observed at 37°C 
*5 Comparison of mortality rates in different clusters at the same temperature 
NA :Not applicable 
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Table 3.23 One-way ANOVA comparison of the G. mellonella larvae mortality rates caused by Yersinia strains of various biotypes 
Biotype 
Number 
of strains 
Average Dead Gm 
larvae ±SD per group 
of 10, 37°C, 120h* 
95% CI** 
Tukey’s 
Grouping*3 
Average Dead Gm 
larvae ±SD per group 
of 10, 15°C, 120h* 
95% CI** 
Tukey’s 
Grouping*3 
P-value *4 
1A 14 6.02 ± 2.6 4.51, 7.54 A 7.4 ± 2.01 6.21, 8.53 A 0.141 
1B 1 1 NA NA 10* NA A NA 
2 3 2.7 ± 1.4 -0.72, 6.06 A 8.2 ± 1.7 4.05, 12.39 A < 0.05 
3 4 2.5 ± 1.0 0.89, 4.03 A 7.5 ± 1.7 4.78, 10.30 A < 0.05 
4 6 3.9 ± 1.6 2.25, 5.53 A 8.6 ± 1.4 7.06, 10.05 A < 0.05 
Non-ent 4 3.2 ± 3.2 -1.93, 8.34 A 6.5 ± 1.8 3.72, 9.28 A 0.147 
P-value *5 NA < 0.05 NA NA 0.399 NA NA NA 
* Average numbers of dead insect larvae observed for all bacterial inocula 
**Confidence Interval 
*3 Means that do not share a letter are significantly different (p < 0.05), (pairwise differences between means not significant for means with the same letter) 
*4 Comparison of mortality rates observed at 15°C against those observed at 37°C 
*5 Comparison of mortality rates in different clusters at the same temperature 
NA :Not applicable 
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The one-way ANOVA comparison with Tukey’s error rate of the average numbers of 
dead larvae observed after incubation at 37°C for 120h revealed that mortality is 
significantly different across different hierarchical cluster mortality groups (P-value 
<0.05) (Table 3.24). Comparison of mean dead larvae observed at 15°C for 120h by 
the same method also found a statistically significant difference in the mortality for 
the different hierarchical clusters (P-value <0.05) (Table 3.24). For incubation at 
37°C the 95% confidence intervals (CI) for means observed for the clusters 1B,1A 
and 2 do not overlap (Table 3.24,Figure 3.9) and the three clusters show statistically 
significantly different mortalities at this temperature. For incubation at 15 °C the 
95% confidence intervals (CI) for mean death rates observed for clusters 1A and 2 
overlap, indicating that they are not significantly different (Table 3.24,Figure 3.9). 
Likewise, using Tukey’s method in ANOVA (95% simultaneous confidence intervals 
for all pairwise comparisons of the three groups) the difference between average 
numbers of dead larvae at 15°C achieved by Yersinia strains from clusters 1A and 2 
is associated with a 95% confidence interval between -1.516 and 1.682, which 
includes zero. This indicates that Yersinia strains from clusters 1A and 2, show 
indistinguishable virulence towards G. mellonella larvae at 15°C. At the same time, 
Yersinia strains from hierarchical cluster 1B are statistically significantly less 
virulent towards insect larvae at 15°C than microorganisms from clusters 1A and 2 
(Table 3.24). 
Comparison of Yersinia infection outcome observed at 37°C and 15°C between the 
strains within the cluster revealed that Yersinia strains from clusters 1A and 1B 
cause higher mortality rates at 15°C than at 37°C, with cluster 1B strains causing 
lower mortality at both 37°C and 15°C than the other groups (Table 3.24, Figure 
3.9). Yersinia strains from cluster 2 were equally lethal towards G. mellonella larvae 
at 37°C and 15°C (Table 3.24, Figure 3.9). The majority of pathogenic Y. 
enterocolitica strains caused significantly higher mortality rates of insect larvae at 
15°C than at 37°C (Table 3.19, Table 3.23). 
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Table 3.24 One-way ANOVA comparison of the G. mellonella larvae mortality rates caused by Yersinia strains grouped in specific hierarchical 
clusters  
Cluster 
Number of 
strains 
Average Dead Gm 
larvae ±SD per group of 
10, 37°C, 120h* 
95% CI** 
Tukey’s 
Grouping*3 
Average Dead Gm 
larvae ±SD per group 
of 10, 15°C, 120h* 
95% CI** 
Tukey’s 
Grouping*3 
P-value4* 
1A 13 3.65 ± 1.21 2.92, 4.38 B 8.21 ± 1.69 7.19, 9.23 A < 0.05 
1B 8 1.19 ± 0.53 0.74, 1.63 C 5.94 ± 1.95 4.30, 7,57 B < 0.05 
2 11 7.49 ± 0.72 7.00, 7.97 A 8.29 ± 1.08 7.56, 9.01 A 0.056 
P-value *5 NA < 0.05 NA NA < 0.05 NA NA NA 
* Average numbers of dead insect larvae observed for all bacterial inocula 
**Confidence Interval 
*3 Means that do not share a letter are significantly different (p < 0.05), (pairwise differences between means not significant for means with the same letter) 
*4 Comparison of mortality rates observed at 15°C against those observed at 37°C 
*5 Comparison of mortality rates in different clusters at the same temperature 
NA :Not applicable 
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Figure 3.9 Comparison of the G. mellonella larvae mortality rates caused by Yersinia 
strains grouped in specific hierarchical clusters analysed by ANOVA in 
Minitab 
     - shows mean death rates; horizontal line indicates median death rates with 95% 
confidence intervals (box) and standard deviations (whiskers). 
In addition to observed mortality rates, an LD50 for each Yersinia strain was 
estimated by an approximation of the Reed-Muench method [612] (Figure 3.10) 
based on at least one of the three inocula reaching mortality rates of insect larvae 
above 50% on observation after 24h of incubation at 37°C, and after 72h incubation 
at 15°C (Table 3.19). 
1. Estimate proportional distance (PD) 
   
                                        
                                                                       
  
2. Estimate logarithm (log) of the inoculum causing mortality below 50% 
3. Estimate sum of PD and  log of the inoculum causing mortality below 50% 
4. Inverse logarithm of the sum is the LD50 
Figure 3.10 Calculation of LD50 by Reed-Muench method [612] 
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Table 3.25 One-way ANOVA comparison of Yersinia strain LD50 for G. mellonella larvae observed at 37°C and 15°C 
Cluster 
Number of 
strains* 
LD50 ± SD, 15°C, 72h 95% CI 
Tukey’s 
Grouping *3 
Number of 
strains* 
LD50 ± SD, 37°C, 24h 95% CI 
Tukey’s 
Grouping *3 
P-value** 
1A 12 6.8x108 ± 6.1x108 
3.0x108, 
1.1x109 
A 12 7.4x108 ± 4.5x108 
4.5x108, 
1.0x109 
B 0.8 
1B 8 1.1x109 ± 9.8x108 
2.9x108, 
1.9x109 
A 2 1.6x109 ± 9.2x107 
8.1x108, 
2.5x109 
A 0.176 
2 11 6.8x108 ± 2.4x108 
5.2x108, 
8.4x108 
A 11 6.1x107 ±3.7x107 
3.6x107, 
8.6x107 
C <0.05 
P-value NA 0.284 NA NA NA < 0.05 NA NA NA 
*Only strains for which LD50 was achieved 
** Comparison of LD50, 15°C against LD50, 37°C 
*3 Means that do not share a letter are significantly different (p < 0.05), (pairwise differences between means not significant for means with the same letter) 
NA :Not applicable 
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Figure 3.11 Comparison of estimated LD50 for Hierarchical Mortality groups observed 
in G. mellonella larvae at 15°C and 37°C analysed by ANOVA in Minitab 
     - shows mean death rates; horizontal line indicates median death rates with 95% 
confidence intervals (box) and standard deviations (whiskers). 
Yersinia strains from clusters 1A and 1B achieved statistically similar LD50 at both 
15°C and 37°C (Table 3.25). LD50 of Yersinia strains from cluster 2 was higher at 
15°C than at 37°C of incubation (Table 3.25). The lowest LD50 at 37°C was achieved 
by the non-pathogenic Y. enterocolitica strains and Y. enterocolitica-like species from 
cluster 2 in comparison to strains from clusters 1A and 1B, corresponding to the 
higher death rates shown in Table 3.20 and Figure 3.9. Many Yersinia strains from 
cluster 1B and highly pathogenic Y. enterocolitica strain 8081 never achieved 50% 
mortality rates in insect larvae after incubation at 37°C (Table 3.19). 
Although, Yersinia strains from all clusters showed statistically similar LD50 after 
incubation of insect larvae at 15°C (Table 3.21), time-dependent difference of insect 
killing by bacteria was observed (Figure 3.12 and 3.13). A time plot analysis of the 
same G. mellonella larvae mortality rates used to compile the hierarchical cluster 
analysis revealed distinct time-dependent mortality at 37°C and 15°C (Figure 3.12 
and 3.13). Thus, at 37°C all Yersinia strains had produced most of their final level of 
G. mellonella larvae mortality by the end of 24 hours (fast killing) and mortality did 
not change much thereafter during further incubation for 120h (Figure 3.12). 
However, at 15°C the mortality of infected larvae continuously increased for all 
strains after the 72h time point (Figure 3.13) (slow killing). Highly pathogenic Y. 
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enterocolitica strain 8081 caused a more rapid form of slow killing at 15°C, with an 
increase in mortality detectable after 48 hours (Figure 3.13). 
 
Figure 3.12 Time plot of Yersinia infection outcome in G. mellonella larvae incubated 
at 37°C based on mean number of dead larvae observed for all inocula 
 
 
Figure 3.13 Time plot of Yersinia infection outcome in G. mellonella larvae incubated 
at 15°C based on mean number of dead larvae observed for all inocula 
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3.3.7 Y. enterocolitica toxicity in CHO cells 
While the expression assay demonstrated that CdtB toxins could be expressed at 
both 15°C and 37°C, eukaryotic cells were more affected by the bacterial cell lysates 
obtained from Yersinia grown at 22°C. However, this could be due to the higher 
protein concentrations applied. Less protein was detected in the bacterial cell 
extracts grown at 37°C. Affected CHO cells exhibited characteristic distension 
(Figure 3.14 (C)) as seen earlier in other studies [469, 615], some CHO cells were 
dead (round cells considered dead) (Figure3.14 (B), and in some wells there were 
no confluent growth (Figure 3.14 (C and D)) as seen in negative control wells (PBS) 
(Figure 3.14 (A)). 
 
     
          A.  PBS (negative control)                          B.  IP383 22°C 
     
         C.  IP102 22°C                                                D.  IP134 22°C 
Figure 3.14 Effect of Yersinia cell lysates in CHO cells 
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Table 3.26 CDT toxicity of Y. enterocolitica cell lysates in CHO cell culture 
Strain Bioserovar 
CHO cells Results Protein conc. µg/µl,  
CDT ITC pYV 
Gm 
Cluster 
Expression 
37°C 22°C 37°C 22°C Gene 37°C 15°C 
E.coli DHα5 NA 1+ NT 0.36 NT NT NT NT NT NT NT NT 
IP102 1A/O:6,30 1+ 4+** 0.24 0.53 A tcd neg 2 cdtB2 + + 
tcaC + + 
IP134 4/O:3 2+ 3+* 0.19 0.52 D tcaA-
tcaC2-like 
neg 1A - - - 
IP383 2/O:9 3+ 4+ 0.21 0.4 E tca-like pos 1A - - - 
IP22228 3/O:5 3+ 3+ 0.16 0.39 D tca-like pos 1A cdtB3 + + 
tcaC2 + + 
8081 1B/O:8 2+ 3+ 0.21 0.36 F neg pos 1A cdtB3 - - 
 tcaC2 - - 
2/A/31NMD14 1A/NST 2+ 2+ 0.22 0.36 A neg neg 2 - - - 
Y/00/01(2) 1A/NEG 2+ 3+ 0.28 0.42 B tcd neg 1A - - - 
1045 1A/O:8 2+ 3+ 0.18 0.38 A neg neg 2 - - - 
*Most of the cells are dead 
**Some cells distended 
NT :Not Tested 
NA :Not Applicable 
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3.4 Discussion 
Structural and functional homology between the insect immune response and the 
vertebrate innate immune response has suggested insects can be a useful model for 
studying microbial pathogenicity [586-589]. Insect models may be particularly 
relevant for organisms of the genus Yersinia because of the success of Yersinia pestis 
in infecting insects [357, 358, 544, 545], the phylogenetic relationship between 
Yersinia and other genera containing recognised insect pathogens from the family 
Enterobacteriaceae such as Photorhabdus [559], and the presence of insecticidal 
toxins genes in many Yersinia species [542, 543, 554-556]. Good correlation of Y. 
pseudotuberculosis virulence has been obtained between mammalian and G. 
mellonella infection models [600]. 
Previous studies investigating virulence of Y. enterocolitica towards G. mellonella 
larvae (Table 3.1, [585]) were confined to mildly pathogenic biovar 2 Serotype O:9 
strains and one highly pathogenic biovar 1B strain as well as Y. enterocolitica-like 
strains. Non-pathogenic biovar 1A strains were not studied [585]. Studies were 
conducted at 15°C only, with a single end point account of death at 5 days [585]. 
Moreover, it has been shown that classical Yersinia mammalian virulence factors 
such as yadA, irpI, and yopE do not affect virulence of Y. enterocolitica in another 
non-mammalian model, the nematode Caenorhabditis elegans, which requires 
incubation at less than 25°C [620]. In this study we compared virulence of 
pathogenic and non-pathogenic Y. enterocolitica strains including Y. enterocolitica-
like microorganisms towards G. mellonella larvae at both 15°C and 37°C with daily 
counts of dead larvae. We found that all Y. enterocolitica and Y. enterocolitica-like 
organisms tested showed a consistent temperature-dependant phenotype of fast 
killing (<24 hours) at 37 °C (Figure 3.12) and a slow (most mortality occurring after 
48 hours or longer) killing phenotype at 15°C (Figure 3.13). 
Hierarchical clustering of the combined temperature data showed that some biovar 
1A strains formed a distinct phenotypic group (Cluster 2, Table 3.19, Figure 3.8) 
showing enhanced fast killing at 37°C (Table 3.20, Figure 3.9, Figure 3.12). These 
non-pathogenic Y. enterocolitica biovar 1A strains lack recognised conventional 
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virulence factors seen in pathogenic Y. enterocolitica biovars [311, 321, 621] but 
were more virulent in most cases in G. mellonella larvae at 37°C than most of the 
mildly and highly pathogenic Y. enterocolitica strains (Cluster 1, Table 3.19, Figure 
3.8). A variety of mammalian pathogens have previously been found to exhibit 
similarly more rapid Galleria killing at higher temperatures, including Acinetobacter 
baumanii [622], the attenuated Live Vaccine Strain (LVS) of Francisella tularensis 
[623], Bacillus cereus [624], and the fungal pathogen Cryptococcus neoformans [625] 
(Table 3.27). 
Delayed mortality (slow killing) of insect larvae was observed at 15°C and not at 
37°C, with continuous increases seen after 72h of incubation (Figure 3.12, Figure 
3.13). The slow killing of insect larvae at 15°C eventually accounted for more deaths 
than the rapid killing at 37°C for both pathogenic and non-pathogenic Yersinia 
strains (Table 3.19, Table 3.23). This phenomenon of enhanced mortality at lower 
temperatures has not been reported with the other pathogens tested in the Galleria 
model described above, but a similar phenomenon has been observed with Bacillus 
weihenstephanensis [624], and Fusarium fungal species [626]. B. weihenstephanensis 
is the proposed name for a group of B. cereus strains not so far shown to have 
mammalian pathogenic properties [624], and Fusarium [626] are human 
opportunist pathogens and plant pathogens prevalent in the environment. 
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Table 3.27 G. mellonella mortality at different temperatures with mammalian pathogens (and some related non-pathogens) 
Organism Inoculum 
Final mortality 
reading 
(hours) 
Final Mortality (%) 
Incubation 
15°C 
Final Mortality (%) 
Incubation 
30 °C 
Final Mortality (%) 
Incubation 
37 °C 
Ref 
Acinetobacter 
baumanii  
3.7x10X105 148 - <30 >80 [622] 
Francisella tularensis 
LVS 
3x105 148 - 50 100 [623] 
Listeria innocua Clip 
11262 
4.2x105 120 - - 50 (LD50) [611] 
Listeria monocytogenes 
EGDe 
3x105 120 - - 50 (LD50) [611] 
Bacillus 
weihenstephanensis 
5x103 to 
1.4x104 
120 50-100 (linear 
regression 80) 
- 20-60 
(linear regression 40) 
[624] 
Bacillus cereus 5x103 to 
1.4x104 
120 30-100  
(linear regression 80) 
- 80-100 
(linear regression 
>95)  
[624] 
Cryptococcus 
neoformans strain H99  
1.5x104  400+ - 80 100 [625] 
Fusarium clinical 
isolates from humans 
1x105 (conidia) 100 (30 °C) 
190 (37 °C) 
- 80-100 0-50 [626] 
Fusarium plant 1x105(conidia) 100 (30 °C) - >90 25-30 [626] 
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Organism Inoculum 
Final mortality 
reading 
(hours) 
Final Mortality (%) 
Incubation 
15°C 
Final Mortality (%) 
Incubation 
30 °C 
Final Mortality (%) 
Incubation 
37 °C 
Ref 
pathogen isolates 190 (37 °C) 
Candida albicans MEN 5x105 72 4°C: 50* 90* 50* [590] 
Y. pseudotuberculosis 
IP32953 
1x106 24 - - 47 [600] 
Y. enterocolitica 
Cluster 1A mean  
6.76x106** 120 82 - 37 (this 
study) 
Y. enterocolitica 
Cluster 1B mean  
6.78x106** 120 59 - 12 (this 
study) 
Y. enterocolitica 
Cluster 2 mean  
6.78x106** 120 84 - 75 (this 
study) 
* This temperature was applied for 24 hours before inoculation into Galleria – all inoculated Galleria were incubated at 30 °C. For comparability, studies recording 
LD50 are given as 50 % mortality 
** Mean CFU of three inoculums injected into G. mellonella larvae 
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Differences in Galleria mortality at different temperatures and with different Yersinia 
strains could relate to bacterial factors or host (Galleria) factors. 
Considering bacterial factors, the insecticidal activity of the mildly and highly 
pathogenic Y. enterocolitica strains in Cluster 1 increased at 15°C in comparison to their 
insecticidal activity towards G. mellonella larvae at 37°C (Table 3.24, Figure 3.9). Most 
non-pathogenic Yersinia strains in Cluster 2 were equally virulent towards G. mellonella 
larvae at both 37°C and 15°C (Table 3.24, Figure 3.9). Several different non-pathogenic 
bacteria (non-pathogenic E. coli, Bifidobacterium spp. and Lactococcus lactis) are 
incapable of causing Galleria death on inoculation [611]. Lethal effects of bacteria non-
pathogenic in mammals in a Galleria model have however been reported, but with 
Gram positive genera, Listeria [611] and B. weihenstephanensis, mentioned above [624]. 
L. innocua is a species lethal in a Galleria model but not in mice or humans (Table 3.4), 
and B. weihenstephanensis [624] (a close relative of B. cereus) has a similar phenotype. 
Interestingly, both of these organisms are psychrotolerant, (psychrotrophic) like 
Yersinia [611, 624]. 
The majority of mildly pathogenic Y. enterocolitica strains in our collection encode a 
tca-like insecticidal toxin complex operon (Table 3.11) similar to that identified in 
pathogenic Y. enterocolitica W22703 strain (2/O:9) [555]. The tca-like insecticidal toxin 
complex operon was previously shown to be repressed at 37°C but increasingly 
induced as the temperature dropped below 30°C, with maximum expression observed 
at 10°C in vitro [555]. Therefore, increased levels of virulence towards G. mellonella 
larvae at 15°C demonstrated by mildly pathogenic Y. enterocolitica strains could be 
attributable to expression of the insecticidal toxin complex operon at low temperatures 
[555]. However, this does not explain the increased insecticidal activity of insecticidal 
toxin complex non-encoding highly pathogenic Y. enterocolitica strain 8081 (1B/O:8) 
towards insect larvae which was observed in this study at 15°C (Table 3.19, Table 
3.23). Moreover, some mildly pathogenic Y. enterocolitica strains in our collection 
encoded a tcaA-tcaC2-like insecticidal toxin complex operon that does not contain a 
tcaB2 gene detectable by the PCR primers used in this study (Table 3.12). The tcaB 
gene of Yersinia species is prone to frameshift mutations [542, 585, 604] that may affect 
insecticidal toxin complex activity in Yersinia at lower temperatures [359, 602, 604]. 
However, there was no apparent statistical difference in insecticidal activity between 
tca-like and tcaA-tcaC2-like-encoding mildly pathogenic Y. enterocolitica strains at 15°C 
(Table 3.21). 
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Only a small proportion of the biovar 1A Y. enterocolitica strains in this study (Table 
3.10) encoded a tcd-like insecticidal toxin complex operon similar to that previously 
identified in biovar 1A Y. enterocolitica strain T83 [556]. The tcd-like insecticidal toxin 
complex operon is known to be expressed at 30°C and 37°C [556]. At 37°C tcd-like 
insecticidal toxin complex encoding non-pathogenic Y. enterocolitica strains were the 
most virulent towards insect larvae (Table 3.21). However, all of these strains also 
encoded CDT type A locus (Table 3.19). Although tcd-like insecticidal toxin complex 
encoding Y. enterocolitica strains were equally virulent at both 15°C and 37°C (Table 
3.21), there was no significant difference between the insecticidal activity at 15°C of 
biovar 1A Y. enterocolitica encoding tcd-like insecticidal toxin complex operons and the 
remaining Yersinia strains not encoding a tcd-like insecticidal toxin complex operon in 
this study (Table 3.21). 
It has been suggested that Yersinia pathogenicity towards G. mellonella could be 
mediated by factors other than the insecticidal toxin complex [559, 585]. Putative 
Cytolethal Distending Toxins (CDTs) have been identified in the genome sequence of 
pathogenic Y. enterocolitica strain Y11 [466] and in the genome sequences of non-
pathogenic Y. enterocolitica (N. Thomson, personal communication). CDTs are able to 
cause cell cycle arrest and apoptosis in various eukaryotic cells [442-445], including 
immune cells, that may subsequently lead to inhibition of an adequate immune 
response towards the pathogen [605, 606]. CDTs are AB2 exotoxins where CdtB is an 
active subunit and CdtA and CdtC facilitate its entry into eukaryotic cells [445, 468, 
627]. It has been proposed that efficient binding of CdtA and CdtC to the target cell 
influences CDT activity and depends on the amino acid sequence of these CDT-binding 
subunits as well as presence of specific cell surface biomolecules such as cholesterol, 
glycoproteins and glycolipids in the target cells [628]. However, no CdtC subunit was 
identified in the present collection of Yersinia strains, suggesting that a different 
mechanism of CdtB subunit delivery into insect cells must occur. For example, 
Salmonella enterica Serovar typhi that does not encode CdtA and CdtC subunits delivers 
CdtB active subunit via the bacterial internalization pathway [449]. 
Various cytolethal distending toxin genes were detected by PCR in pathogenic and non-
pathogenic Y. enterocolitica strains (Table 3.16, Figure 3.4). Expression of cdtB2 in non-
pathogenic and cdtB3 in mildly pathogenic Y. enterocolitica strains was detected at both 
15°C and 37°C (Table 3.18, Figure 3.6, Figure 3.7). However, different levels of 
insecticidal activity were observed for pathogenic and non-pathogenic Yersinia strains 
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at both 15°C and 37°C (Table 3.19). Mildly pathogenic Y. enterocolitica strains that 
encode CDT type E were more virulent towards G. mellonella larvae than strains 
encoding CDT type D at 37°C (Table 3.20). Interestingly, mildly pathogenic Y. 
enterocolitica strains that encode CDT type E also encode tcaA-tcaC2-like insecticidal 
toxin complex genes, and CDT type D-encoding strains encode tca-like insecticidal toxin 
complex operons. The tcaA-tcaC2-like encoding Yersinia strains killed more G. 
mellonella larvae at 37°C than tca-like encoding strains (Table 3.21). Thus, it is difficult 
to differentiate between insecticidal toxin complex and CDT genotype contributions to 
the virulence of mildly pathogenic Y. enterocolitica strains towards insect larvae using 
this data. At 15°C CDT type E and CDT type D-encoding mildly pathogenic strains were 
not significantly different in insecticidal activity (Table 3.20). 
The composition of the CDT loci in non-pathogenic Y. enterocolitica strains is also 
variable. Strains containing CDT type A loci were generally more virulent towards 
insect larvae than strains encoding CDT type B and type C loci at both 15°C and 37°C 
(Table 3.20). In general, irrespective of the presence of a recognised insecticidal toxin 
complex locus, non-pathogenic Y. enterocolitica strains that encoded CDT type A 
(nearly all grouped into hierarchical cluster 2) were more virulent towards insect 
larvae at 37°C than all other Y. enterocolitica (Table 3.19, Table 3.23, Table 3.24, Figure 
3.8). 
Considering host factors affecting Yersinia pathogenesis in insects, the insect immune 
response operating in Galleria has structural and functional homology to the vertebrate 
immune response [586-589]. Antimicrobial peptides (AMP) are an evolutionary 
conserved component of the innate immune response and found in many living 
organisms [629]. AMPs are released at the early stages of the innate immune response 
and are key defensive molecules in invertebrates [630]. In G. mellonella several 
antimicrobial peptides have been identified with antibacterial and antifungal activity 
[631-634]. Microbial pathogens may display constitutive and inducible resistance to 
antimicrobial peptides. In vitro detection of antimicrobial activity of purified Galleria 
mellonella (Gm) AMPs demonstrated that gram negative bacteria were mostly resistant 
to Gm AMPs, only E. coli D31 was sensitive to purified Gm cecropin D-like peptide 
[634]. However, synergetic relationships among different AMPs [635, 636] and 
between AMPs and lysozyme against gram negative bacteria [637, 638] were described 
and therefore microbial resistance to purified AMPs observed in vitro may not be 
exhibited in vivo. 
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The ProPhenolOxidase (ProPO) system (also known as the serine proteinase cascade, 
or melanisation cascade) present in invertebrates such as Galleria is a proteolytic 
process analogous to the alternative complement system of the vertebrate immune 
response [589, 616]. The process of melanisation is activated by binding soluble 
pattern recognition receptors to the foreign target surfaces thus initiating the serine 
protease cascade [589]. The activated serine protease cascade leads to the cleavage of 
ProPO to PO (PhenolOxidase) that then catalyses production of quinines and 
subsequent formation of melanin [589]. Melanin is then transported and deposited 
around the wound or encapsulated foreign material [589, 616, 639]. ProPO is located in 
haemocytes as a zymogen and released from haemocytes by rupture and death [589, 
616] or other mechanisms [639]. All dead insect larvae infected with Yersinia strains in 
this study exhibited melanisation. As was mentioned earlier ProPO cascade resembles 
the alternative complement cascade in vertebrates [589, 616]. Thus, the insect ProPO 
has a sequence similar to thiol-ester region of the vertebrate complement proteins C3 
and C4 [589, 640]. In the mammalian host, there is evidence that Yersinia chromosome-
encoded Ail (expressed at 37°C in stationary-phase growth [641]) and pYV-encoded 
YadA proteins bind the alternative complement cascade regulator Factor H (FH) [385, 
386, 395] and the regulator of the classical and lectin complement activation pathways 
C4b-binding protein (C4BP) [383]. However, low mortality rates seen in this study of G. 
mellonella larvae caused by pathogenic Y. enterocolitica strains at 37°C (Table 3.19, 
Table 3.23, Figure 3.9) suggest that Ail and YadA known to be present in these strains 
do not facilitate ProPO cascade resistance in this invertebrate host. 
The next line of bacterial defence mechanisms against the host innate immune 
response is the ability to survive or avoid phagocytosis. Although signal transduction of 
insect phagocytosis is not clearly understood it has been demonstrated that 
phagocytosis by insect haemocytes stimulates a response similar to the vertebrate 
respiratory burst pathway involving NADPH oxidase activity [642, 643]. The insect 
haemolymph contains various cell types, but the most abundant haemocytes of insect 
haemolymph are plasmocytes and granulocytes that play roles in the insect cellular 
immune response (phagocytosis) [589]. dSR-C1, TLR-like and integrin receptors 
similar to receptors on mammalian cells are present on the surface of insect phagocytes 
(plasmocytes and granulocytes) [644]. Pathogenic Y. enterocolitica interacts with 
mammalian phagocytic cells via binding to β1 integrins by the chromosome-encoded 
Inv invasion protein [301, 304, 305] and pYV plasmid-encoded YadA protein [645] and 
subsequent activation of the Ysc/TTSS system [388] that facilitates translocation of 
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effector YOPs (YopE, YopH, YopO/YpkA, YopM, YopP/J and YopT) into the cytoplasm of 
eukaryotic cells [388, 408] with consequent suppression of phagocytosis [416, 417]. In 
vitro inv gene expression was observed at 26°C (neutral pH) and 37°C (pH5.5) [646]. 
Both YadA and YOPs are expressed at 37°C [388]. Therefore, one might anticipate that 
Y. enterocolitica strains which are pathogenic for mammals would show a similar 
increased capacity to overcome the cellular immune response (phagocytosis) of G. 
mellonella larvae at 37°C. However, in relation to the activity of Y. enterocolitica in 
Galleria at 37°C, it is known that pre-incubation of G. mellonella larvae at 37°C (and 
4°C) results in a stress response including an increase in haemocyte density and 
antimicrobial peptide synthesis which reduces their mortality in subsequent Candida 
albicans infection compared to when pre-incubated at 30°C (Table 3.4) [590]. 
Future work to look at the effects of injecting killed Y. enterocolitica strains or protein 
extracts from bacteria would help to show whether a pre-formed toxin was a likely 
candidate to be responsible for either the rapid (37°C) killing or slow (15°C) killing 
Yersinia insecticidal activity demonstrated in this chapter. Galleria toxicity and 
cytoxicity of culture supernatants grown at different temperatures would also be 
relevant. In vitro expression analysis (Figure 3.6 and 3.7) suggests that the rapid 37°C 
killing is unlikely to be due to insecticidal toxin complex activity, because this operon 
shows less induction at this temperature compared to 15°C (in line with published data 
[555]). The expression of cdtB2 and cdtB3 (i.e. representative component genes for all 
the CDT loci identified in this chapter) (Figure 3.6 and 3.7) was equally evident at both 
temperatures in vitro, suggesting that CDT toxins are candidates for causing both forms 
of killing. Preliminary experiments with CHO (Chinese Hamster Ovary) cells indicated 
that Y. enterocolitica cell lysates have toxic effect at both 37°C and 22°C possibly due to 
the activity of the CDT toxins. However, further experiments are required. The 
presence of various toxin genes in Y. enterocolitica strains which are not recognised 
mammalian pathogens (e.g. Hierarchical cluster 2, Biovar 1A strains), and their 
Galleria-killing capacity, implies that pathogenicity for insects may be useful for non-
mammalian pathogen Yersinia strains in environments like soil, and there may be some 
unrecognized invertebrate host species adapted to temperate environments which 
provide optimal growth temperatures for these psychrotrophic organisms. 
Indeed, it has been suggested that insects may act as a reservoir for emerging human 
pathogens [557] and ancestral Yersinia species were associated with insects or insect 
pathogens [538, 542]. The Galleria pathogenicity of Y. enterocolitica strains which are 
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not pathogenic for mammals strengthens this connection. Understanding of the 
relationships between bacteria and non-human hosts could give clues to the evolution 
of human pathogens. 
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Chapter 4 Comparative genomics 
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4.1 Introduction 
DNA analysis is widely used for investigating bacterial taxonomy, bacterial typing and 
establishing evolutionary relationships between bacteria [485, 486, 531, 533, 536, 538, 
543, 548, 647-650]. Genetic polymorphisms of Yersinia strains can be determined by 
applying DNA analysis techniques that can be grouped into three types (Table 4.1). 
Table 4.1 Molecular typing techniques applied for resolving relationships between 
Yersinia strains* 
Random whole genome 
analysis techniques** 
Specific gene variation 
analysis techniques** 
Comparative genomics 
PFGE 
AFLP 
RAPD (Random Amplification 
of Polymorphic DNA) 
ERIC-PCR 
REP-PCR  
MLVA 
MLEE 
MLST 
Ribotyping 
PCR-ribotyping 
16SrDNA 
 
Genome sequencing 
Microarray genome 
comparison 
*See Chapter 1 for more details  
** After Gürtler [651] 
Random whole genome analysis and specific gene variation analysis techniques resolve 
evolutionary and taxonomic relatedness of bacteria based on limited knowledge about 
their DNA sequences. Comparative genomics facilitates recognition of predicted coding 
sequences (CDSs) that define host-pathogen interactions and hence provides insights 
into molecular evolution of bacterial virulence [530-533, 542, 543, 548, 652-654]. 
Microarray technology allows comparative genomics of test strains against a reference 
without the need to perform whole genome sequencing on all the test strains. 
Microarray technology can be used for genomic typing (genomotyping) – comparative 
genomic hybridization [655] and for gene expression studies [656]. Comparative 
microarray genomotyping is based on competitive DNA-DNA hybridization between a 
mixture of DNA samples from an unsequenced test strain and a sequenced control 
strain (each labelled with a different fluorescent dye) to the reporter DNA probes 
designed from the control strain genome or set of genomes bound to a microarray 
surface [523]. Two microarray technologies exist – the Polymerase Chain Reaction 
product based microarrays (PCR-based) and oligonucleotide-based DNA microarrays 
[523, 657]. Although PCR-based microarrays are easy and relatively cheap to produce, 
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detection of single nucleotide polymorphism (SNP) and mutant alleles is not achievable 
[657]. On the other hand, oligonucleotide-based microarrays are more expensive but 
allow detection of single nucleotide polymorphisms (SNP) and mutant alleles [657]. 
Additionally, oligonucleotide-based microarrays reduce cross-hybridization as they 
employ more specifically designed oligonucleotides, and these have now largely 
replaced PCR product microarrays [523-527]. In situ synthesized oligonucleotide 
arrays (ISO) which can now be made using ink jet printing (Inkjet in situ synthesized 
(IJISS) Agilent Technologies, USA) are more cost effective as they allow production of 
the microarrays as required, moreover arrays can be re-used [658]. The IJISS 
technology also allows greater flexibility in the array design [658]. 
4.1.1 Analysis of comparative genomic hybridization on microarrays  
Comparative genomic hybridization microarray analysis is a multistep procedure that 
involves initial image acquisition and analysis of the hybridised DNA (spot recognition, 
normalization); prediction of presence/absence/divergence for each gene in the array, 
and, finally, phylogenetic analysis [659]. 
Scanning of the microarray slides – image acquisition – is the first step of the 
microarray data analysis. The main priority of image acquisition is correct balance of 
the intensities between two channels corresponding to each fluorescent label (Cy3 and 
Cy5). Next step is an image analysis that involves spot recognition and normalization. 
Subtraction of the background intensity from the foreground intensity for each channel 
gives spot intensity. Spots with low intensity are excluded from further analysis. 
Intensity ratios between channels Cy3 and Cy5 corresponding to differential 
hybridisation between the two bacterial strains are then transformed to log-ratios that 
are used for normalization. 
Normalization of microarray data is required to remove systematic errors associated 
with the microarray procedure which do not reflect underlying biological variation in 
samples [660]. Numerous microarray data normalization protocols are available [660-
666]. They can be grouped into global or intensity-dependent normalization methods. 
Global normalization methods do not correct for intensity or scale differences and often 
perform poorly in comparison to intensity-dependent normalization methods [660, 
666]. There are two types of intensity-dependent normalization methods – linear and 
nonlinear, that perform similarly [666]. 
Many methods (cut-off algorithms) for the prediction of presence/absence/divergence 
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for each gene represented in the array base their results on log-ratio signals. Log-ratio 
based cut-off algorithms as applied by the GENCOM [667], GACK [668] and Porwollik 
[669] methods assume symmetry, normality and linearity of the microarray data [670]. 
When microarray data do not meet these criteria these algorithms are less able to 
identify the presence/absence/divergence of the genes correctly [670-672]. Snipen et 
al [673] have proposed a new cut-off algorithm for the prediction of the 
present/absent/divergent genes based on the supervised learning approach where 
sequence identities are predicted from bias-corrected array signals in each channel 
separately. This approach is superior to the log-ratio based cut-off algorithms [673]. 
The Output of analysis is a binary file scoring gene absence or presence that can be 
used for estimation of the phylogenetic relationships of the taxa (specimens). 
4.1.2 Phylogenetic methods 
The most commonly used methods in comparative phylogeny which are applicable to 
binary character data such as that produced by microarray typing are maximum 
parsimony, maximum likelihood and Bayesian inference. Maximum parsimony is a 
method in which different trees are evaluated to find the tree topology which uses the 
minimum number of changes to explain the observed data [674], it uses non-
parametric statistics [675, 676]. Maximum likelihood methods involve scoring different 
trees and selecting a phylogeny which maximizes the probability of the data D given the 
parameters of the tree values θ, Pr(D|θ) [677] and relies on parametric statistics [678]. 
Non-parametric or “distribution free” statistical tests do not make numerous or 
stringent assumptions about the population, on the other hand parametric statistics 
assume that the data belong to some type of probability distribution [679]. While 
maximum parsimony is a fast method for reconstructing phylogenetic relationships 
between closely related taxa, maximum likelihood is useful for the reconstruction of the 
evolutionary relationships for rapidly evolving taxa or taxa that have been separated 
for a long time [680]. The Bayesian approach to phylogeny is based on Bayes’s theorem 
in which prior probability of a phylogeny is combined with the likelihood to produce a 
posterior probability distribution on trees [681]. Bayesian inference attempts to 
maximise the probability of the tree parameter values given the probability of the 
observed data, Pr(θ|D), known as the posterior probability [677], and uses parametric 
statistics [680]. Markov Chain Monte Carlo (MCMC) sampling of the trees in proportion 
to their likelihood during Bayesian analysis is used to produce the most credible tree 
[682, 683]. 
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Comparative phylogenomic analysis of microarray data obtained from Y. enterocolitica 
strains isolated in Great Britain from humans with diarrhoea and domestic animals 
[50] using a GACK cut-off algorithm for calling gene presence/absence and Bayesian 
inference resulted in the distribution of strains into three clades: highly pathogenic, low 
pathogenic and non-pathogenic clades [531]. Overall the three clades shared only 
20.8% of the reference genome set revealing a high genetic heterogeneity of this 
species [531]. 
Because of the extensive human, animal and food exchanges between the UK and 
Ireland (16% of all Irish exports go to the UK and a third of all Irish imports come from 
the UK) [684], it would be expected that the population structure of Y. enterocolitica 
strains should be similar in the two countries. However, there is currently no data on 
the gene complement of Y. enterocolitica strains isolated in Ireland. The objective of this 
study is to gain further insight into genetic heterogeneity and relationships among 
clinical and non-clinical Y. enterocolitica strains of varying pathogenic potential isolated 
in Ireland in comparison with those from Great Britain. 
4.2 Materials and Methods 
4.2.1 Promega Wizard Genomic DNA purification protocol 
A loopful of overnight bacterial culture grown on tryptic soy agar (TSA) plates at 30°C 
was gently resuspended with 600µl of Nuclei Lysis solution in 1.5ml tubes. After 
bacterial culture was fully homogenized in nuclei lysis solution they were incubated at 
80°C for 5min, then cooled to room temperature. RNA was removed by adding 3µl of 
RNAse solution into the cell lysate, inverting tubes 2-5 times to mix and following 
incubation at 37°C for 60min. Protein precipitation was achieved by adding 200µl of 
protein precipitation solution into the cooled down to room temperature RNAse-
treated cell lysate and following incubation on ice for 5min. Protein was removed from 
DNA samples by series of washes in isopropanol and in 70% ethanol. DNA samples 
were rehydrated by adding 100µl of rehydration solution and overnight incubation at 
4°C. DNA samples were stored at -80°C. DNA quality was assessed by Nanodrop 
NT1000. 
4.2.2 Microarray DNA-DNA hybridization procedure 
The Yersinia specific microarray YP v3.1.0 contains 9048 predicted CDSs from Y. 
enterocolitica subsp. enterocolitica 8081 and non-8081 Yersinia species (Y. 
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enterocolitica subsp. palearctica strains W22703, 647176, R71; Y. enterocolitica subsp. 
enterocolitica strain WA314; Y. pestis strains CO92, 1695, KIM; Y. pseudotuberculosis 
strains 3277, 48790, 931474, AH, CN4, Kuratani, M444, M452, M85, Pa3606, R80, YPT1, 
Yoko), and plasmid encoded genes (pYV, CD1, MT1, PCP1) are also included 
(http://bugs.sgul.ac.uk/A-BUGS-27; ArrayExpress accession: A-BUGS-27). This 
microarray was designed and constructed by the Bacterial Microarray Group at St. 
George’s Hospital Medical School, University of London as described by Hinds et. al 
[685, 686]. Briefly, to avoid cross hybridization, only unique PCR products for each CDS 
were selected, for optimum hybridization all selected PCR products were in line with a 
standard set of requirements (length, GC content and Tm) [685]. Microarrays were 
constructed by robotic spotting of the selected PCR products in duplicate onto UltraGap 
glass slides (Corning) with a MicroGrid II (BioRobotics) [686]. 
DNA from test strains (test DNA) and Y. enterocolitica 8081 (control DNA), respectively 
labelled with the fluorescent dyes Cy5-dCTP and Cy3-dCTP, were competitively 
hybridized onto YP v3.1.0 microarray slides. Labelling and DNA-DNA hybridization 
procedures were performed according to the protocol devised by Bacterial Microarray 
Group at St. George’s, University of London. 
Test and control DNA samples were separately aliquoted into separate 0.2ml sterile 
eppendorf tubes and then prepared as follows: 2µg of each DNA sample was mixed 
with 1µl of random primers (3µg/µl, Invitrogen) and then volume of the mixture was 
increased to 41.5µl with the sterile molecular grade water (Sigma); this mixture was 
then heated at 95°C for 5min. In the next step test and control DNA samples were 
labelled with Cy5 and Cy3 dCTPs (GE Healthcare) respectively as follows: 8.5 µl of 
labelling mixture containing 5µl of 10xREact2 buffer (Invitrogen), 1µl dNTPs (5mM 
dA/G/TTP, 2mM dCTP, Invitrogen), 1.5µl of respective fluorescent dye Cy3 or Cy5 dCTP 
(GE Healthcare) and 1µ of Klenow DNA Polymerase (500U; Invitrogen) was mixed with 
41.5µl of respective DNA sample, this mixture then was incubated at 37°C in dark for 
90 min. 
During DNA labelling procedure 50ml of prehybridization mixture (8.75 ml of 20xSSC 
(Sigma), 250µl of 20% SDS (Sigma), 5 ml of Bovine Serum Albumin (100mg/ml, Sigma) 
and 36ml of molecular grade water (Sigma) was heated to 65°C in a Coplin jar. 
Microarray slides were pre-hybridised by their incubation at 65°C for 20min in pre-
heated prehybridization solution. After pre-hybridisation slides were washed in 400ml 
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water and then 400ml isopropanol (Sigma) for 1 min in each wash and then centrifuged 
at 1,500 rpm for 5 min. 
After labelling reactions Cy3 and Cy5 labelled DNA samples were combined in 1.5ml 
eppendorf tubes and then purified Qiagen MinElute purification kit. 
Purified labelled DNA samples (39µl) were mixed with the hybridisation solution 
containing 12 µl of 20xSSC (Sigma) and 9 µl of 2% SDS (Sigma); this mixture then was 
heated at 95°C for 2 min. Samples were kept at 70°C in dark until needed. 
Hybridisation solution containing labelled DNA samples (total volume 71 µl) was 
applied on the prehybridized microarray slide covered with two 22x22 mm Lifter Slips 
(VWR International). Hybridisation was performed in a Hybridisation Chamber II 
(Corning), submerged in a water bath in the oven at 65°C in the dark overnight (16-
20h). 
After overnight hybridisation slides were washed for 2min in each of three washes. 
Wash A (20xSSC – 20ml, 20% SDS – 1ml, distilled H2O – 379ml) was preheated to 65°C 
overnight; two washes B (20xSSC – 1.2ml, distilled H2O – 398.8ml) were kept at room 
temperature. After washing slides were spanned at 1,500 rpm for 5min. 
4.2.3 Microarray data analysis 
Microarray DNA-DNA hybridizations were scanned with a dual-laser scanner 
Affymetrix 428 (MWG Biotech) using various photomultiplier tube (PMT) gain settings. 
Spot recognition and estimation of the spot fluorescent signal intensity was performed 
by analysing obtained microarray images with Genedirector v2.7 software package that 
included Imagene v6.0 software (Biodiscovery) according to BugsBase Imagene 
settings for array A-BUGS-27 (Y. enterocolitica YPv3.1.0). 
Between-array normalization and assignment of present and absent genes were 
performed by Dr. A. Witney (St George’s, University of London) using the same 
methodology for the single colour microarray data obtained during this study 
(BµG@Sbase (accession number E-BUGS-148 (http://bugs.sgul.ac.uk/E-BUGS-148) and 
also ArrayExpress (accession number E-BUGS-148),and the raw data from the previous 
England and Wales study of Howard et al (BµG@Sbase accession number E-BUGS-36 
(http://bugs.sgul.ac.uk/E-BUGS-36) and also ArrayExpress (accession number E-BUGS-
36), [531]). Single colour data was loaded into R, control spots were removed and then 
a quantile between-array normalisation was performed using LIMMA [687] with the 
recommended weak flagging of array spots [673]. Prediction of present and absent 
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genes was performed as described by Snipen on the single colour normalized data 
using a published Bias-Corrected S-signal Prediction (BCSP) method in the R statistical 
environment [673]. Briefly, ranking of present/absent genes was performed according 
to predicted sequence similarity. The threshold of prediction was 0.7 (70% identity), 
values above 0.7 were rounded to 1 and correspond to present, values below 0.7 were 
rounded to 0 and correspond to absent [673]. A binary matrix of presence/absence 
calls was thereby generated for each gene for each strain for normalized data from 
microarray experiments E-BUGS-148 and E-BUGS-36. 
4.2.4 Comparative phylogenomic analysis 
Using the binary matrix data, evolutionary relationships between taxa were estimated 
by three separate methods. Maximum likelihood using RAxML v7.3.0 [688] and 
Bayesian inference using MrBayes v3.2.1 [689]. Maximum likelihood phylogenomic 
reconstruction was carried out by Dr. A. Witney (St George’s, University of London) 
with RAxML v7.3.0 using a GAMMA model of rate heterogeneity [688]. Branch support 
values were generated by a rapid bootstrap analysis of 1000 replicates. The extended 
majority-rule consensus tree criterion was used to ensure convergence by 1000 
replicates [688]. For Bayesian phylogenetic analysis the binary matrix of 
presence/absence calls was transformed into NEXUS file format with the Fused Matrix 
Exporter in Mesquite v2.75 [690]. Bayesian inference was carried out with four-chain 
MCMC sampling for 1x107 generations with the burn in fraction 0.5 and sample 
frequency of 1000. 
Phylogenetic trees were visualised and formatted with FigTree v1.3.1 software 
(http://tree.bio.ed.ac.uk/). 
4.2.5 Estimation of the genomic content 
The binary matrix was used for the estimation of core and specific set of genes encoded 
by Y. enterocolitica strains using the website GeneVenn [691] based on the following 
list of genes (Table 4.2) as follows. Binary file data was grouped by pathogenicity 
classification of the strains, and then according to their origin (Great Britain or Ireland) 
yielding nine data sets: GB only non-pathogenic, GB only highly pathogenic, GB only 
mildly pathogenic, Irish only non-pathogenic, Irish only highly pathogenic (8081 strain 
only), Irish only mildly pathogenic, GB and Irish non-pathogenic, GB and Irish highly 
pathogenic, GB and Irish mildly pathogenic. Any genes absent in any single strain or 
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multiple strains were manually removed from each data set. Final gene lists for each set 
were compared in GeneVenn. 
Table 4.2 Set of genes used for phylogenomic comparisons 
Yersinia strain Number of genes 
Y. enterocolitica subsp. enterocolitica strain 8081 4208 (chromosomal) 
83 (pYV-encoded) 
Y. enterocolitica subsp. enterocolitica strain WA314 4 
Y. enterocolitica subsp. palearctica strain 56 1 
Y. enterocolitica subsp. palearctica strain 383 2 
Y. enterocolitica subsp. palearctica strain 22703 16 
Y. enterocolitica subsp. palearctica strain 647176 20 
Y. enterocolitica subsp. palearctica strain R71 11 
Y. enterocolitica subsp. palearctica strain A12790 10 
Y. pseudotuberculosis strain 931474 2 
Y. pseudotuberculosis strain AH 5 
Y. pseudotuberculosis strain CN4 1 
Y. pseudotuberculosis strain M444 4 
Y. pseudotuberculosis strain M452 6 
Y. pseudotuberculosis strain M85 6 
Y. pseudotuberculosis strain Pa3606 2 
Y. pseudotuberculosis strain R80 1 
Y. pseudotuberculosis strain YPT1 4 
Y. pestis strain KIM 32 
Total number of genes 4418 
4.2.6 Samples 
Y. enterocolitica strains from patients with yersiniosis were obtained from pre-existing 
culture collections in Queen’s University Belfast (gift of Dr. J. Moore) and University 
College Galway – isolated during 1997-2003 (gift of Prof. M. Cormican), identification of 
strains was confirmed by API 20E BioMérieux incubated at 30°C overnight [130, 131]. Y. 
enterocolitica strains from retail meat samples and animals were obtained during the 
contemporaneous abbatoir study of pig carcasses in Ireland carried out in Cork by 
University College Dublin researchers (Dr. B. Murphy and Prof. S. Fanning) (Table 4.2). 
All strains were biotyped according to the simplified Wauter’s Biotyping Scheme (Table 
3.3, see Chapter 3) and serotyped with MAST Group Yersinia enterocolitica Antisera that 
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included one poly antisera – O:1,O:2 and four mono antisera – O:3; O:5; O:8; O:9. All 
isolates were checked for possible autoagglutination in a drop of sterile 0.85% saline 
solution. 
Table 4.3 List of Y. enterocolitica strains hybridised (from Ireland unless stated) 
Strain Number BioSerotype Source  Locality/year 
1045 1A/O:8 Human Galway* 
1170 1A/O:8 Human Galway 
1572 1A/O:8 Human Galway 
2850 1A/NST Human Galway 
19639_1 1A/NST Human Galway 
19639_2 1A/O:8 Human Galway 
Y0001_2 1A/NST Human/faeces Belfast/2000 
Y0105 1A/NST Human/faeces Belfast/2001 
Y0202 1A/NST Human/faeces Belfast/2002 
2A31NMD14 1A/NST Pig Cork/2007 
3C86CSD7 1A/O:9 Pig Cork/2007 
3C87CSD7 1A/NST Pig Cork/2007 
4C115NMD21 1A/NST Pig Cork/2008 
4C118NMD21 1A/NST Pig Cork/2008 
6A182TBD21 1A/NST Pig Cork/2008 
DOGT43D21 1A/NST Dog Cork/2008 
DOGT50D14 1A/NST Dog Cork/2008 
RS52D21 1A/NST Retail Cork/2007 
RS55D21 1A/NST Retail Cork/2007 
5618 2/O:9 Human Galway 
Y0101 2/O:9 Human/faeces Belfast/2001 
Y0113 2/O:9 Human/faeces Belfast/2001 
1127 3/NST Human  Galway 
1412 3/NST Human Galway 
2484 3/O:9 Human Galway 
1C23NAS_D7 3/O:5 Pig Cork/2007 
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Strain Number BioSerotype Source  Locality/year 
1C30TB_D7 3/O:9 Pig Cork/2007 
2A36TB_D7 3/O:9 Pig Cork/2007 
2A36TB_D14 3/O:9 Pig Cork/2007 
2B49TB_D7 3/O:9 Pig Tipperary/2007 
2C53TA 3/O:9 Pig Cork/2007 
3C87TB_D7 3/O:9 Pig Cork/2007 
4A92TB_D14 3/O:9 Pig Cork/2008 
5C154NM_D7 3/O:9 Pig Cork/2008 
6A187TB_D21 3/O:9 Pig Cork/2008 
2C_COMMONTABLE_D21 3/O:9 Environment Cork/2007 
3C_COMMONTABLE_D14 3/O:9 Environment Cork/2007 
Y0001_1 4/O:3 Human/faeces Belfast/2000 
Y0002 4/O:3 Human/faeces Belfast/2000 
Y0004 4/O:3 Human/faeces Belfast/2000 
Y0208 4/O:3 Human/faeces Belfast/2002 
2A34TB_D7 4/O:3 Pig Cork/2007 
2A40NAS_D7 4/O:3 Pig Cork/2007 
3A61TB_D21 4/O:3 Pig Cork/2008 
3A70TB_D21 4/O:3 Pig Cork/2008 
3B71NAS_D21 4/O:9 Pig Tipperary/2007 
4C113TB_D7 4/O:3 Pig Cork/2008 
3343 Y. rohdei Human Galway 
8081 1B/8081 Human Reference strain 
(USA) 
Total 49  
*Exact year of the isolation not available for all strains from Galway 
The comparator strains from Great Britain in the historical dataset were isolated from 
faeces of domestic animals (cattle, sheep, pigs) at slaughter and from patients with 
yersiniosis during 1999-2000 [50, 531]. A group of highly pathogenic Y. enterocolitica 
biovar 1B strains from the USA was also present in this historical dataset. As in the 
previous microarray study of strains from Great Britain [531] the reference biovar 1B 
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Y. enterocolitica 8081 strain which has been sequenced [532] was used as a control in 
the current experiment (Table 4.2). 
4.3 Results 
4.3.1 Comparative phylogenomic analysis 
 
Figure 4.1 RAxML phylogenomic reconstruction 
Blue taxa :non-pathogenic biovar 1A strains 
Red taxa :highly pathogenic biovar 1B strains 
Green taxa :biotype 2 strains 
Purple taxa :biotype 3 strains 
Orange :biotype 4 strains. 
Red branches represent Irish strains 
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Table 4.4 Rogue strains 
Strain Bioserovar Source Country 
Y3343 Y. rohdei Human Ireland 
Y2850 1A/NST Human Ireland 
Y19639_1 1A/NST Human Ireland 
Y19639_2 1A/O:8 Human Ireland 
Y0105 1A/NST Human Ireland 
DOGT50D14 1A/NST Dog Ireland 
RS52D21 1A/NST Retail pork Ireland 
RS55D21 1A/NST Retail pork Ireland 
Y3C87CSD7 1A/NST Pig Ireland 
Y4C115NMD21 1A/NST Pig Ireland 
Y4C118TBD21 1A/NST Pig Ireland 
Y6A182TBD21 1A/NST Pig Ireland 
Y1603 3/O:5 Human Great Britain 
Y4103 1A/O:6,30 Human Great Britain 
Y7403 3/O:9 Human Great Britain 
Y20302 3/O:5,27 Pig Great Britain 
Y20402 4/O:3 Pig Great Britain 
Y23802 3/O:5,27 Pig Great Britain 
RAxML phylogenomic reconstruction grouped all Y. enterocolitica strains isolated in 
Ireland and Great Britain according to their pathogenic potential. Removal of 18 rogue 
taxa (Table 4.4) was required to improve bootstrap support values of such separation 
(Figure 4.1). Highly pathogenic Y. enterocolitica strains form a subclade within a clade 
of non-pathogenic biovar 1A strains with the bootstrap support values of 100% (Figure 
4.1). Although, there is a clear geographical separation of Y. enterocolitica strains 
isolated in Ireland and Great Britain, this is poorly supported by bootstrap values 
(below 70%) (Figure 4.1). 
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Figure 4.2 MrBayes phylogenomic reconstruction 
Blue taxa :non-pathogenic biovar 1A strains 
Red taxa :highly pathogenic biovar 1B strains 
Green taxa :biotype 2 strains 
Purple taxa :biotype 3 strains 
Orange :biotype 4 strains 
Red branches represent Irish strains 
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Bayesian inference also grouped all Y. enterocolitica strains according to their 
pathogenic potential, and clearly supported geographic separation of Irish and British 
strains with the support of branch probabilities above 95%. (Figure 4.2). 
RAxML phylogeny of British, Irish and North American (highly pathogenic) suggests 
that non-pathogenic biovar 1A and mildly pathogenic Y. enterocolitica subsp. 
palearctica evolved separately from a common ancestor (Figure 4.1). RAxML 
phylogenomic reconstruction aslo shows that highly pathogenic Y. enterocolitica subsp. 
enterocolitica deviated from non-pathogenic biovar 1A Y. enterocolitica subsp. 
palearctica (Figure 4.1). Bayesian inference implies that non-pathogenic biovar 1A Y. 
enterocolitica is a progenitor for both highly and mildly pathogenic Y. enterocolitica 
(Figure 4.2). 
In all trees two mildly pathogenic Y. enterocolitica strains (Y0101 bioserotype 2/O:9 
and Y0001_1 bioserotype 4/O:3) from the Irish collection were clustered together with 
non-pathogenic biovar 1A strains from the same collection. In addition to the 
repeatedly confirmed biotyping these two strains encoded a ystA gene (see protocol in 
Chapter 3) characteristic of pathogenic Y. enterocolitica strains [572]. Y0001_1 
bioserotype 4/O:3 also showed a Galleria pathogenicity profile commonly seen with 
mildly pathogenic biovars (Chapter 3). However, the two closest neighbours of 
Y0001_1 bioserotype 4/O:3 on the Bayesian trees, Y0002_2_1A and Y0202_1A also 
shared this Galleria profile. 
Biovar 1B Y. enterocolitica strain 8081 used as a control strain in the current 
microarray experiment has as its closest neighbour Y. enterocolitica strain Y2 from the 
previous dataset that is also Y. enterocolitica 8081 [531]. 
RAxML and Bayesian phylogenomic reconstruction of the re-analysed microarray data 
for British taxa resulted in the same tree topology as was previously obtained by 
Howard et al [531] (Figure 4.3). 
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Figure 4.3 Phylogenomic reconstruction of the re-analysed microarray data for British taxa 
MrBayes, Howard et al [531] RAxML present study  MrBayes present study 
Mildly 
pathogenic 
Highly 
pathogenic 
Non-
pathogenic 
Mildly 
pathogenic 
Highly 
pathogenic 
Non-
pathogenic 
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4.3.2 Genomic content 
 
       A.    B.    C. 
Figure 4.4 Venn Diagram of core genomic content in Irish and British Y. enterocolitica 
strains 
1B – Highly pathogenic Y. enterocolitica strains: B 2-4 – mildly pathogenic; 1A – non-
pathogenic 
A. Irish and British Y. enterocolitica strains 
B. British Y. enterocolitica strains only 
C. Irish Y. enterocolitica strains only 
Irrespective of their pathogenicity, Irish and British Y. enterocolitica strains share 2791 
genes (68.7% of studied genomes (Figure 4.4 (A)). Non-pathogenic Y. enterocolitica 
strains share an additional 393 genes with highly pathogenic strains only (Figure 4.4 
(A)). Mildly pathogenic strains share only 149 additional genes exclusively with the 
highly pathogenic isolates (Figure 4.4 (A)). Mildly and non-pathogenic strains share 
another 4 genes in addition to the core set of genes (2791 genes) (Figure 4.4 (A)). 
Highly pathogenic “American” strains encode 715 specific genes that are not found 
among mildly and non-pathogenic Y. enterocolitica strains (Figure 4.4 (A)). 
All British Y. enterocolitica strains share 3492 (85.6%) genes (Figure 4.4 (B)), and all 
Irish strains share 2866 (66.2%) genes (Figure 4.4 (C)). British and Irish mildly 
pathogenic Y. enterocolitica strains share respectively 142 and 140 genes with the 
highly pathogenic strains (Figure 4.4 (B, C)). Irish non-pathogenic biovar 1A Y. 
enterocolitica strains share 390 genes with the highly pathogenic strains (Figure 4.4 
(C.)), while British strains shared only 144 genes with the highly pathogenic 
strains(Figure 4.4 (B)). However, the core gene set for the highly pathogenic strains 
compared with the Irish strains is larger than for the highly pathogenic strains 
compared with the GB strains because it comprises Y. enterocolitica 8081 alone, rather 
than a number of highly pathogenic strains as in the case for the GB comparison. 
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Y. enterocolitica subsp. palearctica (mildly and non-pathogenic Y. enterocolitica strains) 
in this study do not share any other specific genes that are not encoded by highly 
pathogenic strains, but this is a function of the geneset used for this experiment (8081-
based). 
 
 
                            A.                                                           B. 
 
                           C.                                                           D. 
Figure 4.5 Venn Diagram of core genomic content in Y. enterocolitica strains 
1B – Highly pathogenic Y. enterocolitica strains: B 2-4 – mildly pathogenic; 1A – non-
pathogenic 
GB – British Y. enterocolitica strains, IRL – Irish Y. enterocolitica strains 
A. Highly pathogenic Y. enterocolitica strains 
B. Mildly pathogenic Y. enterocolitica strains 
C. Non-pathogenic Y. enterocolitica strains 
D. Highly pathogenic Y. enterocolitica strain 8081 analysed in this study (1B IRL) and 
previous study by Howard et al [531] (Y2) 
Highly pathogenic strains analysed by Howard et al [531] and in this study share 4048 
genes, however, Irish strains encode 271 specific genes (Figure 4.5 (A)). Mildly 
pathogenic strains of GB and Irish origin share 2951 genes, however the British strains 
encode more unique genes (711) than the Irish (62 specific genes) (Figure 4.5 (B)). 
British and Irish non-pathogenic biovar 1A Y. enterocolitica strains share 3190 genes, 
additionally British strains encode 459 specific genes and Irish encode only 68 (Figure 
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4.5 (C)). The same Y. enterocolitica strain 8081 hybridized in the current study and as 
previously published by S. Howard et al. [531] studies share 4303 genes but differ by 
24 genes (Figure 4.5 (D)). 
4.4 Discussion 
Phylogenomic reconstruction of the re-analysed British microarray data resulted in the 
same phylogenies between British taxa as in the previous study [531] (Figure 4.3) and 
Y. enterocolitica 8081 strain present in both sets of data emerged adjacent in all trees 
(Figure 4.1 and 4.2), showing reproducibility in data combining hybridisations carried 
out several years apart. 
All Y. enterocolitica strains recovered from domestic animals and humans grouped 
according to their accepted pathogenic potential (mildly pathogenic, highly pathogenic 
and non-pathogenic clades) (Figure 4.1 and 4.2), consistent with previous studies [531, 
692]. Such separation is better supported in MrBayes phylogenetic inference (Figure 
4.2). To achieve better reliability of the RAxML phylogenomic reconstruction (Figure 
4.1), removal of rogue taxa was required (Table 4.4). 
There is no apparent clustering by host (animal or human), or by biotype or serotype 
within the three groups. Although strains did not cluster according to their geographic 
origin within each country, Y. enterocolitica strains recovered in Ireland were distinct 
from Yersinia strains recovered in Great Britain (Figure 4.1 and 4.2). However, such 
separation is better supported by Bayesian phylogenetic inference (Figure 4.2). This 
may indicate a low probability of Yersinia exchange between the UK and Ireland. 
Both RAxML and Bayesian phylogeny of Irish, British and North American Y. 
enterocolitica strains are in agreement with the previous suggestion that highly 
pathogenic biovar 1B strains are more closely related to non-pathogenic biovar 1A than 
to mildly pathogenic Y. enterocolitica strains [531, 692], and support the hypothesis 
that non-pathogenic biovar 1A could be a progenitor of pathogenic Y. enterocolitica 
[692]. According to the genomic content comparison, North American highly 
pathogenic biovar 1B Y. enterocolitica strains are more closely related to Irish and 
British non-pathogenic biovar 1A strains than to mildly pathogenic strains (Figure 4.4 
(A)). It has been previously proposed that highly pathogenic biovar 1B Y. enterocolitica 
subsp. enterocolitica and non-pathogenic biovar 1A Y. enterocolitica subsp. palearctica 
evolved separately from a common ancestor (1A-1B intermediary) due to continental 
drift [531]. 
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Investigation of gene content revealed that pathogenic and non-pathogenic Y. 
enterocolitica strains share from 2790 to 3492 genes depending on the set of strains 
(Figure 4.4 (A, B, C)). The figures previously obtained by microarray hybridisation 
indicated that pathogenic and non-pathogenic Y. enterocolitica strains share only 894 
genes, that is about 20.8% of the Yersinia enterocolitica 8081 genome [531]. However, 
our estimation of the core genome with the same data indicated that British Y. 
enterocolitica strains share 3492 (79%) CDSs (Figure 4.4 (B)). Such discrepancies could 
be due to differences in microarray data analysis between two studies. A log-ratio 
based cut-off algorithm (GACK [668]) was used for calling present and absent CDSs in 
the previous study [531]. This method assumes symmetry, normality and linearity of 
microarray data [670] and when these criteria are not met log-ratio based cut-off 
algorithms are less able to identify the presence/absence/divergence of the genes 
correctly [670-672] than the algorithm used in the present study [673]. Earlier studies 
based on whole genome sequencing indicated that genome sequences of eight non-
pathogenic species from the genus Yersinia share 2497 genes [550], genome sequences 
of Y. pestis, Y. pseudotuberculosis and highly pathogenic Y. enterocolitica subsp. 
enterocolitica strain 8081 share 2747 genes [532], and the core gene set of highly 
pathogenic Y. enterocolitica subsp. enterocolitica strain 8081 and mildly pathogenic 
bioserovar 3/O:9 Y. enterocolitica subsp. palearctica strain 105.1R was estimated at 
3492 genes [550, 693]. These figures are similar to our estimation of the Y. 
enterocolitica core genome using a different microarray data analysis methodology 
(single colour microarray data normalization in LIMMA with weak flagging and BCSP 
cut-off algorithm). 
These results confirmed that microarray technology in combination with phylogenetic 
analysis is a sensitive and robust method for studying genetic relatedness of Y. 
enterocolitica. 
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Chapter 5 General Discussion and 
Conclusions
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5.1 Literature review 
The genus Yersinia belongs to the family Enterobacteriaceae and comprises 18 species 
[1-7] three of which are pathogenic for humans (Y. pestis, Y. pseudotuberculosis and Y. 
enterocolitica). Currently six biovars of Y. enterocolitica (Table 1.4) [133] and four 
biovars of Y. pseudotuberculosis (Table 1.5) [134] are recognised. In general, the 
biotype of Y. enterocolitica [133] and Y. pseudotuberculosis [135-137] correlates with 
the pathogenic potential of the microorganism. 
Pathogenic biovars of Y. pseudotuberculosis and Y. enterocolitica are predominant 
causes of an acute or chronic enteric zoonosis known as yersiniosis. However, various 
extraintestinal manifestations may also occur predominantly in patients with the 
underlying conditions (described in Chapter 1). Patients with persistent enteric 
Yersinia infection [228, 262, 263] and possessing the histocompatibility gene HLA-B27 
[264-267] are at particular risk of developing post-infectious sequelae [204, 268-271]. 
Transient bacteraemia in healthy blood donors after previous unnoticed yersiniosis 
[165, 166, 170, 172, 173, 234, 247-253] is a major cause of fatal blood transfusion 
septicaemia [246, 247]. 
The highest incidence rates of yersiniosis ranging from 5.0 to 12.03 per 100,000 of 
population are reported from Northern and Central European countries [12]. In Ireland 
over the past few years, the annual incidence rate of notified yersiniosis has been the 
lowest in the European Union, and does not exceed 10 cases per year (≤0.1 per 100,000 
population) [12]. Nevertheless, the anti-Yersinia antibody seroprevalence among 
healthy individuals is generally much higher than incidence rates of yersiniosis in the 
same population (Table 1.10) [76, 162-164]. 
Most cases of yersiniosis are sporadic [14-17] but outbreaks of Y. pseudotuberculosis 
[18, 19] and Y. enterocolitica [20-29] involving food have been reported worldwide 
(Table 1.1). The main risk factors of yersiniosis include consumption of contaminated 
pig products [16, 21, 22, 28, 63-67], contact with domestic animals [13, 14, 53, 73] and 
drinking untreated water [13, 16, 65, 75-77]. 
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5.2 Current evidence for human yersiniosis in Ireland 
Despite the high prevalence of pathogenic Y. enterocolitica among pigs in Irish 
slaughter houses it seems these organisms do not enter the food chain at levels that are 
harmful to the local population as no pathogenic Yersinia were isolated from 
symptomatic patients with diarrhoea, appendicitis or pharyngitis. The number of 
negative faeces cultures excludes a true yield of 0.5 % or more of diarrhoeal stools 
containing Y. enterocolitica in our study population with 99% power, suggesting Y. 
enterocolitica is indeed a much less common cause of diarrhoea in Ireland than in other 
European countries. This is consistent with the very low current notification rates of 
clinical yersiniosis in Ireland. PCR targets for pathogenic Y. enterocolitica 
(chromosomal ystA and plasmid-located yadA) were detected in pig slurry and not in 
human sewage by simple PCR. Nested PCR was required to detect yadA in human 
sewage, consistent with a low level of intestinal excretion of pathogenic Y. 
enterocolitica in humans locally compared with pigs. 
However, the detection of anti-Yop antibodies in 25% of Irish blood donors suggests 
occurrence of recent or past Yersinia infection in the Irish human population at levels 
similar to that found in countries where clinical yersiniosis is currently much more 
common [162, 164]. Anti-Yersinia seropositivity in blood donors is a risk factor for 
transfusion-transmitted Yersinia sepsis [173, 248-250, 252, 253, 694], but there have 
been no reports of Yersinia sepsis following blood transfusion in Ireland. There was a 
significant association between increasing age and the presence of anti-Yersinia Yop 
antibodies, compatible with a cohort effect of increased risk of infection with 
pathogenic Yersinia in Ireland. The most probable explanation linking absence of 
culturable Y. enterocolitica, with a high seroprevalence of anti-Yersinia Yop antibodies 
in older blood donors, and some molecular evidence of the presence of pathogenic Y. 
enterocolitica in human sewage, is a combination of a higher incidence of yersiniosis in 
Ireland in the past (caused by both Y. pseudotuberculosis and Y. enterocolitica) and a 
continuing low incidence of mild self-limited Y. enterocolitica infection which does not 
result in diarrhoea specimens being sent for culture. A much larger prospective study 
on patients with mild diarrhoea in the community is required to confirm a continuing 
low incidence of mild self-limiting yersiniosis in Ireland. However, in the absence of a 
major disease burden, such a study would be difficult to justify. Nevertheless, the 
presence of pathogenic bioserotypes of Y. enterocolitica in the local pig population 
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means that there is a potential for future food-borne outbreaks of yersiniosis to occur 
in Ireland. 
5.3 Yersinia insect toxicity 
The prevalence of non-pathogenic Y. enterocolitica in isolates from humans (described 
Chapter 3) and retail meat samples (described Chapter 3) in Ireland prompted 
investigation of their pathogenic potential. 
Invertebrates and vertebrates share structural and functional homology of their 
immune responses and insects have been suggested as a model for studying microbial 
pathogenicity [586-589]. Moreover, a good correlation between virulence of Y. 
pseudotuberculosis has been obtained in mammalian and G. mellonella infection models 
[600]. To demonstrate potential pathogenicity of non-pathogenic Y. enterocolitica we 
compared their virulence towards G. mellonella larvae with that of highly and mildly 
pathogenic Y. enterocolitica strains. This comparison has not been previously reported. 
Virulence of Y. enterocolitica in G. mellonella larvae observed at 37°C did not correlate 
with their pathogenic potential towards humans. Irrespective of their pathogenic 
potential for mammalian hosts, all tested Yersinia strains caused fast killing (<24h) of 
Galleria at 37°C and slow killing (≥48h) at 15°C. For most Yersinia strains, slow killing 
at 15°C accounted for the highest mortality rates among insect larvae. 
In general, irrespective of the presence of a recognised ITC locus, non-pathogenic Y. 
enterocolitica strains that encoded CDT type A (nearly all grouped into hierarchical 
cluster 2) were more virulent towards insect larvae at 37°C than all other Y. 
enterocolitica (Table 3.19, Table 3.23, Table 3.24, Figure 3.8). While distinctive CDT 
complexes are encoded by mildly and non-pathogenic Y. enterocolitica strains (see 
Chapter 3) the expression of cdtB2 and cdtB3 (i.e. representative component genes for 
all the CDT loci identified in chapter 3) (Figure 3.6, 3.7) was equally evident at both 
temperatures in vitro, suggesting that CDT toxins are candidates for causing both forms 
of insect larvae killing. However, biological activity of these toxins is greatly dependent 
on their binding affinity to the surfaces of eukaryotic cells [628] and this may explain 
why other Yersinia strains that also encode CDT did not cause the same mortality rates 
of G. mellonella larvae. 
High mortality rates of G. mellonella larvae at 15°C could be associated with the 
preferential expression of the insecticidal toxins at low temperatures[555] however the 
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current study as well as a previous publication [585] did not establish a distinctive link 
between the presence of ITC genes and subcutaneous toxicity of Y. enterocolitica strains 
in G. mellonella larvae. So other factors could be involved. Interestingly, other 
psychrotrophic bacteria Bacillus weihenstephanensis [624] and Listeria innocua [611] 
that do not share recognised pathogenicity factors also cause increased mortality at 
lower temperatures in a Galleria model. Thus, in the absence of recognised shared 
pathogenicity factors between these different bacteria, enhanced bacterial replication 
at lower temperatures may be important for this phenotype. 
Different physiology of the insect host at 15°C and 37°C could also affect outcome of 
Yersinia infection in G. mellonella larvae. Thus, pre-incubation of G. mellonella larvae at 
37°C (and 4°C) results in a stress response including an increase in haemocyte density 
and antimicrobial peptide synthesis which reduces their mortality in subsequent 
Candida albicans infection compared to when pre-incubated at 30°C (Table 3.4) [590]. 
Further studies are required to establish the activity of Yersinia CDT toxins against 
insect cells as well as human epithelial and immune cells. Additionally, knockout of CDT 
type A loci would be required to confirm whether death of G. mellonella larvae is due to 
its activity. Slow killing of insect larvae at 15°C could be a result of enhanced Y. 
enterocolitica replication at low temperatures. Thus, future experiments are required to 
establish whether a pre-formed Yersinia toxin was responsible for either the rapid 
(37°C) killing or slow (15°C) killing of G. mellonella larvae by Yersinia. This could be 
achieved by injecting Galleria with killed Y. enterocolitica strains or protein extracts 
from bacteria grown at different temperatures. Measuring haemocyte density and 
antimicrobial peptide levels would be required to elucidate the effect of these factors 
on Yersinia-induced Galleria mortality. 
5.4 Comparative genomics 
Genomic microarray proved to be a reliable methodology for studying genomic 
relationships between Yersinia. Comparative microarray analysis of Y. enterocolitica 
strains recovered in Ireland and previously analysed microarray data of strains from 
Great Britain and North America (highly pathogenic strains only) established that all 
strains grouped mainly according to their pathogenic potential, not the host. Despite 
extensive human, animal and food exchanges between the UK and Ireland [684], Irish 
and British strains clustered separately from each other within the groupings by 
pathogenic phenotype. Comparison of their genetic content also confirmed that these 
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strains differ in core genetic content (Figure 4.5). Because these strains were not 
collected at the same time in the two countries, and possibly because the hybridisations 
of UK and Irish strains were to different array types (although renormalised and called 
in the same way), this does not rule out horizontal exchange of Y. enterocolitica 
between the two countries. 
Phylogenomic reconstruction agrees with earlier established evolutionary 
relationships among Y. enterocolitica strains [531, 692]. Consequently, phylogeny of 
Irish, British and North American Y. enterocolitica strains implies that Y. enterocolitica 
subsp. enterocolitica evolved separately from Y. enterocolitica subsp. palearctica and 
non-pathogenic Y. enterocolitica is a possible progenitor for pathogenic Y. 
enterocolitica.  
Twenty two strains that were compared in a G. mellonella death assay (Chapter 3) were 
also used for comparative genomic microarray phylogenomic reconstruction. However, 
the grouping of these strains by hierarchical clustering of their phenotype in causing 
Galleria mortality at different incubation temperatures and their phylogenetic grouping 
based on gene content is different. This may indicate that insecticidal pathogenicity 
factors in Y. enterocolitica are phylogenetically widely distributed. 
5.5 Concluding remarks 
Although, Yersinia selective culture results exclude 0.5% prevalence of pathogenic 
Yersinia in diarrhoeal stool samples and 2% prevalence in throat swabs from patients 
with pharyngitis, high anti-Yersinia seroprevalences in Irish blood donors and presence 
of molecular markers for pathogenic Yersinia in human sewage suggest prevalence of 
mild self-limiting forms of yersiniosis in Ireland that do not result in submission of 
stool samples for culture. 
Virulence of Y. enterocolitica in G. mellonella larvae observed at 37°C did not correlate 
with their pathogenic potential towards humans. Non-pathogenic Y. enterocolitica 
strains that encoded CDT type A were the most virulent towards insect larvae at 37°C 
in comparison to other Y. enterocolitica strains. However, at 15°C all Yersinia strains 
were equally highly virulent towards insect larvae possibly due to unobstructed 
bacterial proliferation in insect host. Future experiments are required to establish CDT 
activity in mammalian and insect cell cultures and whether a pre-formed Yersinia toxin 
was responsible for either the rapid (37°C) or slow (15°C) killing of G. mellonella larvae 
by Yersinia. 
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Although, comparative microarray analysis of clinical and non-clinical Y. enterocolitica 
strains isolated in Ireland and Great Britain did not show evidence for direct transfer of 
Yersinia between two countries, such exchange can not be excluded as analysed strains 
are not contemporaneous. 
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